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 1 ABBREVIATIONS 
 
4E-BP   4E binding protein 
aa-tRNA  amino-acylated-transfer-RNA 
ADP   adenosine diphosphate 
Aer   aerotaxis sensor receptor  
AhR   aryl hydrocarbon receptor 
AKT   RAC serine/threonine-protein kinase, Protein kinase B (PKB)  
AMPK   AMP-activated kinase 
AMP   adenosine monophosphate 
ANTH   AP180 N-terminal homology 
AP   adaptor/assembly protein 
ARNT   aryl hydrocarbon receptor nuclear translocator  
ATP   adenosine triphosphate 
bHLH   basic helix– loop–helix DNA-binding domain  
CAF20   Cap-associated factor 20  
CoA   coenzyme A 
CREB   cAMP response element binding protein  
DAG   diacylglycerol  
DOG   dioctanoylglycerol  
EEA1   early endosome autoantigen 1 
eEF   eukaryotic translation elongation factor  
EGFP   enhanced green fluorescent protein 
eIF   eukaryotic translation initiation factor  
ENTH   epsin N-terminal homology 
ERK   extracellular signal-regulated kinase 
ESCRT  endosomal sorting complex required for transport 
FAPP   Feto-Acinar Pancreatic Protein 
FAS   fatty acid synthase 
FMN   flavin mononucleotide 
GLUT   glucose transporter  
Gsy   glycogen synthase  
GDP   guanosine diphosphate  
GSK   glycogen synthase kinase 
GST   glutathione-S-transferase  
GTP   guanosine trisphosphate  
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 HERG   human eag-related gene  
HFD   high fat diet 
HIF   hypoxia-inducible factor  
INS   insulin 
IP3   inositol trisphosphate  
IR   insulin receptor  
IRS   insulin receptor substrate 
Kif   kinesin family 
LPS   lipopolysaccharides 
MAPK   mitogen-activated protein kinase  
MEF   mouse embryonic fibroblast 
MIN6   mouse insulinoma cell line  
mTOR(C)  mammalian target of rapamycin (complex) 
mRNA   messenger RNA 
NADPH  Nicotinamide adenine dinucleotide phosphate 
NCD   normal chow diet 
NPAS   neuronal PAS protein  
NMR   nuclear magnetic resonance  
NOXO1  NADPH oxidase organizer 1 
P   phosphate 
PA   phosphatidic acid  
PARP   Poly (ADP-ribose) polymerase  
PAS   PER/ARNT/SIM  
PC   phosphatidylcholine  
PDK-1   phosphatidylinositol phosphate-dependent kinase-1  
PDX-1   pancreatic duodenal homeobox-1 transcription factor-1  
PE   phosphatidylethanolamine  
PER   Drosophila period clock protein  
PGC   Peroxisome proliferator-activated receptor gamma coactivator 
PH   pleckstrin homology (domain) 
PHOT   phototrophin 
PI(P)   phosphatidylinositol (phosphate) 
PI3K   phosphatidylinositol 3-kinase  
PIKfyve  phosphoinositide kinase, FYVE finger containing 
PKA   protein kinase A  
PLC/D   phospholipase C/D  
PKC   protein kinase C  
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 PS   phosphatidylserine  
PtdIns   phosphatidylinositol 
PTEN   phosphatase and tensin homolog 
PYP   photoactive yellow protein  
RNA   ribonucleic acid 
S   sphingomyelin  
S6K   p70 S6 kinase 
SIM   Drosophila single-minded protein  
Sds22   protein phosphatase, regulatory subunit 7  
SNARE  soluble N-ethylmaleimide-sensitive-factor attachment receptor 
Snf1   sucrose non-fermenting 1 protein kinase  
TIAM1  T-cell lymphoma invasion and metastasis 1 
Tif11   translation initiation factor 1A  
Tirap   toll-interleukin 1 receptor domain containing adaptor protein 
TOP   terminal oligopyrimidine 
TSC   tuberous sclerosis complex 
Ugp   UDP-glucose pyrophosphorylase  
Vam7   vacuolar morphogenesis protein 7 
VPS   vacuolar protein sorting 
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 2 ZUSAMMENFASSUNG 
 
PER-ARNT-SIM (PAS) Domänen sind in Organismen verbreitet. In Bakterien und Archaeen 
fungieren sie hauptsächlich als sensorische Module für eine Vielzahl von Umwelteinflüssen. 
Dies geschieht entweder direkt durch Binden des zu detektierenden Liganden oder indirekt 
unter Verwendung eines Kofaktors. Dabei induziert die Detektion Veränderungen in der 
Konformation der PAS-Domäne, welche das Signal zu einer Effektordomäne, häufig einer 
Kinase, weiterleitet. In Eukaryoten, insbesondere in basic helix-loop-helix 
Transkriptionsfaktoren, ermöglichen PAS-Domänen oftmals das Dimerisieren zweier 
Proteine. Das PASKIN-Protein besitzt die für Eukaryoten einzigartige Kombination einer 
PAS-Domäne und einer Serin/Threonin Kinase und ist von der Hefe bis zum Menschen 
konserviert. Für die PAS-Domäne von PASKIN wurde ein Modell propagiert, gemäss 
welchem ein unbekannter metabolischer Ligand detektiert wird, worauf die Kinasefunktion 
aktiviert wird. Erste Hinweise für die Kinasefunktion stammen aus der Hefe, wo PASKIN 
Proteine aus dem Glycogenmetabolismus und der Proteintranslation phosphorylieren kann. In 
Säugern wurden bislang zwei durch PASKIN phosphorylierte Proteine aus dem 
Metabolismus entdeckt. Das Erste, wie in der Hefe, ist die Glykogensynthase, und das zweite 
ist das pankreatische und duodenale Homeobox Protein 1 (PDX-1), ein wichtiger 
Transkriptionsfaktor für die Insulinexpression. Entsprechend wurde publiziert, dass PASKIN 
in β-Zellen des Pankreas durch Glukose induziert werden kann. Dies führt zu einer erhöhten 
Insulinexpression und sekundär zu gesteigerter Insulinsekretion. Neueste Erkentnisse haben 
auch eine inhibitorische Funktion von PASKIN in der Glukagonsekretion aufgezeigt. 
Aufgrund all dessen wird angenommen, dass PASKIN nicht nur den Energiehaushalt der 
Hefe reguliert, sondern auch den von höheren Lebewesen. Des Weiteren wurde auch die 
Homöostase auf der Ebene des Gesamtorganismus untersucht, wobei unsere Paskin-/- Mäuse 
verwendet wurden. Nach Fütterung einer Hochfettdiät waren Paskin-/- Männchen vor 
nachteiligen Erscheinungen des metabolischen Syndroms teilweise geschützt. So zeigten sie 
ein reduziertes Körpergewicht und bessere Glukose- und Insulintoleranz auf als Wildtyptiere 
und hatten einen hypermetabolischen Phänotyp in Messungen der indirekten Kalorimetrie. In 
dieser Arbeit hatten wir uns zum Ziel gesetzt, diesen Phänotypen zu reproduzieren. 
Tatsächlich führte die Fütterung einer Hochfettdiät (45% kalorisches Fett) zu reduziertem 
Körpergewicht und besserer Glukosetoleranz. Mit der Fütterung einer Hochfettdiät mit 60% 
kalorischem Fett konnten wir diese Effekte jedoch nicht verstärken. Auch die indirekte 
Kalorimetrie und Messungen der Körpertemperatur bestätigten den hyperetabolischen 
Phänotyp nicht. Wir glauben deshalb, dass PASKIN eine sehr subtile Rolle in der 
Regulierung des Energiehaushaltes spielt, welche von kleinen Unterschieden in der 
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 Tierhaltung, der Nahrung oder dem Alter beeinflusst wird. Aufgrund dessen haben wir uns 
vermehrt auf die Beantwortung von molekularen und zellulären Fragen konzentriert: 1) Was 
ist die Substratspezifität für die PASKIN-Phosphorylierung und was könnten neue 
Zielproteine im Metabolismus und der Proteintranslation sein? 2) Was könnte der 
aktivierende Ligand für die PAS-Domäne von PASKIN sein? In dieser Arbeit zeigen wir auf, 
dass der eukaryotische Elongationsfaktor 1A1 nicht nur ein Interaktionspartner von PASKIN 
ist, sondern auch phosphoryliert werden kann und damit die Translation in vitro verbessert. 
Um weitere von PASKIN phosphorylierbare Proteine zu entdecken, haben wir ausserdem 
einen Peptidchip verwendet. Wir bestimmten die Substratspezifität, welche derer der 
Proteinkinasen A und C sehr ähnlich ist, und entdeckten neue metabolische Zielproteine. Wir 
konnten ausserdem zeigen, dass PASKIN das ribosomale Protein S6 an den Serinen 235/236 
phosphoryliert. Normalerweise wird S6 von p70 S6-Kinasen phosphoryliert. Deshalb gilt 
diese Phosphorylierung als Indikator für die Aktivität des mTOR-Signaltransduktionswegs 
und zeigt sich vorwiegend in proliferierenden Zellen. Beim Vergleich von Fibroblasten aus 
Mäuseembryonen von Paskin-/- und Paskin+/+ Mäusen konnten wir jedoch keine Unterschiede 
in der Proteintranslation, Zellgrösse oder dem Zellwachstum feststellen. Die Proteinkinase C 
weist nicht nur dieselbe Substratspezifität wie PASKIN auf, sondern phosphoryliert den 
eukaryotischen Elongationsfaktor 1A1 an genau demselben Threonin wie PASKIN. Deshalb 
stellten wir uns die Frage, ob PASKIN analog zu der Proteinkinase C, auch Phospholipide als 
Koaktivatoren benötigt. Tatsächlich fanden wir heraus, dass PASKIN an 
Phosphatidylinositolmonophosphate bindet, allerdings nicht wie erwartet über die PAS-
Domäne, sondern via Kinasedomäne. Daraufhin untersuchten wir den Einfluss von 
Phosphatidylinositolphosphaten auf die Autophosphorylierung und die Phosphorylierung von 
Zielproteinen von PASKIN. Interessanterweise induzierten monophosphorylierte 
Phosphatidylinositole die Autophosphorylierung von PASKIN, wohingegen di- und 
triphosphorylierte Phosphatidylinositole die Autophosphorylierung inhibierten. Hingegen 
inhibierten alle getesteten Phosphatidylinositolphosphate die Phosphorylierung von 
Zielproteinen. Da wir ausserdem entdeckten, dass PASKIN entweder an der Zellmembran 
oder entlang des Aktinskeletts lokalisiert ist, nehmen wir an, dass PASKIN am 
Vesikeltransport oder dem Umbau des Zytoskeletts beteiligt sein könnte, und dabei durch die 
Bindung an Phospholipide reguliert wird. 
Abschliessend konnten wir aufzeigen, dass PASKIN durch die Phosphorylierung des 
Elongationsfaktors 1A1 und des ribosomalen Proteins S6 die Proteintranslation in höheren 
Lebewesen regulieren kann. Die Bindung an Phosphatidylinositolphosphate eröffnet 
ausserdem neue Perspektiven und könnte Erklärungen für den metabolischen Phänotyp 
liefern, so zum Beispiel über die Regulation der Glukagonsekretion oder der Exozytose von 
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 GLUT4 im Muskel. Weitere Befunde über die Expression oder Aktivierung von PASKIN 
würden mit Sicherheit das generelle Verständnis verbessern, wie PASKIN mechanistisch als 
Sensor des Energiehaushaltes agieren könnte. 
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 3 SUMMARY 
 
PER-ARNT-SIM (PAS) domains are occurring throughout all kingdoms of life. Bacterial and 
archaeal PAS domains mainly act as sensory modules of a variety of environmental stimuli 
either directly by binding a ligand to be sensed or indirectly involving co-factors. Sensing 
induces conformational changes of the PAS domain that are transduced to effector domains, 
which are often kinases. In other cases, especially in eukaryotic basic helix-loop-helix 
transcription factors, PAS domains can act as dimerisation interfaces. PASKIN is conserved 
from yeast to man and displays the unique combination for eukaryotic proteins of a Per-Arnt-
Sim (PAS) domain and a Ser/Thr kinase function. For the PAS domain of PASKIN, a model 
proposed sensing and binding of a yet unknown metabolic ligand that might activate the 
kinase domain. For the kinase function, a number of proteins involved in glycogen 
metabolism and protein synthesis were identified as phosphorylation targets in yeast. For 
mammalian PASKIN, two targets involved in metabolism have been identified. The first 
target, similar to yeast, is mammalian glycogen synthase, and the second target is pancreatic 
and duodenal homeobox protein 1 (PDX-1), an important transcription factor for insulin 
expression. Accordingly, it has been reported that PASKIN levels are induced in pancreatic β-
cells upon glucose stimulation, itself induces insulin expression and secondarily affects 
insulin secretion. Recent findings also reported an inhibitory function of PASKIN in glucagon 
secretion, suggesting that PASKIN might regulate energy homeostasis not only in yeast, but 
in mammals as well. Furthermore, whole body homeostasis has been investigated making use 
of our Paskin-/- mouse model. It has been shown that male Paskin-/- mice when fed a high fat 
diet (HFD) were protected from detrimental effects of the metabolic syndrome. Paskin-/- male 
mice displayed a lower body weight and a better glucose and insulin tolerance than wildtype 
littermates and showed a hypermetabolic phenotype in indirect calorimetry experiments. 
Using a similar approach, we herein aimed to reproduce the hypermetabolic phenotype on 
HFD feeding. Whereas we could see a lower gain of body weight for Paskin-/- animals and a 
better glucose tolerance after 45% fat by calories HFD feeding, we could not increase the 
effects upon feeding a 60% HFD and failed to see any difference in indirect calorimetry or 
body temperature. We therefore speculate that PASKIN might play a more subtle role in 
energy homeostasis that might be affected by housing, diet or age of the animals. We 
therefore focused on the molecular and cellular level aiming to answer the following 
questions: 1) What is the substrate specificity and what might be potential targets of 
metabolism and protein translation for the PASKIN kinase function? 2) What could be the 
potentially activating ligand for the PAS domain of PASKIN? Herein, we show that the 
human eukaryotic translation elongation factor 1A1 is a novel interaction partner and kinase 
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 target of PASKIN and is able to increase total translation in vitro. To screen for other putative 
PASKIN phosphorylation targets, we assessed the kinase function on a target peptide 
microarray. We found a substrate specificity similar to the consensus sequences of protein 
kinase A (PKA) and C (PKC) and identified new metabolic targets. We further identified 
phosphorylation of ribosomal protein S6 at serines 235/236. Phosphorylation of S6 usually 
originates from p70 S6 kinases and is a marker for mTOR activity, and therefore often 
occurring in proliferating cells. However, comparing Paskin-/- versus Paskin+/+ MEFs we 
could not observe any differences in total translation, cell size or cell growth. Since PKC is 
known to phosphorylate eEF1A1 at the same site as PASKIN and shows a similar substrate 
preference, we wondered wether PASKIN also requires similar phospholipid co-activators as 
PKC. Indeed, we found that PASKIN binds phosphatidylinositol monophosphates, but not as 
we assumed to the PAS domain but to the kinase domain. We also investigated the effects of 
phosphatidylinositol phosphates both on auto- as well as on target phosphorylation in vitro. 
Interestingly, while auto-phosphorylation is induced by the presence of phosphatidylinositol 
monophosphates and reduced by di- and tri-phosphorylated phosphatidylinositides, target 
phosphorylation is reduced by the presence of all phosphatidylinositides tested. Since we 
found that PASKIN mainly localises along the cytoskeleton, either at the cell membrane or 
along stess fibers, this suggests that PASKIN might be involved in vesicular transport or 
cytoskeletal dynamics and its activity might be regulated accordingly dependent on 
phospholipid binding. 
Conclusively, the identification of eEF1A1 and S6 as novel mammalian phosphorylation 
targets confirmed a role for PASKIN in the regulation of protein translation. The observation 
that PASKIN can bind phosphatidylinositides opens novel perspectives for future research as 
well, and might be connected to a metabolic phenotype by interfering with glucagon granule 
secretion or GLUT4 exocytosis. Further experiments to find conditions upregulating PASKIN 
and the identification of an activating ligand would certainly help to understand the general 
mechanistics of PASKIN as a sensor of energy homeostasis. 
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 4  INTRODUCTION 
 
4.1 Per-ARNT-Sim (PAS) domains 
As cells have to adapt to a dynamic environment, nature evolved sophisticated systems to 
sense environmental changes. To adapt to new conditions, sensors activate intracellular 
signaling cascades and allow a cell to adjust to the altered environment. A major class of 
sensors is represented by Per-ARNT-Sim (PAS) domains. They are named after three 
domains of homologous primary sequence (1). These basic helix-loop-helix (bHLH) proteins 
are the Drosophila protein period (per), a component of the circadian clock (2), the aryl 
hydrocarbon receptor nuclear transporter (ARNT), a transcription factor dimerising with the 
aryl hydrocarbon receptor (AHR) (3) or hypoxia-inducible factor α-subunits (HIFα) (4), and 
single-minded (sim), a protein involved in neurogenesis related to Down syndrome (5). Since 
the discovery of a common domain structure, many additional PAS proteins added up to the 
list, deriving from all kingdoms of life. Currently, the Pfam database includes more than 
33.000 PAS domain annotations (version 24.0, October 2010) (6). 
Structurally, the PAS fold comprises a central five stranded β-sheet flanked by several α-
helices, forming a structure resembling a baseball glove with, in some cases, a ligand or 
cofactor bound to the center (Fig.1). They often occur as tandem PAS repeats of 70-130 
amino acids in a stretch of ~275 residues and are termed PAS A and PAS B (7). Functionally, 
PAS domains either serve as dimerisation interfaces or act as sensors for various stimuli. In 
eukaryotic systems, bHLH-PAS transcription factors are the most studied PAS domain 
containing proteins. For example the HIF-system needs protein-protein interaction of a HIFα 
and ARNT subunit to form a functional bHLH-transcription factor that induces target gene 
expression and allows the cell to adapt to the hypoxic environment (8). 
PAS-domains, however, also serve as sensory modules. Sensory PAS-domains induce 
conformational changes that alter the activity of transmitter domains. These changes are 
induced by the agent to be sensed and activate other domains of the protein such as histidine 
kinases, serine/threonine kinases, ion transporters or transcription factors (9). For the aryl 
hydrocarbon receptor, also known as dioxin receptor, the ligand to be sensed can bind directly 
to the PAS domain (3), but many cases involve co-factors. NPAS2 is a bHLH transcription 
factor that requires a heme co-factor to sense its ligand, carbon monoxide (10). CO acts as a 
neurotransmitter in the forebrain and is inhibitory to NPAS2 transcription factor function 
(11). A fascinating example for another co-factor containing PAS domain linked to a kinase 
function is represented by plant phototrophins (phot). Blue light for plant phototropism is 
sensed by a flavin mononucleotide (FMN) co-factor in the PAS domains (12). Blue light 
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 induces covalent linkage of FMN to a cysteine residue, and conformational changes activate 
the serine/threonine kinase domain (13). Other sensors include the mammalian voltage gated 
potassium channel HERG with a PAS domain that is able to sense membrane potentials (14), 
or the flavoprotein Aer of Eschrichia coli that senses changes in redox potential (15). 
Whereas in prokaryotes and archaea many PAS domains are linked to kinase domains, mostly 
histidine kinases, PAS kinase or PASKIN is the only mammalian representative linking a 
PAS fold to a serine/threonine kinase domain. 
 
 
Fig. 1. Structures of various PAS domains. (A) PAS domain heterodimerization between HIF-2α and 
ARNT/HIFβ. (B) Structural similarity between various PAS domains. Structures are based on the 
following Protein Data Bank coordinates: HADDOCK structure of HIF-2α:ARNT/HIFβ heterodimer 
(2A24) (16);NMR structure of ARNT/HIFβ (1X0O) (16) and PASKIN (1LL8) (17); Structure of HERG 
(1BYW) (14) and FixL including the heme group (1D06) (18). 
 
 
4.2 Human PASKIN, a PAS domain containing Ser/Thr kinase 
FixL is an oxygen sensor of nitrogen fixating Bradyrhizobium and Rhizobium species, the 
bacteria living in symbiosis with Fabaceae in root nodules. In the FixL PAS domain, oxygen 
can bind to ferrous iron within a heme moiety in the center of the PAS domain. Binding 
inactivates the histidine kinase function of FixL and thereby interrupts downstream signaling 
that would lead to transcription of genes required for nitrogen fixation (19). Performing a 
blast search of the PAS domain, our group found an uncharacterised protein showing 
relatively high similarity to the PAS domain of FixL (20). Similarity searches of the 
uncharacterised mammalian protein suggested a serine/threonine kinase domain linked C-
terminally to the PAS domain. This protein with a PAS and a kinase domain was therefore 
called PASKIN. At the same time, the group of Steven McKnight identified PASKIN by 
similar blasting procedures, naming it PASK (21). Due to the fact that the name PASK is 
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 already used for proline- and alanine-rich Ste20 related kinase (22), the name PASKIN will 
be used throughout this text. 
 
4.2.1 PASKIN gene structure 
PASKIN is encoded by a single copy gene that is conserved throughout mammalian species. 
The human PASKIN gene is located on chromosome 2 and consists of 18 exons coding for a 
protein of 144 kDa (20). Interestingly, only 1 kb upstream of the first exon of PASKIN, the 
gene for protein phosphatase 1, regulatory subunit 7 (PPP1R7) encodes a protein named 
Sds22 (20).  
A similar intron/exon structure as for the human PASKIN gene was found for the mouse gene 
(20). To investigate PASKIN expression, a Paskin knockout mouse was generated by 
replacing exon 10-14 with a β-geo cassette, expressing β-galactosidase as a reporter (23). 
Paskin-/- mice showed no difference in viability, fertility, growth or behaviour. Analysis of 
Paskin expression in different organs in human (20) and mouse (23) tissues by Northern 
blotting revealed a high expression of Paskin in the testis and lower expression in brain and 
thymus, whereas general expression of the gene seemed to ubiquitous at very low levels. The 
Northern blot data were confirmed later on by quantitative real time PCR, adding bone 
marrow to the list of Paskin expressing tissues (24). 
 
4.2.2 The PAS domain of PASKIN 
At its N-terminus, PASKIN contains two PAS domains named PAS A and PAS B. The PAS 
A domain of PASKIN exhibits a typical PAS fold with a five-stranded β-sheet flanked by 
several α-helices (Fig. 1), as demonstrated by NMR methods (17). However, despite the 
structural relation, we found heme bound to FixL but not to PASKIN (unpublished data), and 
there is ample evidence to rule out a role for PASKIN in direct oxygen-sensing in mammals. 
Nevertheless, the Gardner Lab identified synthetic ligands that bind to PAS A of PASKIN, 
implying that there might exist yet unidentified endogenous ligands (17). 
Functionally, the PAS-domain of PASKIN seems to inhibit the kinase function as the 
catalytic activity of a N-terminal deletion of the PAS domain increased PASKIN activity by a 
factor of five (21,17). Additionally, by adding increasing amounts of purified PAS A domain, 
kinase activity was decreased in trans (17). Derived from the structural analysis of the PAS 
domain, it could be shown that residues in the flexible FG-loop were responsible for kinase 
binding (17). Altogether, these results combined to a model where in unbound state the PAS 
domain was inhibitory to the kinase function, whereas binding of a ligand would induce 
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 conformational changes in the PAS fold leading to de-repression of the kinase domain and 
allow transmission of the sensory signal (Fig. 2). 
 
 
Fig. 2. Activation of PASKIN by binding of a small organic ligand. The flexible FG-loop of the PAS 
domain of PASKIN binds the kinase domain, inhibiting the kinase in cis. Upon ligand binding, 
conformational changes are induced and binding is lost leading to de-repression the kinase domain 
(17). 
 
 
4.2.3 The kinase domain of PASKIN 
PASKIN belongs to the family of serine/threonine kinases and is a member of the CamK 
superfamily (25). Very recently, the crystal structure of the kinase domain of human PASKIN 
has been solved (PDB: 3dls) (26). It shows a typical two-lobe fold with an N-terminal five 
stranded β-sheet and a C-terminal α-helical domain (Fig.3). Many kinases are regulated 
through phosphorylation of an activation loop (27). This loop is thought to stabilise an active 
conformation by forming hydrogen bonds with both the N-terminal β-sheet and the C-
terminal α-helical domains when phosphorylated. PASKIN indeed shows such an activation 
loop structure (26). An earlier report identified two autophosphorylation sites at T1161 and 
T1165 (21), leading to the hypothesis that these residues might be critical for activation loop 
functionality. However, functional assays along with the three dimensional structure do not 
attribute functionality to this autophosphorlyation, as T1161A mutant PASKIN 
phosphorylates targets in vitro to the same extent as wildtype PASKIN (26). Another function 
of the activation loop is its involvement in substrate binding and catalysis. In the activation 
loop of PASKIN, a conserved catalytic arginine (R1127) precedes a conserved aspartate 
(D1128) residue. This feature classifies PASKIN as a RD kinase. Typically, a (auto-) 
phosphorylated moiety of the activation loop directly interacts with this conserved RD motif 
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 to stabilise the active conformation (27). In PASKIN, however, the structure and noncovalent 
binding partners of the RD-residues support a phosphorylation-independent stabilisation (26). 
 
 
 
 
 
 
 
Fig. 3. Kinase domain of PASKIN. The X-ray 
structure of the kinase domain of PASKIN co-
crystallised with ADP (PDB: 3dls) shows a 
typical fold with a β-sheet and a C-terminal 
α-helical domain and comprises two Mg2+ 
ions. The RD-motif is located in the loop 
between β6 and β7. The auto-
phosphorylation sites T1161 and T1165 are 
located on the αE helix. (26) 
 
The structure of PASKIN confirmed the previously suggested presence of an ATP binding 
site comprising T1032. This residue is also involved in binding of one of two Mg2+ ions 
present in the kinase domain (26). To determine the substrate specificity, a combinatorial 
peptide library screen was performed that suggested a substrate specificity relative to the 
phosphorylatable serine or threonine as follows: -5 position: histidine or arginine, -3 position 
arginine and -2 histidine, arginine or lysine (26). For in vivo situations, however, not many 
direct PASKIN kinase targets have been published. First insight came from yeast Psk proteins 
which target proteins of the glycogenic and glycogenolytic pathways as well as proteins 
responsible for protein synthesis (28). Human phosphorylation targets published to date 
include glycogen synthase (29), pancreatic and duodenal homeobox protein 1 (30) and 
eukaryotic elongation factor 1A1 (31). 
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 4.3 PASKIN in yeast 
Saccharomyces cerevisiae possesses two orthologous PASKIN genes, Psk1 and Psk2. 
Primary sequence analysis shows 71% homology among the two isoforms, with 90% 
homology in the kinase domain and 81% in the PAS domain (32). First insights into Psk 
function were gained from yeast with a deletion in both Psk1 and Psk2. While under standard 
growth conditions no phenotype was observed, Psk deletions showed unability to grow on 
galactose as only energy source at high temperature (39°C) (28). A genomic DNA library 
screen was performed, aiming to find targets rescuing this growth defect under stress 
conditions. Besides Psk1 and Psk2, most suppressors of the phenotype affected protein 
synthesis, either by increasing protein synthesis or indirectly by modifying RNA 
transcription. The same publication also addressed a biochemical approach that revealed 
novel Psk kinase targets (28). Three of the targets found, namely Caf20, Tif11 and Sro9 are 
involved in protein translation and will be discussed in more detail in section 3.5.1. Another 
target protein, Ugp1, is involved in glucose metabolism. UDP-glucose pyrophosphorylase 
(Ugp1) produces UDP-glucose, an activated substrate for glycogen and cell wall glucan 
biosynthesis. Interestingly, a yeast strain expressing an unphosphorylatable form of Ugp1 
(S11A) displays a similar phenotype to the Psk1-/-Psk2-/- double mutant on galactose energy 
source at high growth temperature (28,33). These findings led to the proposal that Psk 
proteins phosphorylate Ugp1 in order to upregulate cell wall biosynthesis in favor of glycogen 
synthesis. This regulation seems to depend on the subcellular localisation of Ugp1, where 
phosphorylation at S11 does not alter the activity of Ugp1 but accumulates the protein at the 
outer cell membrane (33). In line with the Ugp1 related function of Psk in Saccharomyces 
cerevisiae, Psk1 is also invovled in the regulation of the cell wall damage response in 
Candida albicans (34). Psk1 induces the expression of genes directly involved in cell wall 
repair, and hence, a Psk1-/- strain showed hypersensitivity to cell wall damage induced by the 
antifungal drug caspofungin. 
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 4.4 Energy homeostasis 
Dietary food intake supplies living organisms with energy which is either used for 
consumption, growth or storage. The system maintaing the availability of energy is highly 
sophisticated and tightly controlled. Energy homeostasis ensures the constant supply of 
organs, mainly muscle and brain, with rapidly available energy and regulates body 
temperature and storage of excess energy. The main storage forms of energy are glycogen in 
muscle and liver and triglycerides in adipose tissue and liver. 
The master regulator of glucose homeostasis is the peptide hormone insulin. After a diet, 
glucose levels in the blood increase and stimulate the β-cells of the islets of Langerhans to 
secrete insulin into the blood stream. Insulin stimulated uptake of glucose from the blood 
occurs predominantly into liver, muscle and adipose tissue. In these tissues, glucose uptake 
leads to increased glycogen and fatty acid synthesis and inhibition of degradative processes 
and gluconeogenesis. The counter player of insulin is glucagon, produced in the α-cells of the 
pancreatic islets. Glucagon is secreted upon a drop of blood glucose levels. The degradative 
effect of glucagon can be observed in the liver, where it leads to the breakdown of glycogen 
and release of glucose into the blood stream. Additionally, glucagon stimulates 
gluconeogenesis in the liver and lipolysis in adipose tissue. 
An imbalance of the tightly regulated system is a major health concern especially for Western 
countries. Western diets consist of high caloric meals combined with reduced physical 
activity. This imbalance results in what is called metabolic syndrome, characterised by 
obesity and eventually development of type 2 diabetes and cardiovascular disease. Estimates 
for 2010 by the International diabetes federation show that as much as 11.3% of the Swiss and 
8.6% of the European population of 20-79 years of age suffer from diabetes mellitus, causing 
3350 deaths per year in Switzerland and 634.000 deaths per year in Europe (35). 
Diabetes mellitus is classified into two types, type 1 and type 2 diabetes. Type 2 diabetes is 
characterised by insulin resistance in peripheral tissues. Reduced insulin stimulated blood 
glucose uptake into tissues leads to hyperglycemia, and as a reaction to elevated blood 
glucose levels, pancreatic β-cells further secrete insulin. On long term, this leads to β-cell 
exhaustion, where patients enter a vicious circle of both peripheral insulin resistance and 
reduced insulin secretion. In contrast, type 1 diabetes is characterised by a β-cell malfunction. 
Type 1 diabetic patients are not able to produce and secrete sufficient insulin, resulting in 
hyperglycemia, whereas insulin stimulated (by insulin injection) peripheral glucose uptake is 
normal. 
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 4.4.1 PASKIN and glucose homeostasis 
PDX-1 is the major transcription factor for preproinsulin expression in pancreatic β-cells. 
Upon glucose stimulation, PDX-1 gets phosphorylated in a phosphatidylinositol 3-kinase 
dependent manner, leading to import of PDX-1 into the nucleus and subsequent induction of 
insulin gene expression (36). First investigations on Min6 cells and isolated rat islets 
demonstrated that also PASKIN is involved in the expression of preproinsulin (37). PASKIN 
mRNA and protein were induced upon glucose stimulation in pancreatic β-cells. When 
overexpressed, PASKIN mediated the onset of the preproinsulin promoter, usually occuring 
under elevated glucose levels, already under low levels of glucose in culture media. Indeed, a 
direct connection between PDX-1 and PASKIN was evidenced. PDX-1 promoter activity was 
higher when PASKIN was overexpressed and lower when PASKIN was knocked down (37). 
A follow up report demonstrated that PDX-1 is also an in vitro phosphorylation target of 
PASKIN. Hence, it was speculated that the transcription of the insulin gene might be due to 
increased translocation into the nucleus upon PASKIN mediated phosphorylation (30).  
In contrast to these results, our lab could not confirm increased PASKIN expression in islets 
of Langerhans in mice stimulated with high glucose (24). Even though the expression of 
insulin was slightly lower in Paskin-/- islets compared to Paskin+/+ islets, the differences were 
neglectable and no difference in inducibility upon glucose stimulation could be observed. In 
contrast, secreted insulin from the supernatant of cultivated islets of Langerhans were even 
higher in Paskin-/- cells (24). 
Diabetic patients develop hyperglycemia and hyperlipidemia due to insulin resistance in 
peripheral tissues. Elevated serum glucose and fatty acid levels trigger pancreatic β-cells to 
produce and secrete more insulin, which leads in long term to β−cell exhaustion and 
apoptosis, an effect which is called glucolipotoxicity (38-39). It was found that palmitate 
could inhibit insulin expression (40). As PASKIN levels were increased in glucose stimulated 
pancreatic β-cells, expression levels of islets stimulated by glucose and palmitate 
simultaneously were analysed. Interestingly, such mimicking of glucolipotoxicity reversed the 
effect of increased PASKIN expression to levels comparable to unstimulated cells (41). If, as 
previously suggested, PASKIN is essentailly involved in insulin gene expression via 
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Fig. 4. Model for PASKIN function in insulin expression of pancreatic β-cells. Glucose stimulated 
pancreatic β-cells induce PASKIN mRNA expression. Upregulation of PASKIN leads to increased 
expression of the transcription factor PDX-1. Furthermore, PASKIN phosphorylates and thereby 
eventually triggers the nuclear import of PDX-1, where the transcription factor activates insulin gene 
expression. In glucolipotoxic situations, palmitate inhibits PASKIN mRNA expression and inhibits the 
pathway leading to expression of insulin despite stimulatory glucose concentrations.  
 
PDX-1 (37), these data suggest that the reduced PASKIN levels are responsible for palmitate 
inhibition of insulin gene expression. This hypothesis was further supported by the fact that 
overexpression of PASKIN circumvented the inhibition of insulin gene expression upon 
palmitate stimulation. 
Hypothesizing that PASKIN acts as a metabolic sensor, in pancreatic α-cells PASKIN effects 
opposite to the β-cells are expected. Indeed, isolated islets of Langerhans of Paskin+/+ mice 
showed decreased glucagon secretion at elevated glucose levels, whereas islets of Paskin-/- 
mice secreted glucagon almost to the same extent as in a low glucose situation. Supportingly, 
PASKIN overexpression in cultivated human islets inhibited glucagon secretion (G. da Silva 
Xavier, personal communication). 
Despite our findings of low PASKIN expression in islets of Langerhans and a lack of 
stimulatory PASKIN expression (24), altogether these data suggest a role in whole body 
glucose homeostasis by regulating insulin and glucagon levels. To complement a role for 
PASKIN in whole body energy homeostasis, several findings imply a PASKIN function in 
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 peripheral tissues. Early findings showed – analogous to the findings in yeast – that human 
PASKIN interacts with and phosphorylates rabbit glycogen synthase in vitro and that 
phosphorylation of glycogen synthase could be inhibited by the presence of glycogen (29). 
Going into more depth, the laboratory of Jared Rutter performed in vivo experiments based on 
high fat diet induced obesity (42), making use of our Paskin-/- mouse model (23). Whereas 
glucose and insulin tolerance tests were equal for Paskin+/+ and Paskin-/- animals on normal 
chow, Paskin-/- mice on high fat diet showed better glucose tolerance than wildtype animals. 
This finding went in line with observations of the body weight, since Paskin-/- animals were 
partially protected from high fat diet induced obesity, and was was reconfirmed by the 
observation of a fatty liver phenotype of Paskin+/+ animals. Together with the incidence that 
Paskin-/- mice also showed increased O2 consumption and CO2 production in indirect 
calorimetry, this led to the assumption that Paskin-/- mice were hypermetabolic. Several 
experiments aimed to support this phenotype on the cellular level. Permeabilised Paskin-/- 
soleus muscles showed higher ATP synthesis rate and a knockdown of PASKIN in L6 
myoblast cells showed increased glucose and palmitate oxidation along with slightly elevated 
ATP-levels. Yet, these data lack mechanistical proof, as there was no difference in 
mitochondrial number nor in AMPK or S6 kinase activity nor in PGC1α levels. The 
hypermetabolic phenotype is also challenged by findings of our lab, as we could not show 
differences in body weight gain on high fat diet and no hypermetabolic phenotype was 
observed in indirect calorimetry experiments. 
 
 
4.5 Protein synthesis 
Cell growth requires large amounts of nutrients and is energy consuming. As proteins are a 
major component of total cellular mass, protein synthesis is increased in growing cells. This 
process of protein translation is complex and tightly regulated. 
For an efficient increase of overall protein synthesis, several criteria need to be fulfilled, 
namely the stimulation of cells by growth factors, the supply with nutrients (especially amino 
acids) and the energy status. These growth stimuli are mainly integrated through the 
serine/threonine kinase ‘mammalian target of rapamycin’ (mTOR). Two complexes of mTOR 
exist, complex1 (mTORC1 or mTOR-raptor complex) and complex 2 (mTORC2 or mTOR-
rictor complex) (43). The function of mTORC1 has been extensively studied, as this complex 
can be directly inhibited by the drug rapamycin (43). Complex 1 is mainly involved in 
processes increasing overall protein translation whereas complex 2, that cannot be inhibited 
by rapamycin, seems to play a role in actin cytoskeleton dynamics (44). 
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 Among nutrients activating mTORC1, amino acids play a central role (45). Amino acid 
starvation of cultured cells, especially leucine starvation, results in rapid dephosphorylation of 
the mTORC1 effectors S6K1 and 4E-BP1 (46). Readdition of amino acids leads to 
reactivation of this pathway, thereby linking amino acid availability to overall protein 
synthesis (46). For cellular growth the energy status is at least as important as nutrient 
availability. The main cellular sensor of the energy status is AMP-activated protein kinase 
(AMPK). As the name of the protein implies, high levels of AMP activate the kinase, thus 
sensing the AMP/ATP ratio. Consequently, activated AMPK stimulates ATP-generating 
processes and inhibits energy consuming processes. With respect to mTOR signalling, the 
protein synthesis with its high energy costs is reduced when AMPK is activated. This happens 
through activating phosphorylation of tuberous sclerosis protein 2 (TSC2) an inhibitor of the 
mTOR pathway (47). 
Nutrients and energy are not the only prerequisites for cell growth, but cells also need growth 
factor stimuli. Activation of the mTOR pathway after growth factor stimuli (see Fig. 5) 
happens via the PI 3-kinase (PI3K) pathway (48). Growth factor receptors such as the insulin 
receptor recruit PI3K via insulin receptor substrate (IRS) to the plasma membrane, where 
PI3K converts PtdIns(4,5)P2 (PIP2) to PtdIns(3,4,5)P3 (PIP3) (49). Increased levels of 
PtdIns(3,4,5)P3 recruit PDK1 and Akt to the membrane, leading to activation of Akt (50). Akt 
in turn, signals by inhibtory phosphorylation to tuberous sclerosis proteins (TSC1-TSC2) (51) 
activating mTOR. Activated mTORC1 regulates protein translation by activating p70 S6 
kinase (S6K) and phosphorylating 4E binding protein (4E-BP). Additionally, mTOR regulates 
transcription factor recruitment to the nucleus transcribing genes for ribosome biogenesis or 
genes involved in metabolic pathways  
Regarding a potential function of PASKIN in intracellular signaling related to protein 
translation, it is interesting to note that increased AMPK activity and reduced mTOR pathway 
activity show a phenotype with resistance to diet-induced obesity as demonstrated by 
transgenic and pharmacologic strategies (52-53). Rutter and colleagues performed Western 
blots of Paskin+/+ and Paskin-/- samples from liver and gastrocnemius muscle using antibodies 
against phospho-AMPK and phospho-S6K. However, no difference in the activation of these 
two pathways could be observed (42). Still, there is some evidence that PASKIN might be 
involved in translation especially by phosphorylated targets found in yeast and mammals, 
even though a pathway activating PASKIN remains unidentified. 
 
4   Introduction
-  21  -
  
Fig. 5. Growth factor signaling in translation. A central role is attributed to the PI 3-kinase and Akt 
dependent activation of the mTOR pathway, signaling to S6K and ribosomal protein S6. See text for 
details. (54) 
 
 
4.5.1 PASKIN function in protein translation 
Translation consists of three major steps, namely initiation, elongation and termination. The 
most regulated step is translation initiation, which involves the ribosomal 40S and 60S 
subunits as well as several eukaryotic translation initiation factors (55). For the assembly of a 
translationally active ribosome, complexes of the 40S ribosomal subunits and initiation 
factors form. This involves the binding of eIF4E to the 5’-cap structure of the mRNA, which 
is a tightly controlled and rate limiting step. The control mechanism is mediated by the 4E 
binding protein (4E-BP). Phosphorylation of 4E-BP by mTOR releases eIF4E and allows 
ribosome assembly at the cap structure (56). Once this complex is formed, the mRNA is 
scanned until a start codon is recognised. With the addition of a 60S subunit to form the full 
80S ribosomal complex, translation initiation is terminated and elongation starts. 
Rutter and colleagues identified novel Psk phosphorylation targets in yeast (28) that are 
mainly involved in mRNA binding and translation initiation: Caf20p, eIF1A and Sro9p. 
Caf20p (Cap-Associated Factor 20 protein/p20) is a small cap-associated protein that can be 
phosphorylated at several positions (57). Since Caf20p was shown to interact with eIF4E in a 
competitive way against eIF4G binding and therefore negatively regulates cap-dependent 
translation initiation, it may functionally be equivalent to 4E-BP of mammalian cells (58). In 
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 the screening for phosphorylation targets of Psk2, Caf20p was only phosphorylatable in vitro 
in presence of its binding partner eIF4E at two distinct phosphorylatable serine residues (28). 
The eukaryotic initiation factor 1A. (eIF1A) mediates the transfer of Met-tRNA to the 40S 
ribosomal subunit (59). In vitro analysis revealed phosphorylation at S125 (28), however, no 
phosphorylation-dependent function of eIF1A has been reported so far. 
The third target of Psk2, Sro9p, has been shown to bind to RNA and associates with 
translating ribosomes (60). A more recent report involved Sro9p in several complexes 
involved in transcription and translation (61). Therefore, it is hypothesized that Sro9p is 
recruited to nascent mRNA already during transcription, keeps the interaction during mRNA 
export up to the translation in ribosomes. Even though phosphorylation has been shown 
previously in high throughput screenings (62), the physiological function awaits further 
investigations. 
 
 
4.5.2 Eukaryotic elongation factor 1A1 
Whereas first hints on PASKIN function involve mRNA binding and translation initiation, we 
identified the eukaryotic elongation factor 1A1 (eEF1A1) as novel PASKIN phosphorylation 
target (31). In the elongation phase, amino-acylated tRNAs (aa-tRNAs) supply translating 
ribosomes with the respective amino acids. The recruitment of amino-acylated tRNAs to the 
acceptor site of the ribosome is controlled by eEF1 consisting of the two subunits eEF1A and 
eEF1B. The G-protein eEF1A binds the acceptor site of the ribosome as a complex of eEF1A-
GTP-aa-tRNA. Subsequent hydrolysis of GTP releases eEF1A-GDP from the ribosome for 
recycling to eEF1A-GTP. Two different isoforms of eEF1A are known, eEF1A1 and 
eEF1A2. They share 92% sequence identity (63), but have a different tissue distribution. In 
rat, eEF1A1 is expressed in brain, liver and spleen, whereas eEF1A2 is predominantly found 
in heart, brain and muscle (64-65). 
A function of eEF1A distinct from its role in aa-tRNA recruitment involves the cytoskeleton. 
It has been shown, that efficient protein synthesis is relying on an intact actin cytoskeleton 
(66). Indeed, eEF1A interacts with F-actin directly and a GFP-eEF1A fusion protein 
colocalises with phalloidin (actin stain) at the edges of the cell (67). Hence, the cytoskeleton 
might concentrate the translational machinery for efficient protein synthesis. Interestingly, we 
could show a colocalisation of PASKIN with eEF1A in the midpiece of the sperm tail, where 
cytoskeletal structures are highly abundant (31). 
Eukaryotic elongation factor 1A is also a phosphoprotein. Large scale proteomics studies 
have shown tyrosine phosphorylation at several residues conserved in both eEF1A1 and 
eEF1A2 (68-70). However, as many as 11 residues differing in primary sequence between 
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 eEF1A1 and eEF1A2 involve serine or threonine residues (63), implying a tissue-specific 
regulatory function for Ser/Thr kinases. We have shown, that PASKIN phosphorylates 
eEF1A1 at T432 and increases the elongation activity in vitro (31). What other kinases are 
known to phosphorylate eEF1A1, and what physiological consequences of phosphorylation 
are known? Most interestingly, protein kinase Cδ (PKCδ), a kinase that is fully active only 
upon binding of phospholipids, phosphorylates eEF1A1 similar to PASKIN at T432 (71). 
Upon phosphorylation, elongation activity was increased by threefold and was suggested to 
be due to increased GDP/GTP exchange activity in the recycling step of eEF1A1 (72-73). 
Another kinase phosphorylating eEF1A1 is Rho-associated kinase, however, the 
phosphorylated peptides identified did not include T432 (74). A third kinase, C-Raf both 
interacts as well as phosphorylates eEF1A1. Cells stimulated with interferon α induced 
apoptosis, increased the content of eEF1A1 and exhibit phosphorylation of serine and 
threonine residues, identified by anti-phosphoserine/threonine antibodies. However, the 
phosphosites were not experimentally determined, but predicted in silico by analysing the 
structure of eEF1A1. Accordingly, potential phosphorylation could occur at S18, S157, T242, 
S316, S383 and T432, the site phosphorylated by PASKIN (75). 
 
 
4.5.3 Ribosomal protein S6 
Herein, data identifying ribosomal protein S6 (rpS6) as a novel PASKIN phosphorylation 
target will be presented. Therefore, this section summarises current literature about 
phosphorylation of rpS6. 
In eukaryotic cells, the ribosomes consist of two subunits. The small 40S ribosomal subunit is 
a complex of a single RNA molecule (18S rRNA) and 33 proteins, whereas the large 60S 
subunit is composed of three RNAs (5S, 5.8S and 28S rRNA) and 46 proteins. Among the 
proteins, ribosomal protein S6 (rpS6) has attracted most attention. It is located in the 40S 
ribosomal subunit and can be phosphorylated. This implied that translational activity could be 
regulated by kinases via rpS6. 
Phosphorylation of rpS6 was first detected in rabbit reticulocytes (76) and is located at five 
clustered residues at the C-terminus, S235, S236, S240, S244 and S247 (77). p70 ribosomal 
protein S6 kinases (S6K1, S6K2) phosphorylate all five serine residues (77) and are induced 
through mTOR complex 1 (78). Other kinases phosphorylating rpS6 are the p90 ribosomal S6 
kinases (p90RSK, see Fig. 5). They phosphorylate rpS6 at S235 and S236 and are activated 
by the extracellular signal-regulated kinase (ERK) pathway (79). Interestingly, ribosomal 
protein S6 is dephosphorylated by protein phosphatase 1 (80), of which the gene for its 
regulatory subunit SDS22 is located just 1 kb upstream of the PASKIN gene (20). 
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 The classical idea how phosphorylation of rpS6 could influence protein translation is based on 
translation of 5’-terminal oligopyrimidine (5’-TOP) mRNAs. 5’-TOP mRNAs are a special 
set of mRNAs defined by two criteria. The structural characteristics of a 5’-TOP sequence 
following the mRNA cap and the functional effect of growth-associated translational 
regulation by selective recruitment to polysomes (81). Most of the 5’-TOP mRNAs are 
coding for components of the translational machinery itself. Thus, all 80 ribosomal proteins 
(including rpS6) (81) and also the elongation factors (including eEF1A1 (82)) are encoded by 
TOP genes (83). For rpS6, this translational regulation coincides with phosphorylation of 
rpS6. Therefore it was proposed and widely accepted that phosphorylation of rpS6 increases 
the affinity of ribosomes to incorporate 5’-TOP mRNAs (84). However, several findings 
challenge this hypothesis of direct interdependence of rpS6 phosphorylation and 5’-TOP 
mRNA expression, as shown in the following paragraphs describing relevant in vivo mouse 
models.  
First, a conditional knockout of the RPS6 gene in mouse liver showed that ribosomal protein 
S6 was indispensible for proliferation of hepatocytes after a partial hepatectomy (85) and T-
lymphocytes displayed a cell cycle arrest due to failure of proliferation (86). Upstream of 
ribosomal protein S6, mice deficient for p70 S6 kinases displayed growth-related phenotypes, 
as well. Disruption of S6K1 revealed mice with growth defects manifested in reduced body 
weight already at embryonic stage all through to adult mice (87) and S6K1-/-/S6K2-/- mice 
even exhibited perinatal lethality (88). However, MEFs derived from S6K1-/-/S6K2-/- mice still 
showed incorporation of 5’-TOP mRNAs into polysomes. This finding challenges the idea of 
a direct effect of rpS6 phosphorylation to 5’-TOP mRNA translation. 
To investigate the physiological function of rpS6 phosphorylation directly, mice unable to 
phosphorylate rpS6 were generated. In these knockin mice (designated rpS6P-/-), all five 
phosphorylatable serines of rpS6 were substituted with alanines (89). Neither in liver nor in 
cultured MEFs, differences in expression of 5’-TOP mRNAs between rpS6P+/+ and rpS6P-/- 
material could be observed, and global protein synthesis rate assessed by [35S]-Met and [35S]-
Cys incorporation surprisingly even showed a higher rate in rpS6P-/- MEFs. In vivo 
experiments showed that cell size might be regulated by rpS6 phosphorylation in certain cell 
types. In rpS6P-/- mice, pancreatic β-cells were smaller and displayed reduced plasma and 
pancreatic insulin with impaired glucose tolerance. A follow up study focused on the exercise 
performance (90). Knock-in mice performed worse in muscle strength and endurance 
exercises than rpS6P+/+ mice. This could partially be explained by reduced soleus muscle mass 
due to smaller myofibers, suggesting again a defect of the reduced ‘cell size’ type. Muscles of 
rpS6P-/- mice also displayed impaired energy storage manifested in reduced levels of ATP and 
phosphocreatine and increased levels of glycogen. The latter could be explained by increased 
glycogen synthase activity. 
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 4.6 Other PASKIN functions: testis and regulation of ventilation 
In testis, a high expression of PASKIN was repeatedly reported (20,23-24). However, 
reproduction rate of Paskin-/- mice was not affected (23). To further investigate the high 
PASKIN levels, X-Gal stainings for β-galctosidase reporter gene activity in testis derived 
from Paskin-/- mice were performed and restricted the expression to the seminiferous tubules 
(23,31). Cross-sections confirmed PASKIN expression in the outermost layer of the tubules 
corresponding to spermatocytes, spermatids and spermatozoa (23). The upregulation of 
PASKIN expression in postmeiotic spermatids suggest a role for PASKIN in mature 
spermatozoa. Indeed, in ejaculated human sperm cells, PASKIN is localised to the midpiece 
of the sperm tail (31). However, a lack of PASKIN affects neither fertility, sperm production 
nor motility (23). As sperm maturation is a very dynamic process involving genetic 
rearrangement, meiosis, differentiation and spermatozoa expend energy on motility, no 
function could yet be attributed to PASKIN. Noteworthy, the midpiece of the sperm tail is 
enriched in mitochondria and cytoskeletal structures, that might imply a potential metabolic 
function in moving spermatozoa. 
One publication suggested a function for PASKIN in hypoxic ventilatory response (91). 
Paskin-/- females but not males had increased respiratory frequency and tidal volume in an 
acute hypoxic setting (up to 70 min, decrease to 8% O2) and decreased tidal volume in a 
chronic (3 days, 10 % O2) hypoxic setting. This might partially be explained by elevated 
levels of catecholamines in the brainstem of female Paskin-/- mice. 
 
 
4.7 Phospholipids 
A large amount of the cell is composed of membranes. They build up closed compartments, 
namely the nucleus, mitochondria (with inner and outer membrane), the endoplasmic 
reticulum, the Golgi apparatus and the cellular (outer) membrane. Small vesicles such as 
exosomes, endosomes, lysosomes or other transport vesicles complement the set of static 
membranes with a dynamic component. All membraneous compartments display specific 
hallmarks allowing trafficking and signaling at the appropriate intracellular site. One 
component are phospholipids, the building blocks of membranes. Different phospholipids 
vary in their occurrence among the inner and the outer layer of a membrane as well as among 
the different organelles both in composition and relative amounts (92). They are amphipatic 
molecules consisting of hydrophobic fatty acid chains (forming the bilayer of the membrane) 
esterified to a glycerol backbone (or sphingoside in sphingolipids) and a polar head group 
pointing towards the aequous phase. 
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 The hydrophobic fatty acid chains of phospholipids vary in length. They are synthesized 
intracellularly by fatty acid synthase (FAS). Originating from malonyl-CoA, C2-units are 
added to an elongating fatty acid chain, and therefore hydrocarbon backbones of fatty acids 
usually are of even number of 16-20 carbon atoms. They may be saturated, meaning that all 
C-C bonds are single bonds or unsaturated with C=C double bonds occuring within the fatty 
acid chain, resulting in higher fluidity of membranes (93). 
Whereas the fatty acid chains mainly change the physical properties of a membrane, the 
various polar head groups are of great importance for intracellular signaling. Many different 
headgroups are known, such as choline (resulting in phosphatidylcholine), ethanolamine 
(phosphatidylethanolamine), serine (phosphatidylserine) or inositol (phosphatidylinositol). 
For signaling, these headgroups serve as binding platforms that allow proteins to form 
complexes and excert their function at the appropriate intracellular locus (92). 
  
 
 
Fig. 6. Intracellular levels of phosphatidylinositides. Phosphatidylinositol (structure from (94)) can be 
phosphorylated at the 3-, 4- or 5- position. The relative intracellular amounts in erythrocytes are 
shown in table derived from (92). Phosphatidylinositol, PtdIns(4)P and PtdIns(4,5)P2 show the highest 
relative amounts and are not induced upon stimulation, because they serve as precursors for 
inducible phosphatidylinositol phosphates. PtdIns(3,4,5)P3 is barely detectable under unstimulated 
conditions and therefore does not appear on the list. When stimulated, however, it reaches levels 
comparable to PtdIns(3)P. 
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 4.7.1 Phosphatidylinositides 
Phosphatidylinositides consist of a diacyl-glycerol backbone with a D-myo-inositol headgroup 
that can be phosphorylated at the 3-, 4- or 5- position of the myo-inositol ring in living 
organisms (Fig. 6). Phosphatidylinositides play important roles in signaling and trafficking, 
serving as intracellular localisation markers for proteins, and orchestrate functional processes 
at the appropriate membrane structure (94). Thus, differentially phosphorylated 
phosphatidylinositides show different occurrence at different subcellular structures (Fig. 7), 
regulated by phospholipid-kinases and phosphatases. Due to the flexibility of phosphorylation 
at different residues, phosphatidylinositides can transduce signals very quickly, depending on 
the activities of the modifying kinases and phosphatases. 
 
PtdIns and PtdIns(4)P 
Phosphatidylinositol (PtdIns) is synthesized at the endoplasmic reticulum. Its precursor is 
phosphatidic acid. Phosphatidic acid has a very basic structure with a single phosphate as 
headgroup, and therefore serves as precursor of a number of phospholipids. In the 
endoplasmic reticulum, phosphatidic acid is converted to CDP-diacylglycerol by CDP-
diacylglycerol synthetase. Subsequently, phosphatidylinositol synthase (CDP-diacylglycerol-
inositol 3-phosphatidyltransferase) attaches a D-myo-inositol headgroup (95). Hence, PtdIns 
is predominantly found in the endoplasmic reticulum. PtdIns gets phosphorylated at the Golgi 
apparatus at the 4-position of the inositol headgroup. As mentionned above, changes in 
phosphorylation of phosphatidylinositides in cells are mediated by phosphatidylinositol 
kinases and phosphatases. Four kinases phosphorylating PtdIns at the 4-position are known, 
namely the type II kinases PI4KIIα and PI4KIIβ and the type III kinases PI4KIIIα and 
PI4KIIIβ (96). The major kinases of the Golgi apparatus are PI4KIIα (97-99) and PI4KIIIβ 
(100). The importance of PtdIns(4)P is substantiated by the phenotypes of cells disturbed in 
proper PtdIns(4)P synthesis. Overexpression of PI4KIIα increased the number of cells with 
either a scattered or no perinuclear Golgi apparatus, whereas knock-down of PI4KIIα resulted 
in a slightly expanded organelle (99). Also overexpression of PI4KIIIβ resulted in irregular 
perinuclear Golgi structures (100). Thus, PtdIns(4)P is found predominantly at the Golgi 
complex, and is indispensable for Golgi structure maintenance. 
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Fig. 7. Subcellular occurrence of phosphatidylinositides. Different phosphatidylinositides are 
localised at different membrane structures. Predominant species are PtdIns in the endoplasmic 
reticulum, PtdIns(4)P in the Golgi apparatus, PtdIns(4,5)P2 at the plasma membrane, PtdIns(3)P in 
early endosomes and PtdIns(3,5)P2 in late endosomes. See text for detailed explanations. (94) 
 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 
Being one of the most abundant PtdIns species, PtdIns(4)P is phosphorylated by type I 
phosphatidylinositol 5-kinases to form PtdIns(4,5)P2 (also known as PIP2), another very 
abundant phospholipid. The other way of synthesis, phosphorylation of PtdIns(5)P by type II 
PI4-kinases also occurs, but since PtdIns(5)P is not very abundant, this pathway is not 
discussed herein. Phosphorylation of PtdIns(4)P mainly occurs at the plasma membrane, as 
soon as PtdIns(4)P from the Golgi complex or recycling organelles reaches the plasma 
membrane. PtdIns(4,5)P2 is involved in most processes at the plasma membrane, such as 
exocytosis, endocytosis, cell motility, signal transduction and cell adhesion (94). 
PtdIns(4,5)P2 is also well known as a substrate for intracellular signalling processes. 
Phospholipase C hydrolyses PtdIns(4,5)P2, resulting in diacylglycerol (DAG) and inositol 
1,4,5-trisphosphate (IP3). IP3 serves as a second messenger that activates IP3-receptors to 
release Ca2+ ions from the intracellular calcium storage in the endoplasmic reticulum into the 
cytoplasm (101). This IP3 mediated Ca2+ signalling is of utmost importance in many 
physiological processes such as smooth muscle contraction (102) lymphocyte activation and 
T-cell proliferation (103) or proliferation of a fertilized ovum (104). The other second 
messenger derived from PtdIns(4,5)P2 is DAG. This molecule is, together with Ca2+, 
activating protein kinase C that signals through the MAP kinase pathway, regulating 
processes such as growth, differentiation or apoptosis (105). 
For a different mode of signaling, PtdIns(4,5)P2 serves as a substrate for phosphoinositide 3- 
kinases (PI 3-kinases). This conversion results in the rapid production of PtdIns(3,4,5)P3 (or 
PIP3) at the plasma membrane. This is of major importance in a large number of signaling 
events that are mainly transduced by Akt-activation through phosphoinositide-dependent 
4   Introduction
-  29  -
 kinase 1 (PDK-1) (50). The shut-down of the PtdIns(3,4,5)P3-signal at the cell membrane is 
predominantly mediated by PTEN, a PI 3-phosphatase (106). 
 
PtdIns(3)P and PtdIns(3,5)P2 
Phosphatidylinositides play an important role in endocytosis and endosomal trafficking. 
Internalisation of receptors in the clathrin coated vesicle pathway relies largely on 
PtdIns(4,5)P2 which bind the clathrin adaptors AP-2 and AP180 (107-108). Upon 
internalisation, the vesicles need to be introduced into the endocytic system, which involves a 
set of lipid phosphatases and kinases. However, endosomes are identified by PtdIns(3)P as 
major phospholipid. The conversion of endocytosed membranes from outer cell membranes 
to PtdIns(3)P containing endosomes is not completely understood. One model suggests the 
production of a pool of PtdIns(3)P generated by lipid dephosphorylation of PtdIns(3,4,5)P3 at 
the 5- and 4-position (109). A more sophisticated view, however, suggests lipid phosphatase 
and kinase activities dephosphorylating PtdIns(4,5)P2 to PtdIns and subsequent 
phosphorylation at the 3-position. The importance of a 5-phosphatase activity in endocytosis 
has been nicely demonstrated for synaptic vesicle endocytosis at nerve terminals mediated by 
synaptojanin1 (110). Synaptojanin 1 is a dual phosphatase. It contains a 5-phosphatase 
activity that converts PtdIns(4,5)P2 to PtdIns(4)P and a Sac1-like domain that acts less 
specifically by hydrolysing PtdIns(3,5)P2, PtdIns(4)P and PtdIns(3)P to PtdIns (111). Cortical 
neurons of synaptojanin knock-out mice show an accumulation of clathrin coated vesicles 
within nerve terminals, suggesting that synaptojanin function is coupled to clathrin coat 
disassembly (110). For efficient endocytosis and clathrin coat maintenance, however, an 
equilibrium between PtdIns(4,5)P2, PtdIns(4)P and PtdIns is required. To maintain this 
equilibrium, the PI 5-kinase PIPK Iγ counteracts dephosphorylation of synaptojanin 1 (112). 
For the final endocytic pool of PtdIns(3)P, the class III PI 3-kinase VPS34 is accounted for 
PtdIns phosphorylation (113). 
In the endosomal compartment, PtdIns(3)P exerts its role by serving as a binding partner for a 
number of proteins involved in sorting. One prominent adaptor protein is the early-endosomal 
antigen 1 (EEA1) that possesses a binding domain for PtdIns(3)P (114). EEA1 interacts with 
SNARE proteins, which are important for membrane fusion throughout the endosomal system 
(115). Besides membrane fusion, endosomal trafficking along actin filaments and 
microtubules also depends on phospholipids. Kif16B represents such a kinesin motor that 
directly binds to PtdIns(3)P, executing early endosome motility (116). 
Another phosphatidylionsitol species, PtdIns(3,5)P2, is a very important lipid for the 
endosome-lysosome transition. This becomes clear by a vastly enlarged cellular vacuole when 
PIKfyve, the lipid kinase phosphorylating PtdIns(3)P at the 5-position of the inositol, is 
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 inhibited (117). Effectors binding to PtdIns(3,5)P2 are suggested to be involved in processes 
such as vacuolar membrane trafficking, vacuole acidification, stress-signaling and autophagy 
(118). 
 
 
4.7.2 Phosphatidylinositide binding motifs 
Phospholipids usually consist of acidic headgroups which are linked to the backbone as 
phosphoesters resulting in a negative charge pointing to the aequous phase. Thus, a hallmark 
of phospholipid binding is the presence of basic amino acid residues in the phospholipid 
binding region. For phosphatidic acid and phosphatidylserine, binding regions may consist of 
unstructured stretches of basic residues without displaying a known globular domain structure 
(119). The same holds true for phosphatidylinositides. However, for the differentially 
phosphorylated phosphatidylinositides with different subcellular localisations, lipid binding 
domains require a high degree of specificity for individual phosphatidylinositides, which is 
mainly mediated by well-defined and highly specific three dimensional folds (92). 
Even though protein-lipid interactions are rather weak, binding strength can be increased by 
additional effects. For example hydrophobic structures in proximity to the basic residues may 
lead to partial integration of the protein into the lipid bilayer (120). Also oligomerisation of 
the lipid binding protein strengthens binding by increasing the avidity (i.e. number of binding 
sites for the oligomeric structure). This may even contribute to the binding specificity: if two 
proteins with lipid binding domains for different phospholipids oligomerise, a strong 
membrane localisation can only occur when both phospolipids are present in the target 
membrane (Fig.7). Furthermore, some domains require a membrane curvature, which is 
important for functions related to membrane budding in vesicle trafficking and directional 
movement of a cell (92). 
Protein lipid overlay assays presented herein show binding of PASKIN to 
monophosphorylated phosphatidylinositides. For this reason, the following paragraphs will 
focus on some of the best characterised folds for phosphatidylinositide binding. All of the 
domains presented all bind monophosphorylated phosphatidylinositides. Further less-
characterised domains or domains with other substrate specificities are not discussed herein 
and the reader is referred to excellent reviews (121,92). 
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Fig. 7. Strength and specificity of phospholipid binding. (a) Phospholipid binding can be strengthened 
by oligomerisation. (b) If oligomers show specificity for different phospholipids, the specificity for 
target membranes consisting of both phospholipids is increased and allows spatially regulated protein 
activity. (92) 
 
Pleckstrin homology (PH) domains 
The pleckstrin homology (PH) domain is the oldest phosphatidylinositide binding domain 
described. In the platelet protein pleckstrin, two such domains bind to PtdIns(4,5)P2 (122). 
The pleckstin homology domain is characterised by a region of ~100 amino acids of sequence 
homology. Structurally, the canonical pleckstrin homology domain consists of a seven 
stranded β-sandwich with a C-terminal α-helix. The loop between β1 and β2 displays the 
sequence motif KXn(K/R)XR, where the basic amino acids form substrate residues for the 
headgroup-phosphate binding of the lipid. PH domains are the most frequent binding modules 
found in more than 250 proteins (92). Many examples for PH domains are known to bind 
PtdIns(4,5)P2, PtdIns(3,4)P2 and PtdIns(3,4,5)P3 with high specificity (92). To outline the 
high specificity, it was shown that PtdIns(3,4,5)P3 binding PH domains formed 17-19 
hydrogen bonds between lipid phosphates and spatially distributed basic headgroups in co-
crystallisation experiments (123). 
In addition to these canonical PH domains, so called non-canonical PH domains have been 
identified in TIAM1 and Rho GTPase-activating protein-9 (ARHGAP9) (124). Analysis of 
the sequence homology and structure suggest the involvement of two pairs of basic residues 
(R or K) in the β1-β2 loop and in the β5-β6 loop instead of the canonical KXn(K/R)XR motif. 
The involvement of two double lysine (KK) motifs has also been reported to mediate 
PtdIns(4,5)P2 binding for Toll-interleukin1 receptor domain containing adaptor protein 
(TIRAP) (125), a scaffolding protein for Toll-like receptor 2 and 4 signaling. There exist a 
number of examples where PH-domains are binding to PtdIns(4)P. This was described for 
four-phosphate-adaptor proteins (FAPP) 1 and 2, that are important for membrane trafficking 
from the trans-Golgi network to the cell surface membrane (126). An interesting example of a 
non-canonical PH-domain with a broad range of phosphatidylinositide binding is present in 
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 the yeast Vps36 (ESCRT-II) protein. Liposome sedimentation assays showed substantial 
binding to PtdIns(3)P and weaker binding to PtdIns(4)P, PtdIns(3,4)P2, PtdIns(3,5)P2, 
PtdIns(4,5)P2 and PtdIns(3,4,5)P3 (127). Since ESCRT complexes are the essential proteins 
for endosome-lysosome sorting, preferential binding of Vps36 to endosomal PtdIns(3)P is 
substantial for appropriate function (127). 
 
PX domains 
PX domains are of ~130 amino acids length and are named after the phagocyte NADPH 
oxidase (phox) complex. The binding pocket of a PX-domain consists of an N-terminal three 
stranded β-sheet and an α-helical domain. In the p40phox subunit, binding of PtdIns occurs via 
hydrogen bonds to conserved basic headgroups in the pocket between the β-sheet and the α-
helical subdomain (128). From NMR structural analysis of Vam7 (129), it has been suggested 
that PX domains display partial insertion of an α-helical structure into the lipid bilayer which 
essentially contributes to lipid binding. They show specificity for monophosphorylated 
phosphatidylinositides because additional phosphate groups are sterically infavourable (128). 
In line with the common specificity for PtdIns(3)P, which mainly occurs in endosomal 
membranes, many PX domain proteins are involved in vesicular trafficking and protein 
sorting (130). However, binding of PX domains to other phosphoinositides has been reported 
as well, for example NOXO1 (nox organising protein 1) binds to PtdIns(4)P, PtdIns(5)P and 
PtdIns(3,5)P2 (131).  
 
FYVE domains 
FYVE is an acronym for four proteins in which such a domain was identified, namely Fab1, 
YOTB, Vac1 and EEA1 (132). It is a 60-70 amino acids zinc-finger domain containing two β-
hairpins. In the first β-strand, FYVE proteins contain a RR/KHHCR basic motif that binds to 
PtdIns(3)P (114). Characteristic of FYVE domains is their much stronger binding to 
membrane-embedded PtdIns(3)P because of partial membrane insertion of the domain and 
oligomerisation of the protein. The binding mechanism has been nicely demonstrated for the 
early endosome antigen 1 (EEA1). High resolution NMR and X-ray structures revealed the 
precise residues forming the hydrogen bonds with the lipid, membrane insertion and the 
increased avidity of PtdIns(3)P binding by dimerisation (133-134). Another FYVE-domain 
containing protein is the lipid kinase PIKfyve. Its FYVE-domain binds PtdIns(3)P, and 
subsequently PIKfyve phosphorylates phosphatidylinositides at the 5’-position generating 
PtdIns(3,5)P2 and PtdIns(5)P (135). The FYVE-domain thus ensures the appropriate 
subcellular localisation at the endosomes, where PIKfyve can trigger the endosome-lysosome 
transition by generating PtdIns(3,5)P2. The importance of this mechanism was nicely 
demonstrated by overexpression of a dominant negative kinase-deficient K1831E mutant that 
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 displayed exacerbated cytoplasmic vacuolation (117), implying a crucial function in 
endomembrane homeostasis. 
 
Fig. 8. Phospholipid binding domains. The dimer of the FYVE domain of EEA1 (PDB: 1JOC) binds to 
PtdIns(3)P and shows membrane insertion. The non-canonical PH domain of ARHGAP9 (2P0D) binds 
to PtdIns(4,5)P2. The PX domain of p47
phox is supposed to bind PtdIns(3)P (1O7K) and has a proposed 
second anin-binding site presumably binding phosphatidic acid. The PtdIns(4,5)P2 binding ANTH 
domain of AP 180 (1HFA) does not show the additional helix 0 of the ENTH domain of epsin (1H0A). 
The amphipathic helix 0 is inserted into the membrane and deforms the lipid bilayer priming vesicle 
budding. (Fig. modified from (92)) 
 
ENTH (ANTH) domains 
Two domains with homologous structure derive from proteins involved in clathrin-mediated 
endocytosis and cytoskeleton organisation. These domains are called epsin NH2-terminal 
homology (ENTH) and AP180 NH2-terminal homology (ANTH) domain. In epsin1, the 
ENTH domain primarily binds PtdIns(4,5)P2 (136). However, the related EpsinR prefers 
PtdIns(4)P and PtdIns(5)P, rather than PtdIns(4,5)P2. Structural analysis could demonstrate 
that residues involved in PtdIns(4,5)P2 binding in epsin1 were altered in epsinR despite a high 
overall sequence identity of 48% between the two ENTH domains (137). As expected, 
PtdIns(4,5)P2 binding epsin1 is involved in clathrin-coated vesicle budding at the cell surface 
membrane, whereas PtdIns(4)P binding epsinR has the identical function in clathrin-coated 
vesicle budding in the trans-Golgi network and endosomal compartments (137). Noteworthy, 
ENTH domains insert an α-helix (called helix 0) into their target membrane, and thus deform 
the membrane. This deformation primes the membrane invagination needed for clathrin-
coated vesicle formation (138). 
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 4.8 Goals of the thesis 
First, we aimed to identify and characterise novel phosphorylation targets of PASKIN. Based 
on the findings in yeast and the physiological function in energy homeostasis in mammals, we 
were particularly interested in targets involved in protein translation and metabolism. The first 
target we characterised was eEF1A1. Interestingly, PASKIN phosphorylates eEF1A1 at the 
same site as published for PKC. Since PKC needs phospholipid co-activators for full kinase 
function, we addressed the second question of the thesis; whether phospholipids or their 
headgroups could be the long sought-for activating ligands of the PAS domain of PASKIN 
modifiying kinase function. Finally, we were interested to confirm the phenotype published 
for Paskin-/- male mice upon feeding of a HFD. Accordingly, Paskin-/- males should be 
partially protected from HFD induced obesity and insulin resistance. Based on our results, we 
intended to clarify potential mechanistics underlying this phenotype.  
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Abstract. The PAS domain kinase PASKIN, also
termed PAS kinase or PASK, is an evolutionarily
conserved potential sensor kinase related to the heme-
based oxygen sensors of nitrogen-fixing bacteria. In
yeast, the two PASKIN homologs link energy flux and
protein synthesis following specific stress conditions.
In mammals, PASKIN may regulate glycogen syn-
thesis and protein translation. Paskin knock-out mice
do not show any phenotype under standard animal
husbandry conditions. Interestingly, these mice seem
to be protected from the symptoms of the metabolic
syndrome when fed a high-fat diet. Energy turnover
might be increased in specific PASKIN-deficient cell
types under distinct environmental conditions. Ac-
cording to the current model, binding of a putative
ligand to the PAS domain disinhibits the kinase
domain and activates PASKIN auto- and target
phosphorylation. Future research needs to be con-
ducted to elucidate the nature of the putative ligand
and the molecular mechanisms of downstream signal-
ling by PASKIN.
Keywords. Diabetes mellitus, glucose tolerance, glycogen synthesis, insulin, metabolic syndrome, nitrogen
fixation, protein translation, respiration.
Introduction
Energy homeostasis is central to life. All organisms
need to adapt to nutrition availability by reducing
energy expenditure when food is scarce and by storing
energy when food is plentiful. Whereas many impor-
tant insights have been obtained into the signalling
pathways and effector mechanisms involved in meta-
bolic energy adaptation, less is known about the actual
cellular mechanisms sensing primary nutritional
compounds and secondary metabolic intermediates.
This review focuses on PASKIN, a novel protein that
contains a possibly sensory PAS domain and an
effector Ser/Thr kinase domain. Recent results sug-
gest that PASKIN serves as a sensor involved in
metabolic energy homeostasis.
The PAS domain: heterodimerization interface and
ligand binding site
The ~7000 PAS folds identified up to date maintain
similar structures despite low sequence conservation
and a large functional flexibility. The name PAS is an
acronym derived from the three PAS fold-containing
transcription factors period (PER), aryl hydrocarbon
receptor nuclear translocator (ARNT) and single-
minded (SIM). PER is a component of a network of
+ Present address: Cytos Biotechnology, 8952 Schlieren, Switzer-
land.
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transcription factors, all of them containing PAS
domains, which compose the circadian clock [1].
ARNT is the common heterodimerization partner of
the aryl hydrocarbon receptor (AHR), also called
dioxin receptor, and the hypoxia-inducible factor
(HIF) a subunits [2, 3]. SIM controls midline cell
specification during neurogenesis, and SIM is a critical
locus gene in Down syndrome [4–6].
As part of transcription factors, the PAS region usually
consists of two adjacent degenerate repeats of ~130
amino acids, called PAS A and PAS B. PAS domains
contain five antiparallel b-sheets flanked by a-helices
(Fig. 1). In basic-helix-loop-helix (bHLH)DNA-bind-
ing proteins, the main role of the PAS region is to
confer specific protein-protein interactions within the
family (Fig. 1a). However, the three-dimensional
structure of the PAS domain resembles a left-handed
glove, and just like a baseball in a mitt, the PAS
structure is also well-suited to host small-molecule
ligands (Fig. 1b). Indeed, AHR was discovered based
on its role in the mammalian xenobiotic response, and
AHR is the only known biological receptor that binds
the environmental pollutant dioxin.NeuronalNPAS2,
a circadian clock component and a putative tumour
suppressor, is another mammalian PAS transcription
factor reported to contain a ligand. Each PAS domain
of NPAS2 coordinates a heme group that specifically
binds carbon monoxide [7]. Both the possible endog-
enous ligand of AHR and the physiological meaning
of the carbon monoxide binding by NPAS2 remain
under investigation. Up to date, no other mammalian
transcription factors have been reported to contain
ligand-binding PAS domains.
The archaeal and bacterial ancestors of mammalian
PAS proteins
Physiological adaptations of an organism to changing
environmental conditions require molecular sensors
capable of sensing and signalling specific physico-
chemical parameters. Especially in Bacteria and
Archaea, the PAS domain is often found in environ-
mental protein sensors involved in the perception of
external signals, including light intensity, gas partial
pressures, redox potentials, and certain organic li-
gands [8–11]. In the mammalian HERG potassium
channel, the PAS domainmight even sensemembrane
potentials [12].
BacterialRhizobium andBradyrhizobium species live
in root nodules of some plants, such as soybean and
clover. Oxygen sensing in these species is required for
regulated expression of the oxygen-sensitive enzymes
involved in nitrogen fixation. The PAS domain in the
histidine kinase FixL serves as a heme-bearing mo-
lecular oxygen sensor. Upon oxygen binding by the
ferrous iron within the heme group, the PAS domain
changes its conformation and inhibits the histidine
kinase domain, regulating the activity of the FixJ
transcription factor in an oxygen-dependent manner
[13]. Other bacterial gas-responsive PAS proteins
include the Escherichia coli direct oxygen sensor
(EcDos) and the Burkholderia xenovorans regulator
of CO metabolism (RcoM). Similar to eukaryotic
Figure 1. Structures of various PAS domains. (A) PAS domain
heterodimerization between HIF-2a and ARNT/HIFb. (B) Struc-
tural similarity between various PAS domains. Structures were
prepared using Sirius1.2 software (http://sirius.sdsc.edu/) based on
the following Protein Data Bank coordinates: HADDOCK
structure of HIF-2a :ARNT/HIFb heterodimer (2A24) [35];
NMR structure of ARNT/HIFb (1X0O) [35] and PASKIN
(1LL8) [20]; X-ray structure of HERG (1BYW) [12] and FixL
including the heme group (1D06) [36]. ARNT, aryl hydrocarbon
nuclear translocator; HERG, human ether--go-go-related gene;
HIF, hypoxia-inducible factor.
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NPAS2, bacterial RcoM coordinates heme and binds
carbon monoxide and nitric oxide [14].
PASKIN, a mammalian relative of bacterial oxygen
sensors
Of physiological interest, the oxygen-regulated HIF
transcription factors contain PASdomains just like the
oxygen sensing FixL of nitrogen-fixing bacteria. In
analogy to the binding of dioxin and carbonmonoxide
by thePASdomains ofAHRandNPAS2, respectively,
this raised the question as to whether the HIF PAS
domain can sense oxygen directly. However, no
evidence was found for HIF being a direct oxygen
sensor. Moreover, in the meantime it became clear
that oxygen sensitivity is conferred by oxygen-de-
pendent protein hydroxylation of HIF a subunits,
leading to transcriptional inactivation as well as poly-
ubiquitination and proteasomal destruction [3, 15].
Nevertheless, this intriguing relation between the
bacterial and mammalian oxygen-sensing systems
raised the possibility that a mammalian homolog of
the bacterial oxygen sensors might be involved in
oxygen sensing inmammals.Only a singlemammalian
gene could be found which has a domain architecture
similar to FixL, i. e. a PAS region combined with a
kinase domain.We called the human andmouse genes
PASKIN and Paskin, respectively [16]. Interestingly,
the nucleotide sequence provides more evidence that
PASKIN might have evolved from the FixL gene.
First, the PASKIN PAS region shares a higher
sequence similarity with the FixL PAS region than
with any other known PAS domain. Second, a single
long exon between the PAS B and serine/threonine
kinase regions of PASKIN is weakly similar to the
histidine kinase domain of FixL and only few point
mutations within the introns interrupt an even longer
open reading frame, suggesting that the histidine
kinase domain might have been replaced by a serine/
threonine kinase domain during evolution [16]. How-
ever, the presence of potential sensing and signalling
domains raised the possibility that PASKIN might
serve as a sensor protein.
The PAS domain of PASKIN inhibits
serine/threonine kinase domain-dependent
autophosphorylation
Despite the structural relation, we found heme
bound to FixL but not to PASKIN (unpublished
data), and there is ample evidence to rule out a role
for PASKIN in direct oxygen-sensing in mammals. A
first hint for another kind of functional relationship
between FixL and PASKIN was provided by the
group of S. L. McKnight, J. Rutter and colleagues
who cloned human PASKIN and alternatively
termed it PAS kinase or PASK [17]. However, since
this name had been in use before for an unrelated
kinase [18, 19], we herein refer to the unambiguous
designation PASKIN throughout this review.
McKnight, Rutter and colleagues reported that
PASKIN autophosphorylates the threonine residues
Thr1161 and Thr1165 and that the N-terminal PASA
domain of PASKIN partially represses the C-termi-
nal kinase activity in trans as well as in cis. Following
de-repression, presumably by ligand binding to the
PAS domain, autophosphorylation in trans results in
the switch-on of the kinase activity of PASKIN.
Mutations of Thr1161or Thr1165 completely inacti-
vated PASKIN kinase activity [17] .
Further evidence for intrinsic kinase inhibition by the
PAS domain was provided by structural studies: in
contrast to other PAS proteins, the PAS A domain of
PASKIN contains a short F a-helix and a long and
dynamic FG loop that interacts with the kinase
domain. Distinct mutations mimicking the ligand-
bound state de-repressed the kinase activity without
affecting the overall structure of the PAS A domain
[20]. Thus, it was tempting to speculate that PASKIN
binds (so far unknown) organic ligands, increases its
kinase activity by autophosphorylation and signals to
(so far unknown) downstream phosphoproteins.
PASKIN has also been found in a large biochemical
screen for nuclear phosphoproteins in HeLa cells,
confirming that PASKIN is a phosphoprotein and
providing a hint for its subcellular localization [21]. In
this study, PASKIN was found to be phosphorylated at
Ser116. Since Ser116 is located adjacent to the PAS A
domain, it potentially might regulate the PAS domain
function. However, to date neither the kinase nor the
functional implications of this phosphosite are known.
PSK1 and PSK2, the yeast homologs of PASKIN
Important insights into the function of PASKIN were
derived from the cloning and analysis of two genes
with high sequence similarity from Saccharomyces
cerevisiae, termed PSK1 and PSK2 [22]. These bud-
ding yeast homologs of PASKIN phosphorylate three
translation factors and two enzymes involved in the
regulation of glycogen and trehalose synthesis, sug-
gesting that they might coordinately control trans-
lation and sugar flux. Under specific stress conditions
(a temperature-sensitive growth defect on galactose
medium, called Galts phenotype), albeit not under
standard culture conditions, yeast glycogen synthase
and UDP-glucose pyrophosphorylase (Ugp1) are
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phosphorylated by Psk1 and Psk2, resulting in the
downregulation of carbohydrate storage, whereas
deficiency in Psk1 and Psk2 resulted in elevated
glycogen stores. Simultaneously, Psk2-dependent
phosphorylation of the yeast translation factors
Caf20p (corresponding to 4E-BP in mammals),
eIF1A and Sro9p leads to the downregulation of
protein synthesis [22]. Further experiments revealed
that the Galts phenotype might be exclusively related
to the lack of Ugp1 Ser11 phosphorylation in the PSK
mutant yeast strains. Upon Ser11 phosphorylation,
Ugp1 translocates to the plasma membrane where it
increases cell wall glucan synthesis at the expense of
glycogen storage. In the absence of PSKs, glycogen
rather than glucan is produced, affecting the strength
of the cell wall. This effect was fully phenocopied by a
Ugp1 Ser11Ala mutation, and it could be reversed by
adding the osmotic stabilizer sorbitol [23]. Two
independent cell stressors have been identified to
activate PSKs in yeast. Cell integrity stress (e. g. heat
shock or SDS treatment) required the Wsc1 mem-
brane stress sensor, and growth in non-glucose carbon
sources (e.g. raffinose) required the AMP-dependent
kinase (AMPK) homolog Snf1 [24]. While PSK2 was
predominantly activated by Wsc1, PSK1 was indis-
pensable for Snf1 function.
Because the Ser/Thr kinase domain of PASKIN is
highly related to the kinase domains of AMPK family
members (30 and 32% identity over a stretch of 253
amino acids for AMPKa1 and AMPKa2, respective-
ly), it is tempting to transfer this latter finding to the
mammalian system. However, despite its relationship
with bacterial FixL, PASKIN most probably does not
serve as a mammalian oxygen sensor; likewise, a
putative role for PASKIN as an AMPK-like energy
sensor in mammalian cells needs to be approached
with caution. Indeed, the PASKIN Ser/Thr kinase
domain is also highly similar to the PIM1, PIM2 and
PIM3 oncogenes (35, 37 and 33% identity, respec-
tively) and generally shares 28–37% sequence iden-
tity with a number of other kinases of the calcium/
calmodulin-dependent protein kinase family. Thus,
functional predictions based only on sequence com-
parisons with the kinase domain are likely to be of
minor relevance. Regarding the second function of
PSKs in yeast, mammalian Ugp1 is not a PASKIN
target, and the yeast Ugp1 Ser11 phosphorylation site
is not conserved in mammalian Ugp1 [25].
Parallels between yeast and mammalian PASKIN
downstream targets
The exciting findings regarding the function of the
PASKIN homologs in yeast raised the question as to
whether similar downstream targets phosphorylated
by PASKIN might exist in mammalian cells. Indeed,
the mammalian muscle glycogen synthase has sub-
sequently been reported to be a PASKIN target [26].
Glycogen synthase is known to be regulated by a
number of kinases targeting various phosphorylation
sites. PASKIN inactivates glycogen synthase by phos-
phorylation at Ser640. The middle region of PASKIN
between the PAS and kinase domains interacts with
glycogen synthase. Glycogen inhibits this interaction,
suggesting a glycogen-sensing function [26].
By yeast two-hybrid screening for novel protein
interactors of PASKIN, we found that the eukaryotic
translational elongation factor eEF1A1 is phosphory-
lated by PASKIN at Thr432, probably leading to
increased translation elongation, at least following
PASKIN overexpression [27]. Additional screenings
of kinase target peptide arrays revealed novel poten-
tial targets of PASKIN that are known to be involved
in the regulation of sugar flux and protein synthesis,
including the ribosomal subunit S6, which is also
phosphorylated by S6-kinase, a major regulator of
protein translation (unpublished data). However,
neither the biological stimulus nor the physiological
relevance of PASKIN-dependent phosphorylation of
glycogen synthase and translation factors is currently
known. Thus, additional work will be required to
clarify the functional relation between yeast PSK and
mammalian PASKIN function.
Is the PASKIN PAS A domain binding a ligand?
The 3-dimensional structure of the PASKIN PAS A
domain has been resolved, and synthetic ligands
binding to this domain were identified [20]. The
identified molecules are slightly reminiscent of the
dioxin structure with two aromatic rings as most
prominent feature. Intriguingly, ligand binding as well
as ligand-mimicking mutations relieved the kinase
domain fromPASdomain inhibition, as is known from
FixL following oxygen binding to the heme-bearing
PAS domain. However, these synthetic ligands bind
only with rather low affinity, and no data have been
provided to date for putative cellular functions of the
synthetic ligands. Thus, despite the beauty of the
concept of ligand-mediated kinase de-repression, it is
important to note that neither an endogenous ligand
of PASKIN has been identified nor has this concept
been confirmed in a cellular system, including yeast,
or in animals in vivo.
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Generation and initial characterization of Paskin
knock-out mice
In order to better understand the physiological role of
PASKIN in mammals, we targeted the mouse Paskin
gene by homologous recombination in embryonic
stem cells. Therefore, exons 10–14, forming the
upstream and N-terminal parts of the kinase domain,
were replaced by an IRES/lacZ reporter gene [28].
This loss-of-function mutation maintained normal
expression of a truncated PASKIN mRNA and
hooked it up to a b-galactosidase reporter. It cannot
be excluded that the truncated PASKIN N-terminal
regionmight have some biological effects, but since no
suitable antibodies are available, the expression levels
of this truncated protein remain unknown. However,
while the PAS domain is still present, at least on the
mRNA level, a potential truncated PASKIN protein
will be non-functional because central regions and the
kinase domain are missing.
Initial analyses revealed that PASKIN mRNA ex-
pression inwild-typemice and b-galactosidasemRNA
in heterozygous animals was identical, allowing the
identification of PASKIN expressing cell types by in
situ X-gal staining for b-galactosidase activity. Sur-
prisingly, PASKIN expression is strongly upregulated
in post-meiotic germ cells during spermatogenesis [28,
29]. In fact, PASKIN mRNA in testis is at least 100-
fold higher than in any other organ examined.
Assuming that physiological functions and the major
expression site of PASKIN will overlap, we concen-
trated our initial investigations on the testis. However,
neithermale fertility nor sperm production ormotility
were affected in homozygous knock-out mice. The
animals do not show any gross alterations. In partic-
ular, life expectancy, food intake, energy expenditure,
locomotor activity (unpublished data kindly provided
by P. Wielinga, B. Alder, C. Loewenstein and T. Lutz,
Zurich, Switzerland), fat distribution and liver fat
content (unpublished data kindly provided by J.
Hillebrand and W. Langhans, Zurich, Switzerland)
and circadian activity under constant dark conditions
(unpublished data kindly provided by I. Tobler,
Zurich, Switzerland) are indistinguishable from con-
trol littermates. Despite glycogen synthase being a
downstream target of PASKIN, periodic acid-Schiff
staining did not reveal any alterations in glycogen
deposits in the tissues of Paskin knock-out mice
(unpublished data). Thus, at least under standard
animal husbandry conditions Paskin knock-out mice
do not display any developmental, morphological or
behavioural phenotype.
A recent report suggested that PASKIN might be
involved in respiratory regulation [30]. Female but not
male Paskin knock-out mice showed an increased
ventilatory response to acute hypoxia and failed to
reachventilatory acclimatization to chronic hypoxia. L-
DOPA production as a means to determine tyrosine
hydroxylase activity was decreased in catecholaminer-
gic cells of the brainstem of male but increased in
femalePaskin knock-out mice when compared towild-
type animals. Peripheral chemoreceptors were not
affected in Paskin knock-out mice, consistent with a
lack of PASKIN expression in carotid bodies (unpub-
lisheddata kindlyprovidedby J. Lpez-Barneo, Sevilla,
Spain). Of note, body temperature, O2 consumption
and CO2 production decreased following exposure to
hypoxia, but the values were indistinguishable between
Paskinwild-type and knock-outmice of either sex [30].
Despite its putative significance considering the bacte-
rial ancestors of PASKIN, these studies failed to
provide a mechanistic explanation for the respiratory
differences. Especially the relation between tissue-
specific PASKIN expression, tyrosine hydroxylase
activity and the oxygenation- and sex-specific functions
deserve further investigations.
A role for PASKIN in glucose-stimulated insulin
production in the pancreas?
Intriguingly, it has been suggested that PASKIN kinase
activity followed by mRNA and protein expression is
increased in MIN6 cells and in isolated pancreatic b-
cells after exposure to high glucose concentrations [31].
IncreasedPASKINactivity appeared to be required for
glucose-dependent transcriptional induction of the
pancreatic duodenal homeobox-1 (PDX-1) transcrip-
tion factor, leading to transcriptional induction of
preproinsulin but not glucokinase or uncoupling pro-
tein 2 gene expression. Mutations of the PDX-1 DNA
binding site onboth thepreproinsulin promoter and the
PDX1 promoter itself inhibited glucose and PASKIN
overexpression-dependent promoter activity [31]. In
contrast to this PDX1 gene-activating function of
PASKIN, it has subsequently been reported by the
same group that PASKIN phosphorylates PDX-1 at
Thr152, which might drive PDX-1 out of the nucleus
[32].However, the authors concluded that decreases in
PASK activity in b cells may thus contribute to some
forms of type 2 diabetes, whereas activation of the
enzymemay provide a new therapeutic strategy for this
disease [31].
To examine the role of PASKIN in glucose-stimulated
insulin production, we used pancreatic b-cells derived
from our Paskin wild-type and knock-out mice [33].
We found PASKINmRNA regulation by high glucose
neither in various pancreatic b-cell or testicular cell
lines, nor in isolated islets or tubuli seminiferi.
Increasing the ambient glucose concentration in
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cultured islets resulted in a similar increase in insulin
mRNAand insulin secretion, whether the b-cells were
derived from Paskin wild-type or knock-out mice. In
young as well as in older Paskin wild-type and knock-
out mice, glucose tolerance tests showed equal blood
glucose clearance, whether the animals were fed a
normal chow diet or fasted overnight. These experi-
ments demonstrated normal acute and chronic insulin
function in Paskin knock-out mice in vivo, leading to
the conclusion that insulin expression is independent
of PASKIN, at least under our laboratory conditions
[33]. A lack of constitutive and glucose-induced
PASKIN protein expression was confirmed in
human b-cells (unpublished data kindly provided by
M. Donath, Zurich, Switzerland).
Paskin knock-out mice seem to be protected from all
aspects of themetabolic syndromewhen fed a high-fat
diet
Excitingly, when feeding mice with a high fat diet
(HFD, 45% fat by calories), J. Rutter and colleagues
found that Paskin knock-out mice are protected from
obesity, liver triglyceride accumulation, glucose intol-
erance and peripheral insulin resistance, the symp-
toms common to the metabolic syndrome [34]. These
differences were accounted for by an increase in
energy turnover as measured by O2 consumption and
CO2 production. The molecular mechanisms leading
to this interesting phenotype are unclear. An involve-
ment of mitochondrial biogenesis, AMPK andmTOR
activity could be excluded. As in skeletal muscle of
Paskin knock-out mice, a partial (~50%) PASKIN
knock-down in L6 myoblasts resulted in increased
glucose and fatty acid oxidation with a concomitant
increase in ATP levels [34]. While these results
implied a cell-autonomous effect of PASKIN on
energy turnover, we did not find any differences in
ATP levels in mouse embryonic fibroblasts derived
from wild-type or Paskin knock-out mice (unpublish-
ed data), suggesting that these effects are cell type-
specific. Considering the phenotype of Paskin knock-
out mice (see above), constitutive changes in intra-
cellular ATP production are also unlikely to occur in
b-cells of the pancreas.
The lean phenotype of Paskin knock-out mice ap-
peared only after feeding a HFD. Under normal chow
diet (NCD), body weight, fat composition, body
temperature, O2 consumption and CO2 production
ofPaskin knock-out mice are not distinguishable from
wild-type littermates [30, 34]. After an independent
repetition of the feeding studies, we could confirm that
an NCD made no significant difference, whereas a
HFD led to a stronger increase in body weight in wild-
typemice than inPaskin knock-outmice (unpublished
data). Rather surprisingly, when we further increased
the fat content of the food (from 45 to 60% calories by
fat) there was no longer any difference in body weight
increase between wild-type and Paskin knock-out
mice (Fig. 2). Currently, we have no explanation for
this unexpected finding.
It is important to mention that the same Paskin knock-
out mouse strain was used for these experiments as for
all other studies mentioned above [28]. The only
notable difference was that the mice were backcrossed
into C57BL/6 five times in the Hao et al. study [34],
whereas we used the 10th backcross. Despite an
apparently impaired glucose-stimulated insulin secre-
tion by islets of Langerhans isolated from Paskin
knock-out mice, glucose and insulin tolerance were not
significantly different between wild-type and knock-
outmice fed anNCD [34]. Moreover, in contrast to the
previous report [31], PDX-1 mRNA levels were
independent of PASKIN in this study [34]. While
these apparently contradictory data are difficult to
interpret, they confirm our previous results [33].
Figure 2.Bodyweight gain of wild-type andPaskin knock-out mice fed with increasingly fat-containing diets (11.7, 45 and 60% calories by
fat, respectively). Male mice received the indicated diets beginning at the age of 14 weeks. Mean values SEMof the indicated number of
mice per group are shown.
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Conclusions
Figure 3 provides an overview of the current model of
the molecular functions of PASKIN as a potential
sensor protein. Much less is known about the physio-
logical significance of PASKIN. Similar to yeast, the
reports on the functions of mammalian PASKIN
clearly demonstrate that PASKIN plays a role under
changing environmental conditions (oxygen, glucose,
nutrition) rather than under standard laboratory
conditions. This might also explain the different
outcomes of similar experiments in different labora-
tories: subtle changes in nutritional and/or other
environmental parameters of the animals as well as
of the cell cultures might have influenced PASKIN-
dependent cellular effects. However, in contrast to the
previous suggestion [31], it appears to be the decrease
rather than an increase in PASKIN activity that
protects from the metabolic syndrome, at least in the
mouse model described in this review. PASKIN has
been suggested to provide a signal for metabolic
sufficiency by sensing a yet unknown metabolic
ligand [25, 34]. Pharmaceutical inhibition of PASKIN
thus might be useful for treatment of the metabolic
syndrome, especially regarding the finding that PAS-
KIN deficiency apparently does not affect the health
of knock-out mice. It will be a major challenge to
identify the endogenous ligand of PASKIN. Only
knowledge of the nature of this ligand will eventually
clarify the role of PASKIN as an energy sensor.
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Figure 3. Model of PASKIN-de-
pendent signalling. Upon binding
of an unknown organic ligand,
PASKIN autophosphorylation
and target phosphorylation in-
crease, resulting in the regulation
of critical factors in energy ho-
meostasis. GS, glycogen syn-
thase; eEF1A1, eukaryotic trans-
lation elongation factor 1A1;
PDX-1, pancreatic duodenal ho-
meobox-1.
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Abstract
PASKIN links energy flux and protein synthesis in
yeast, regulates glycogen synthesis in mammals, and
has been implicated in glucose-stimulated insulin pro-
duction in pancreatic E-cells. Using newly generated
monoclonal antibodies, PASKIN was localized in the
nuclei of human testis germ cells and in the midpiece
of human sperm tails. A speckle-like nuclear pattern
was observed for endogenous PASKIN in HeLa cells
in addition to its cytoplasmic localization. By yeast two-
hybrid screening, we identified the multifunctional
eukaryotic translation elongation factor eEF1A1 as a
novel interaction partner of PASKIN. This interaction
was mapped to the PAS A and kinase domains of
PASKIN and to the C-terminus of eEF1A1 using mam-
malian two-hybrid and GST pull-down assays. Kinase
assays, mass spectrometry and site-directed muta-
genesis revealed PASKIN auto-phosphorylation as
well as eEF1A1 target phosphorylation mainly but not
exclusively at Thr432. Wild-type but not kinase-inac-
tive PASKIN increased the in vitro translation of a re-
porter cRNA. Whereas eEF1A1 did not localize to the
nucleus, it co-localizes with PASKIN to the cytoplasm
of HeLa cells. The two proteins also showed a re-
markably similar localization in the midpiece of the
sperm tail. These data suggest regulation of eEF1A1
by PASKIN-dependent phosphorylation in somatic as
well as in sperm cells.
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Introduction
Physiological adaptations of an organism to changing
environmental conditions require molecular sensors
capable of sensing and signalling specific physico-
chemical parameters. The PAS (Per-Arnt-Sim) domain
is a widespread protein fold of environmental protein
sensors involved in the perception of light intensity, oxygen
partial pressure, redox potentials, voltage and certain
ligands [1]. In mammals, the PAS domain is mainly found
as a heterodimerization interface of transcription factors
involved in the molecular circadian clock, dioxin toxicity
and oxygen sensing [2-4].
We and others previously identified a novel
mammalian PAS protein, termed PASKIN [5] or PAS
kinase [6]. The domain architecture of PASKIN
resembles that of the oxygen sensor protein FixL from
nitrogen-fixing Rhizobium species. PASKIN contains two
PAS domains (PAS A and PAS B) and a serine/threonine
kinase domain related to AMP kinases which might be
regulated in cis by binding of so far unknown ligands to
the PAS domain [7]. Following de-repression,
autophosphorylation in trans results in the “switch-on”
of the kinase domain of PASKIN [6]. The budding yeast
PASKIN homologs PSK1 and PSK2 phosphorylate three
translation factors and two enzymes involved in the
regulation of glycogen and trehalose synthesis, thereby
coordinately controlling translation and sugar flux [8].
Under stress conditions (nutrient restriction combined with
high temperature), PASKIN kinase activity results in
increased protein synthesis and decreased carbohydrate
storage in yeast. PASKIN-dependent phosphorylation
also inhibits the activity of the mammalian glycogen
synthase [9]. In addition, a recent report suggested that
PASKIN expression as well as kinase activity is increased
in isolated pancreatic -cells following stimulation with high
glucose levels [10]. Increased PASKIN activity appeared
to be required for glucose-dependent transcriptional
induction of preproinsulin gene expression, which might
be related to PASKIN-dependent regulation of the nuclear
import of pancreatic duodenal homeobox-1 transcription
factor [11].
We recently generated PASKIN null mice by tar-
geted replacement of the kinase domain of the mouse
Paskin gene by a lacZ-neo fusion construct in embry-
onic stem cells [12, 13]. Surprisingly, PASKIN expres-
sion is strongly upregulated in post-meiotic germ cells
during spermatogenesis as revealed by in situ hybridiza-
tion, galactosidase staining and mRNA blotting. In fact,
PASKIN mRNA levels in testis are several magnitudes
higher than in all other organs tested. However, at least
under laboratory conditions, fertility as well as sperm pro-
duction and sperm motility were not affected in PASKIN
knock-out mice. No other organs, including pancreas,
stained positive for galactosidase, and we could not de-
tect any PASKIN-dependent insulin regulation [14].
To obtain more insights into PASKIN function, we
generated specific monoclonal antibodies derived against
PASKIN and screened a HeLa cDNA expression library
in a yeast two-hybrid system to identify novel PASKIN
interaction partners in mammals. Here we show that the
eukaryotic translational elongation factor eEF1A1 inter-
acts with PASKIN. eEF1A1 is a GTP-binding protein
catalyzing the binding of charged aminoacyl-tRNA to the
A-site of the ribosome [15-17]. eEF1A1 is of particular
interest because it is related to the yeast translation ini-
tiation factor eIF1A that mediates the transfer of Met-
tRNA to the 40S subunit of the ribosome, and which was
shown to be regulated by the yeast PASKIN homologs
PSK1 and PSK2 [8].
Materials and Methods
Plasmids
If not indicated otherwise, cloning work was carried out
using Gateway technology (Invitrogen, Basel, Switzerland).
pcDNA3hPASK [6], containing wild-type or mutant human
PASKIN cDNA (kindly provided by J. Rutter, Salt Lake City,
UT, USA), was digested with NcoI (all restriction enzymes were
purchased from MBI Fermentas, Labforce, Nunningen,
Switzerland), blunted with Klenow polymerase and subcloned
into SalI-EcoRV-blunted pENTR4 (Invitrogen) to obtain
pENTR4hPASK. The PAS domain plasmid pENTR4PAS was
obtained by BamHI digestion and re-ligation of
pENTR4hPASK. The kinase (KIN) domain plasmid
pENTR4KIN was obtained by subcloning the Ecl136II fragment
of pcDNA3hPASK into the XmnI-EcoRV sites of pENTR4.
Other fragments of PASKIN were amplified by PCR using Pfu
polymerase (MBI Fermentas), digested with NcoI and XhoI
and subcloned into the same sites of pENTR4. The following
primers (synthesized by Microsynth, Balgach, Switzerland) were
used: PAS A (5'-cat gcc atg gta agt gtg tcc tgc tgc tcc ct-3' and
5'-cta gct cga gtt act gcc gca tcc tct tca tcc-3'); PAS B (5'-cat gcc
atg gct tgg gtg ttc tgc acc atc-3' and 5'-cta gct cga gtt agg cca
ggt ctg gga gct gta-3'); N-terminal (5'-cag gac gcc cgc cat aaa
ct-3' and 5'-cta gct cga gtt atg agg acc acc ctg-3'); centerpiece
(5'-cat gcc atg gag atc cga aag ctg atg gaa-3' and 5'-cta gct cga
gtt act cag cag cgg tag agt gg-3'). pENTR4PASA1/2 was
obtained by digesting pENTR4PASKIN with BamHI and
HindIII, Klenow fill-in and re-ligation. The plasmid pCMV6-
XL5-eEF1A1, containing the full-length human eEF1A1 cDNA,
was purchased from OriGene (Rockville, MD, USA). eEF1A1
was amplified by PCR (full-length: 5'-cat gcc atg gga aag gaa
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aag act cat atc-3' and 5'-cta gct cga gcc gtt ctt cca cca ctg att-3';
1-241: 5'-aag cag aag gcc atc ctg ac-3' and 5'-cta gct cga gtt atg
gac gag ttg gtg gta gga-3'; 247-462: 5'-cat gcc atg gtg cgc ctg
cct ctc cag gat-3' and 5'-gat atc tcg agc cgt tct tcc ac-3') and
subcloned into pENTR4 as above. The T432A mutation was
introduced by Pfu polymerase-based site-directed mutagenesis
using the primer 5'-cgt gat atg aga cag gct gtt gcg gtg ggt g-3',
followed by DpnI digestion of the parental template. The inserts
of all ENTRy vectors were verified by DNA sequencing
(Microsynth). To generate expression vectors for fusion
proteins, ENTRy vectors were recombined in vitro with
DESTination vectors using LR Clonase recombination enzyme
mix (Invitrogen). pDEST15 and pDEST17 were used to generate
bacterial or rabbit reticulocyte lysate expression vectors for
GST- and His6-fusion proteins, respectively. pDEST10 and
pDEST20 were used to generate expression vectors for His6-
and GST-fusion proteins, respectively, in the baculovirus/Sf9
insect cell system (Invitrogen). pcDNA3.1/nV5-DEST was used
to express N-terminal V5-tagged proteins in mammalian cells or
in rabbit reticulocyte lysates.
Generation of monoclonal antibodies
GST-PAS fusion protein expression was induced in E.
coli BL21-AI by 0.2% arabinose for 4 hours and affinity purified
with glutathione sepharose (Amersham Biosciences,
Dübendorf, Switzerland). Two mice were immunized with this
antigen using standard procedures. Hybridoma cell lines were
established and culture supernatant tested against the antigen,
or GST alone, by ELISA and immunoblotting. Antibodies from
positive hybridoma supernatants were purified using protein
A agarose (EconoPac protein A cartridge, BioRad, Reinach,
Switzerland) liquid chromatography. Antibody isotyping was
performed using ISOstrip mouse strips (Roche Diagnostics,
Mannheim, Germany).
Immunoblotting
Combined cytoplasmic and nuclear extracts of cultured
cells were prepared using 0.4 M NaCl and 0.1% NP-40 in
extraction buffer as described previously [18]. Nuclear extracts
were prepared from isolated nuclei using 0.4 M NaCl. Protein
concentrations were determined by the Bradford method using
bovine serum albumin as a standard. Immunoblotting and
chemiluminescence detection was performed as described
previously [19]. The following antibodies were used: mouse
monoclonal antibody (mAb) Gal4 and mAb VP16 (Santa Cruz
Biotechnology, Heidelberg, Germany); mAb eEF1A1
(Stressgen, Biomol, Hamburg, Germany); mAb V5 tag
(Invitrogen); mAb His6 tag (Abcam, Cambridge, UK); rabbit
polyclonal E-actin (Sigma); and secondary polyclonal goat anti-
mouse or anti-rabbit antibodies coupled to horseradish
peroxidase (Pierce, Perbio, Lausanne, Switzerland).
Immunohistochemistry
Paraffin-embedded human testis samples (tumor
orchidectomy) were sectioned (2 μm) and antigen retrieved by
boiling the sections in 0.1 M citrate buffer for 90 minutes.
Peroxidase activity was blocked by incubating with 3% H2O2
and unspecific binding sites were blocked with protein-block
(Dako, Hamburg, Germany). The slides were incubated with
PASKIN mAb2 or mAb6, or eEF1A1 mAb, diluted 1:50 and
1:100, respectively, in 50 mM Tris-HCl pH 7.6, 0.5 M NaCl, 0.1%
Tween 20, 10% FCS for 15 minutes. Following washing, primary
antibodies were detected with the CSA enhancing system
(Dako) and DAB (for PASKIN) or FastRed (for eEF1A1)
substrates. PASKIN production in SF9 was detected as
described above except that the Envision system (Dako) with
FastRed as chromogen was employed. All slides were
counterstained with hemalaun.
Immunofluorescence
Collection of human ejaculated spermatozoa was approved
by the ethics committee of the University of Leipzig (approval
number 067-2005). Spermatozoa were washed in PBS, streaked
onto microscope slides, incubated for 5 minutes in
demembranization buffer (2% Triton-X100, 5 mM DTT, 50 mM
Tris-HCl pH 9.0) and fixed with 3% paraformaldehyde. The non-
specific binding sites were blocked with 3% BSA in PBS for 30
minutes. Spermatozoa were incubated for 1 hour with PASKIN
mAb2 or mAb6 diluted 1:10 in 3% BSA in PBS followed by a
TexasRed-coupled secondary anti-mouse antibody (Dako) or
an AlexaFluor 488-coupled secondary anti-mouse antibody
(Invitrogen) diluted 1:100 with 3% BSA in PBS. HeLa cells were
grown on cover slips and treated accordingly. Finally, nuclei
were stained with Hoechst33258 dye for 5 minutes. After exten-
sive washings with PBS, the slides were mounted and analyzed
by fluorescence microscopy (Axioplan 2000, Carl Zeiss Vision,
Mannheim, Germany) or confocal microscopy (LSM510, Carl
Zeiss Vision).
Cell culture, transient transfection and co-
immunoprecipitation
Human Hep3B hepatoma, HeLa cervical carcinoma and
NCCIT male germ tumor (kind gift of S. Schweyer, Göttingen,
Germany) cell lines were cultured in high glucose Dulbecco’s
modified Eagle’s medium (Sigma) as described previously [20].
Transient transfection was performed with the
polyethylenimine method as described before [19].
Transfection efficiency usually reached 60-80% as determined
by green fluorescent protein expression (data not shown). For
co-immunoprecipitation, pre-cleared cell extracts were
incubated with PASKIN mAb6 covalently coupled to sepharose
A beads [21]. The beads were washed with 0.5% NP-40, 50 mM
Tris-HCl pH 7.5, 250 mM NaCl, 5 mM EDTA and bound proteins
were analyzed by immunoblotting.
Yeast two-hybrid
A HeLa cell-derived cDNA library was screened using
the PAS domain of human PASKIN as bait according to the
instructions provided by the manufacturer (Clontech). There-
fore, the full-length human PASKIN cDNA clone
pDKFZp434O1522 [5] was digested with NcoI and SmaI and
the cDNA fragment inserted into the NcoI-SmaI sites of the
pAS2 vector (Clontech). Subsequently, the C-terminal part was
deleted by BamHI digestion and re-ligation to obtain pAS2PAS.
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Mammalian two-hybrid
The mammalian Matchmaker vectors pM and pVP16
(Clontech) were converted to DESTination vectors by ligation
of the Gateway vector conversion cassette reading frame B
(Invitrogen) into the EcoRI sites (blunted with Klenow polymer-
ase) of pM and pVP16 to obtain pMGAL4BDattb and
pVP16ADattb, respectively. Mammalian expression vectors for
Gal4 DNA-binding domain (BD) or VP16 activation domain
(AD) fusion proteins were obtained after in vitro recombina-
tion with the corresponding ENTRy vectors. The pG5FL firefly
luciferase reporter gene vector was obtained by replacing the
SalI-XbaI SEAP cDNA fragment from pG5SEAP (Clontech) with
the SalI-XbaI luciferase cDNA amplified by PCR (primers 5'-
gat ccg tcg act cta gca tgg aag acg cca aaa aca-3' and 5'-gct cta
gaa tta cac ggc gat ctt tcc-3') from pGL3Basic (Promega, Madi-
son, WI). Hep3B cells were transiently co-transfected with the
BD and AD fusion protein vectors, the firefly luciferase re-
porter vector and the pRL-SV40 renilla luciferase reporter vec-
tor (Promega) to control for differences in transfection effi-
ciency. Luciferase reporter gene activity was determined as
described before [22]. Ratios between firefly and renilla
luciferase activities were normalized to negative control co-
transfections with the pM-53 and pVP16-CP vectors (Clontech)
which were arbitrarily defined as 1.
In vitro transcription/translation (IVTT) and GST pull-
down
IVTT reactions were carried out as described by the manu-
facturer (Promega) using recombined DESTination vectors in
the presence of 35S-Met (Hartmann Analytic, Braunschweig,
Fig. 1. Generation of two monoclonal anti-
bodies (mAbs) specific for human PASKIN.
(A) Mouse monoclonal PASKIN antibodies
mAb2 and mAb6 were purified and used for
immunoblot detection of human and two dif-
ferent clones of the mouse V5-tagged PAS
AB fragments produced by IVTT and full-
length human His6-PASKIN expressed in Sf9
cells. The same blot was subsequently incu-
bated with an anti-V5 tag antibody as con-
trol. (B) PASKIN wild-type or knock-out
(KO) mouse and human tissue extracts were
probed with mAb6 by immunoblotting. An
extract from Sf9 cells expressing His6-
PASKIN was included as positive control.
The same blot was subsequently incubated
with an anti-E-actin antibody as control. Note
that the PASKIN mAbs react with human
but not mouse PASKIN.
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Germany). For translation assays, separate IVTT reactions
(1 μl), containing the pDEST17 expression vector alone, galac-
tosidase expressing lacZ expression vector, wild-type or mu-
tant PASKIN, were mixed with fresh reticulocyte lysate (12.5
μl) and 12.5 ng renilla luciferase cRNA (Promega). Luciferase
activity was determined as above. GST-tagged proteins or GST
alone were expressed in E. coli BL21-AI by induction with
0.2% arabinose for 4 hours and affinity purified using glutath-
ione sepharose columns (GSTrap FF, Amersham Biosciences)
by liquid chromatography (BioLogic DuoFlow, BioRad). Pull-
down experiments were performed by mixing either purified
proteins or 20 μl wheat germ IVTT reactions with 10 μg purified
GST-tagged proteins or GST alone bound to glutathione
sepharose beads. After 30 minutes incubation at room tem-
perature in bead binding buffer (50 mM Tris-HCl pH 8.0, 1 mM
EDTA, 1 mM DTT, 150 mM NaCl, 0.01% NP40), beads were
washed 3 times with washing buffer (50 mM Tris-HCl pH 8.0, 1
mM EDTA, 1 mM DTT, 150 mM NaCl, 0.5% NP40), boiled in
sample buffer (40 mM Tris-HCl pH 6.8, 1% SDS, 50 mM E-
mercaptoethanol) for 5 minutes and the proteins separated by
SDS-PAGE. Gels were stained with coomassie blue, dried and
radioactively labelled proteins detected by phosphorimaging
(Molecular Imager FX, BioRad).
Kinase assays and mass spectrometry
His6-PASKIN was purified from baculovirus-infected Sf9
insect cells using Ni-NTA agarose (Qiagen, Basel, Switzerland).
His6-PASKIN was incubated with 2 μg bacterially expressed
and purified GST-tagged eEF1A1 (full-length or fragments) or
GST alone in 25 mM Tris-HCl pH 8.0, 10 mM MgCl2, 1 mM DTT
for 20 minutes in the presence of 5 μCi (J33P)ATP (Hartmann
Analytic). Proteins were separated by SDS-PAGE and analyzed
by phosphorimaging of the dried gels. To determine the
phosphorylation site, GST-eEF1A1 was incubated with ATP
and PASKIN, separated by SDS-PAGE and excised from the
gel. One third of the gel band was cut into small pieces and
washed twice with 100 μl 100 mM NH4HCO3, 50% acetonitrile
and once with 50 μl acetonitrile. GST-eEF1A1 was digested in-
gel with 30 μl trypsin solution (modified trypsin, Promega, 10
fg/μl in 50 mM Tris-HCl pH 8.2, 2 mM CaCl2) at 37°C over night.
The supernatant was removed and the gel pieces were extracted
twice with 100 μl 0.1% TFA, 50% acetonitrile. All three
supernatants were combined in autosampler vials, dried, and
dissolved in 10 μl 0.1% formic acid for LC/ESI/MS/MS analysis
run in the neutral loss mode for phosphopetides (Q-TOF Ultima
API, Waters/Micromass, Manchester, UK; equipped with a
capLC, Waters).
Results
Generation and characterization of monoclonal
antibodies against PASKIN
In order to determine the physiological sites of ex-
pression in vivo as well as the subcellular localization of
mammalian PASKIN, monoclonal antibodies (mAbs)
derived against PASKIN were generated. Therefore, a
GST-PAS AB fusion protein was expressed in E. coli,
purified and used for the immunization of mice. mABs
were purified from hybridoma cell lines which reacted
with GST-PAS AB but not GST alone. Two PASKIN
IgG2a mAbs, mAb2 and mAb6, recognized in vitro tran-
scribed and translated (IVTT) human V5-PAS AB as
well as His6-PASKIN by immunoblotting (Fig. 1A). How-
ever, none of the mAbs reacted with mouse PAS AB
fragments, while V5-tag antibodies readily detected the
recombinant proteins (Fig. 1A), demonstrating that these
mAbs do not cross-react with mouse PASKIN. In hu-
man testis extracts both mAbs detected a single band
that co-migrated with recombinant His6-PASKIN isolated
from baculovirus-infected Sf9 cells (predicted MW: 146.4
kDa), suggesting that endogenous human PASKIN (pre-
dicted MW: 143.7 kDa) is either not or only slightly post-
translationally modified in the testis (shown for PASKIN
mAb6 in Fig. 1B). No corresponding band could be ob-
served in mouse organs, including testis and brain
(Fig. 1B).
PASKIN protein localization in germ cells of the
testis
We previously reported that the mouse Paskin gene
is expressed in the testis at least 100-fold stronger than in
any other organ tested [12]. As shown above, also
immunoblotting revealed PASKIN protein only in the testis.
Thus, PASKIN mAb2 and mAb6 were used to analyze
the PASKIN protein localization in human testis by im-
munohistochemistry. Signals for PASKIN were obtained
in the outermost layer of cells in human seminiferous tu-
bules, corresponding to the self-replicating spermatogo-
nia, and in spermatocytes and round spermatids (Fig. 2A
and C). At higher magnifications it became apparent that
apart from some cytoplasmic staining PASKIN localized
to the nuclei of spermatogonia and spermatocytes with a
pattern that might match the nucleoli, at least in sperma-
togonia (Fig. 2B and D). In ejaculated human sperm cells,
PASKIN localized mainly to the midpiece of the tail and
was absent in the nucleus as determined by immunofluo-
rescence (Fig. 2E and F).
Cytoplasmic and nuclear localization of PASKIN
in cultured cells
Ectopically overexpressed V5-PASKIN had origi-
nally been reported to localize to the cytosol of transfected
HEK293 cells [6]. Likewise, we detected exogenously
overexpressed human His6-PASKIN exclusively in the
cytoplasm of baculovirus-infected Sf9 insect cells by im-
munohistochemistry using PASKIN mAb6 (Fig. 3A).
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Fig. 2. Subcellular localization of PASKIN
in human testis and spermatozoa. Indirect
immunohistochemistry of human testis (A
to D) and indirect immunofluoresence of
ejaculated human sperm cells (E, F). The pri-
mary DPASKIN antibodies are indicated; the
secondary antibodies were coupled to HRP
(A to D) or Texas red (E, F).
Fig. 3. PASKIN localizes to the cytoplasm as
well as to nuclear speckle-like structures in cul-
tured HeLa cells. (A) Uninfected Sf9 cells, or
Sf9 cells infected with human His6-PASKIN-
baculovirus for 50 hours, were fixed, pelleted,
embedded in paraffin, sectioned and analyzed
by immunhistochemistry using PASKIN mAb6.
(B) Immunoblotting of cytoplasmic, nuclear or
total cell extracts derived from HeLa cells using
PASKIN mAb6. Subsequent incubation with
antibodies derived against the transcription
factor Sp1 confirmed the identity of the extracts.
(C) Immunoblotting of nuclear or total cell ex-
tracts derived from untransfected HeLa and
NCCIT cells, or cells transfected with a V5-
PASKIN expression vector, using PASKIN
mAb6. Subsequent detection of actin served
as control for equal loading and blotting (B, C).
(D) Confocal indirect immunofluorescence
microscopy of untransfected HeLa cells using
DPASKIN mAb6. Nuclei were counterstained
with Hoechst33258. The optical XZ and YZ
planes are indicated on the sides of the XY
picture to demonstrate the intranuclear locali-
zation of PASKIN.
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However, by biochemical separation and immunoblotting,
endogenous PASKIN had also been partially detected in
the nuclear fraction of HeLa cells [6]. Moreover, a re-
cent high-throughput screen identified PASKIN in nu-
clear extracts derived from HeLa cells [23]. Because
PASKIN showed an unexpected nuclear pattern in hu-
man testis, we analyzed subcellular PASKIN localization
in HeLa human cervical carcinoma cells as well as in
NCCIT human male germ tumor cells. As shown by
immunoblotting with PASKIN mAb6, endogenous
PASKIN could be detected in nuclear fractions derived
from these cell lines in addition to the cytoplasmic frac-
tions (Fig. 3B). Over-expression markedly increased the
portion of PASKIN in the nuclear fractions (Fig. 3C).
Confocal microscopy of HeLa cells using PASKIN mAb6
revealed a cytoplasmic as well as a nuclear PASKIN
localization, not overlapping with areas that stained weakly
with Hoechst33258 DNA stain (Fig. 3D). At present it is
unclear whether the nuclear speckle-like PASKIN pat-
tern in HeLa cells corresponds to the nucleolar-like pat-
tern in spermatogonia. The cytoplasmic PASKIN stain-
ing overlapped neither with markers for the golgi appara-
tus (wheat germ agglutinin and concanavalin A) nor mi-
tochondria (mitotracker) (data not shown). Taken together,
these data show that PASKIN can localize to the nu-
cleus as well as to the cytoplasm.
The eukaryotic translation elongation factor
eEF1A1 interacts with PASKIN
In order to better understand the function of
mammalian PASKIN, a yeast two-hybrid screen for novel
proteins interacting with PASKIN was performed.
eEF1A1 was identified as a prey when a region spanning
the PAS A and B domains was used as bait. In order to
confirm this interaction, mammalian two-hybrid
experiments were performed in Hep3B human hepatoma
cells co-transfected with Gal4 BD-PASKIN and VP16
AD-eEF1A1 fusion constructs. The activity of a co-
transfected luciferase reporter gene construct containing
five Gal4 DNA-binding sites is greatly enhanced when
Fig. 4. PASKIN:eEF1A1 interaction in
Hep3B cells. Fusion proteins between
VP16-AD and full-length PASKIN (A),
or the KIN domain (C), or the PAS AB
domain (D), together with Gal4-BD and
eEF1A1 were co-transfected into Hep3B
cells together with a firefly luciferase re-
porter gene, containing Gal4 DNA-bind-
ing sites, and a renilla luciferase control
vector. Firefly luciferase reporter gene
activity was determined 24 hours later,
corrected for the control renilla luciferase
activity and normalized to the values
obtained with a negative control
transfection of a non-interacting fusion
protein pair. (B), Immunoblotting of
transfected Hep3B cells to confirm ex-
pression of the fusion proteins. Anti-Gal4
mAb detected the BD and anti-VP16
mAb detected the AD. An unspecific
band reacting with the anti-Gal4 mAb
served to control for equal loading. Mean
values ± SEM are shown of 7 (A, C) or 3
(D) independent experiments performed
in duplicates. P values were obtained by
paired t tests and considered significant
if p < 0.05.
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the AD comes to lie in the vicinity of the BD. As shown
in Fig. 4A, luciferase expression was significantly higher
when the BD-PASKIN and AD-eEF1A1 fusion
constructs were co-transfected compared with co-
transfection of either the BD or the AD alone. Expression
of the exogenous fusion proteins was confirmed by
immunoblotting with anti-Gal4 or anti-VP16 antibodies
(Fig. 4B). As shown in Fig. 4C, the KIN domain of
Fig. 5. PASKIN:eEF1A1 protein-protein
interaction. (A) Co-immunoprecipitation
of endogenous eEF1A1 with c-myc-
tagged PASKIN expressed in HeLa cells.
PASKIN mAb6 but not control
antibodies co-precipitated eEF1A1 as
shown by immunoblotting. (B) Purified
recombinant proteins derived from E. coli
(GST alone or GST-tagged eEF1A1, full-
length or the indicated fragments) or Sf9
insect cells (His-PASKIN) were mixed,
incubated and analyzed by GST pull-
down with glutathione-sepharose
followed by immunoblotting using
PASKIN and GST mAbs. (C, D)
Protein:protein interaction between
radioactively labelled fragments of
PASKIN produced by IVTT and purified
recombinant GST-eEF1A1 fusion protein,
or GST alone, were analyzed by GST pull-
down with glutathione-sepharose
followed by SDS-PAGE and
phosphorimaging (upper panels in C and
D). „Input“ reflects fractions of the IVTT
reactions before GST pull-down. The
coomassie-stained gels are shown in the
lower panels of (C) and (D) to
demonstrate equal pull-down efficiency.
Note that the full-length GST-eEF1A1
fusion protein is barely visible in (C).
PASKIN conferred even a stronger induction of
luciferase activity than the full-length protein. Intriguingly,
the two PAS domains did not stimulate luciferase
expression but rather inhibited it when compared with
the non-interacting negative control transfections (Fig.
4D). Thus, these results confirmed the interaction between
the full-length PASKIN and eEF1A1 proteins, but showed
that the PAS domains of PASKIN were inhibitory in the
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Fig. 6. PASKIN auto-phosphorylation and eEF1A1 target-
phosphorylation. (A) Purified recombinant GST-eEF1A1 was
in vitro phosphorylated by His-PASKIN, separated by SDS-
PAGE and detected by phosphorimaging. T432A mutants and
fragments of eEF1A1 were included as indicated. (B) Corre-
sponding coomassie-stained gel to indicate equimolar loading
of phosphorylation target proteins. (C) Neutral loss measure-
ment by LC/ESI/MS/MS of phospho-eEF1A1 following in-gel
digestion. The mass difference of 48.989 between the measure-
ments of the peptide DMRQTVAVGVIK at low collision energy
(upper trace) and at high collision energy (lower trace) shows
the presence of a phosphorylation site in this peptide. Thr432
was identified as the main PASKIN-dependent phosphoryla-
tion site in eEF1A1.
mammalian eEF1A1 interaction assay whereas they were
activatory in the yeast eEF1A1 interaction assay.
Mapping of the PASKIN domains interacting with
eEF1A1
The interaction between endogenous eEF1A1 and
PASKIN was further confirmed by co-
immunoprecipitation. Because only very low amounts of
endogenous PASKIN are expressed in HeLa cells (see
Fig. 3B), c-myc-tagged PASKIN was transiently
overexpressed and immunoprecipitated with PASKIN
mAb6. As shown in Fig. 5A, mAb6 but not an isotype-
matched control IgG co-precipitated endogenous
eEF1A1.
The PASKIN:eEF1A1 interaction was then
characterized by GST pull-down experiments in vitro.
Therefore, purified full-length His6-PASKIN was co-
precipitated together with full-length, N-terminal or the
C-terminal GST-tagged eEF1A1 using glutathione
sepharose (Fig. 5B). Immunoblotting with PASKIN
mAb6 detected His6-PASKIN bound to full-length and
C-terminal GST-eEF1A1 but not to N-terminal GST-
eEF1A1 or GST alone (Fig. 5B, top), while GST antibodies
detected all proteins on the same blot (Fig. 5B, bottom).
To map the PASKIN site(s) interacting with
eEF1A1, fragments of PASKIN were transcribed and
translated in wheat germ extracts and radioactively
labelled by incorporation of 35S-Met. These fragments
were tested for interaction with purified GST-eEF1A1
fusion proteins, or GST alone, by precipitation with
glutathione sepharose. In this assay, the PAS A, PAS AB
(Fig. 5C) as well as the KIN (Fig. 5D) domains interacted
with eEF1A1, whereas the N-terminal half of PAS A,
PAS B, the N- and C-termini and the piece between the
PAS and KIN domains (centerpiece) did not interact with
eEF1A1.
In conclusion, both the C-terminal part of the PAS
A domain as well as the KIN domain independently
interact with the C-terminal part of eEF1A1, providing
an explanation why eEF1A1 could interact with the PAS
domain of PASKIN in yeast and with the KIN domain of
PASKIN in Hep3B cells.
eEF1A1 is phosphorylated by PASKIN at Thr432
We next determined whether eEF1A1 can be phos-
phorylated by PASKIN. Therefore, His6-PASKIN was
purified from baculovirus-infected Sf9 insect cells. As
expected from published results [6], His6-PASKIN auto-
phosphorylated in the presence of 33P-ATP, demonstrat-
ing that it was functionally active (Fig. 6A). PASKIN
Male Germ Cell Expression of PASKIN and its Novel Target
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also phosphorylated full-length GST-eEF1A1 and GST-
eEF1A1247-462, whereas GST-eEF1A11-241 was phospho-
rylated to a clearly lower extent (Fig. 6A) and GST alone
was not phosphorylated at all (data not shown). As shown
by coomassie staining, all recombinant GST-tagged pro-
teins were present in approx. equimolar concentrations
(Fig. 6B), whereas the concentration of the kinase was
too low to be detected by this technique.
To determine the phosphoacceptor site of eEF1A1,
full-length GST-eEF1A1 was phosphorylated by His6-
PASKIN, separated by SDS-PAGE and in-gel digested
with trypsin. Separation of the fragments by liquid chro-
matography followed by electrospray ionization-tandem
mass spectrometry in the neutral loss mode for
phosphopetides identified the C-terminal peptide
DMRQTVAVGVIK with Thr432 as the only
phosphoacceptor site in this analysis (Fig. 6C).
To confirm the role of Thr432 it was mutated to
alanine by site-directed mutagenesis. As shown in Fig.
6A, phosphorylation of full-length GST-eEF1A1T432A
by His6-PASKIN was almost completely abolished. How-
ever, while GST-eEF1A1247-462T432A also showed im-
paired phosphorylation by His6-PASKIN, some residual
phosphorylation of this eEF1A1 fragment was still de-
tectable, suggesting that T432A is the major but not the
only phosphoacceptor site on eEF1A1.
PASKIN increases translation efficiency in a cell-
free in vitro assay
PASKIN-dependent phosphorylation of eEF1A1
suggests that PASKIN might influence translation effi-
ciency. To test for this hypothesis, wild-type and kinase-
inactive mutants of PASKIN were synthesized by IVTT
in rabbit reticulocyte lysates (Fig. 7A). PASKIN was then
tested for its effects on translation of a renilla luciferase
cRNA in fresh rabbit reticulocyte lysates containing en-
dogenous eEF1A1 (see Fig. 8A). While the empty IVTT
expression vector, galactosidase, and kinase-inactive
PASKIN T1161A and/or T1165A mutants [6] did not sig-
nificantly alter protein synthesis, wild-type PASKIN in-
creased renilla luciferase protein synthesis by 80% (Fig.
7B).
Co-localization of PASKIN and eEF1A1 in the
midpiece of the sperm tail
Functional interaction between PASKIN and
eEF1A1 requires a cellular co-localization. Thus, we next
analyzed the subcellular localization of eEF1A1. There-
fore, HeLa cells were analyzed by immunofluorescence
using an eEF1A1 mAb. Immunoblotting of IVTT reticu-
Fig. 7. PASKIN increases translation in a cell-free translation
assay. (A) Wild-type PASKIN or the indicated kinase-inactive
PASKIN mutants were produced by IVTT. Linearized expres-
sion vectors (agarose gel electrophoresis and ethidium bro-
mide staining; top panel) were used to produce similar amounts
of PASKIN protein (immunoblotting using PASKIN mAb6;
bottom panel). (B) Translation was assayed by adding frac-
tions of these IVTT reactions to reticulocyte lysates contain-
ing renilla luciferase cRNA. Luciferase activities were normal-
ized to the empty vector control and are shown as mean values
± SEM of n=3 independent experiments. IVTT reactions using
a lacZ vector expressing galactosidase served as negative con-
trols.
locyte extracts, containing or not containing an eEF1A1
expression vector, and of HeLa total cell extracts dem-
onstrated the presence of eEF1A1 in HeLa cells and
confirmed the specificity of the antibody (Fig. 8A). Indi-
rect immunofluorescence with this antibody followed by
an Alexa488-coupled secondary antibody localized
eEF1A1 exclusively to the cytoplasm (Fig. 8B). A similar
cytoplasmic localization was observed in germ cells of
the human testis by immunohistochemistry (Fig. 8C). In-
terestingly, by indirect immunofluorescence using a Texas
red-coupled secondary antibody eEF1A1 was also de-
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Fig. 8. eEF1A1 and PASKIN co-localization in HeLa
and sperm cells. (A) Immunoblot analysis of eEF1A1 in
unprimed reticulocyte lysates, or following IVTT of an
eEF1A1 expression vector, and in untransfected HeLa
cells, demonstrating the specificity of the eEF1A1 mAb.
(B) Confocal indirect immunofluorescence microscopy
of untransfected HeLa cells using eEF1A1 primary and
Alexa488-coupled secondary antibodies. (C) Immuno-
histochemistry of human testis using eEF1A1 mAb
(red). Note that both in HeLa (B) as well as in testis (C),
eEF1A1 localizes to the cytoplasm, suggesting that this
is the main site of interaction with PASKIN in these
cells. (D) Indirect eEF1A1 immunofluorescence
microscopy of human ejaculated sperm using eEF1A1
primary and Texas red-coupled secondary antibodies.
(E) Confocal indirect immunofluorescence microscopy
of the midpiece of the human sperm tail using eEF1A1
or PASKIN mAb6 primary and Texas red-coupled sec-
ondary antibodies. Nuclei were counterstained with
DAPI (B) or Hoechst33258 (D, E).
tected in the tail of ejaculated human sperm (Fig. 8D).
Confocal immunofluorescence microscopy revealed a
very similar pattern of eEF1A1 and PASKIN, suggest-
ing co-localization of the two proteins in the midpiece of
the sperm tail (Fig. 8E).
Discussion
We previously identified PASKIN as a gene that is
ubiquitously expressed at low abundance in most mouse
organs analyzed. In contrast, much higher mRNA levels
were found in the testis [5, 12]. Presumably, these low
levels in somatic tissues can further be induced by chang-
ing environmental conditions, as suggested by the recent
demonstration that high glucose induces PASKIN in pan-
creatic  cells [10]. Of note, in a large-scale characteriza-
tion of nuclear phosphoproteins, a PASKIN-derived
phosphopeptide (Ser116) was identified in HeLa cells,
suggesting a potentially regulable function for PASKIN
[23]. Thus, HeLa appeared to be a valuable tool to iden-
tify PASKIN downstream targets in non-germline cells,
and we identified the translation elongation factor eEF1A1
as a novel PASKIN interaction partner by yeast two-
hybrid screening.
We further demonstrated that the C-terminal part
of eEF1A1 interacts with both the PAS A and KIN do-
mains of PASKIN as schematically summarized in Fig.
9. Human eEF1A1 is phosphorylated by PASKIN at
Thr432, suggesting that PASKIN regulates eEF1A1 func-
tion. Several other kinases are known to phosphorylate
eEF1A1, including PKC, Rho-associated kinase, and S6
kinase [24-26]. Interestingly, PKC has been shown pre-
viously to phosphorylate the corresponding Thr431
PASKIN target site in mouse eEF1A1 [24], and we found
PKC-dependent human eEF1A1 phosphorylation at
Thr432 (data not shown). Up to date the functional con-
sequences of this phosphorylation remain unknown. In-
sulin stimulation of protein synthesis involves S6 kinase-
dependent eEF1A1 phosphorylation [26], and here we
could demonstrate that PASKIN increases protein trans-
lation in a cell-free translation assay. Thus, PASKIN-
dependent phosphorylation of eEF1A1 might link energy
metabolism with protein translation in mammalian cells
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as it has been demonstrated previously for yeast [8].
However, the major site of PASKIN expression in vivo
is the testis. Because no corresponding cell culture model
is available, at present we can only speculate on a role
for PASKIN in protein translation in male germ cells.
In addition to protein translation, PASKIN-depend-
ent eEF1A1 phosphorylation might also have completely
different consequences. In fact, eEF1A1 displays a mul-
titude of functions unrelated to protein synthesis, includ-
ing cytoskeletal organization, signal transduction, RNA
synthesis, proteasomal degradation of damaged proteins,
apoptosis and activation of the heat-shock transcription
factor; eEF1A1 hence is involved in major diseases such
as diabetes and cancer [15, 17, 27]. We thus reasoned
that the identification of the subcellular compartments
which show co-localization of eEF1A1 and PASKIN
might give further hints to the physiological functions of
PASKIN-dependent eEF1A1 phosphorylation. In
baculovirus-infected insect cells, we found PASKIN ex-
clusively in the cytoplasm, consistent with a previous re-
port on transiently transfected HEK293 cells [6]. Cyto-
plasmic localization of endogenous PASKIN was also
found in HeLa cells, suggesting a role for the
PASKIN:eEF1A1 interaction in this compartment. How-
ever, in order to study the major physiological site of
PASKIN expression, the testis, it was necessary to gen-
erate specific PASKIN antibodies. Unexpectedly, endog-
enous PASKIN showed an apparently nucleolar pattern
in spermatogonia and a more speckled nuclear pattern in
spermatocytes and in HeLa cells in addition to the cyto-
plasmic localization. A previously not recognized phos-
phorylation site of PASKIN (Ser116) has been identified
in nuclear extracts derived from HeLa cells [23]. It is
currently unknown whether phosphorylation of PASKIN
Ser116 affects PASKIN subcellular localization, PASKIN
kinase activity, or both.
Although eEF1A1 has also been reported to local-
ize to the nucleus under certain circumstances [15], we
detected endogenous eEF1A1 exclusively in the cyto-
plasm of HeLa cells and germ cells of human testis. How-
ever, there was a complete, and thus far not recognized,
overlap in PASKIN and eEF1A1 expression and locali-
Fig. 9. Scheme of the
PASKIN:eEF1A1 interaction.
Results from Figs. 4 and 5 are
summarized on the right part
of the picture. The eEF1A1
phosphopeptide identified
following PASKIN-depend-
ent phosphorylation is indi-
cated. Y2H, yeast two-hybrid;
M2H, mammalian two-hybrid;
coIP, co-immunoprecipi-
tation.
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zation in mature human spermatozoa. Because these cells
ceased protein translation, a translation-unrelated func-
tion of PASKIN-dependent eEF1A1 phosphorylation ap-
pears to be likely. The midpiece of the sperm tail is a
highly organized structure comprising cytoskeletal com-
ponents, the mitochondria, and most of the remaining cy-
toplasmic liquid which contains several testis-specific
isoforms of glycolytic enzymes as well as of the tran-
scription factor HIF-1, another PAS domain protein [13,
28, 29]. Thus, this site is involved in the response to ex-
ternal stimuli by regulation of energy flux, heat-stress
response and apoptosis, features that would be consist-
ent with the known functions of PASKIN and eEF1A1.
Future experiments will be required to identify the exter-
nal stimuli affecting these features.
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SUMMARY 
 
The PAS domain serine/threonine kinase PASKIN, or PAS kinase, links energy flux and 
protein synthesis in yeast, regulates glycogen synthesis and protein translation in mammals, 
and might be involved in insulin regulation in the pancreas. According to the current model, 
binding of a putative ligand to the PAS domain disinhibits the kinase domain, leading to 
PASKIN autophosphorylation and increased kinase activity. Up to date, only synthetic but no 
endogenous PASKIN ligands have been reported. Here, we identified a number of novel 
PASKIN kinase targets, including ribosomal protein S6. Together with our previous 
identification of eukaryotic translation elongation factor eEF1A1, this suggests a role for 
PASKIN in the regulation of mammalian protein translation. While searching for endogenous 
PASKIN ligands, we found that various phospholipids can bind PASKIN and stimulate its 
autophosphorylation. Interestingly, strongest binding and autophosphorylation was achieved 
with monophosphorylated phosphatidylinositols. However, stimulated PASKIN 
autophosphorylation did not correlate with ribosomal protein S6 and eEF1A1 target 
phosphorylation. Whereas autophosphorylation was enhanced by monophosphorylated 
phosphatidylinositols, di- and tri-phosphorylated phosphatidylinositols inhibited 
autophosphorylation. In contrast, target phosphorylation was always inhibited, with highest 
efficiency of di- and tri-phosphorylated phosphatidylinositols. Since phosphatidylinositol 
monophosphates were found to interact with the kinase rather than with the PAS domain, 
these data suggest a multi-ligand regulation of PASKIN activity, including a still unknown 
PAS domain binding/activating ligand and kinase domain binding modulatory 
phosphatidylinositol phosphates. 
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INTRODUCTION 
 
In lower organisms, the PAS (Per-Arnt-Sim)6 domain is often found in environmental protein 
sensors involved in the perception of light intensity, oxygen partial pressure, redox potentials, 
voltage and certain ligands [1]. In mammals, the PAS domain is mainly found as a 
heterodimerization interface of transcription factors involved in dioxin signalling, the 
circadian clock and oxygen sensing [2-4]. We and others previously identified a novel 
mammalian PAS protein, alternatively called PASKIN [5] or PAS kinase [6]. PASKIN 
contains two PAS domains (PAS A and PAS B) and a serine/threonine kinase domain which 
might be regulated in cis by binding of so far unknown ligands to the PAS domain [7]. 
PASKIN shows a striking structural similarity to the bacterial oxygen sensor FixL that 
contains an oxygen-binding heme group within its PAS domain [5]. Following derepression 
by ligand binding, autophosphorylation in trans results in the "switch-on" of the kinase 
domain of FixL. A similar mode of activation has been suggested for PASKIN, too [6]. 
 PSK1 and PSK2, the budding yeast homologs of PASKIN, phosphorylate three 
translation factors and two enzymes involved in the regulation of glycogen and trehalose 
synthesis, thereby coordinately controlling translation and sugar flux [8]. Further experiments 
revealed that under stress conditions, yeast PSK regulates Ugp1 translocation to the plasma 
membrane where it increases cell wall glucan synthesis at the expense of glycogen storage. In 
the absence of PSKs, glycogen rather than glucan is produced, affecting the strength of the 
cell wall [9]. Two independent cell stressors have been identified to activate PSKs in yeast. 
Cell integrity stress (e.g. heat shock or SDS treatment) required the Wsc1 membrane stress 
sensor, and growth in non-glucose carbon sources (e.g. raffinose) required the AMP-
dependent kinase (AMPK) homolog Snf1. While PSK2 was predominantly activated by 
Wsc1, PSK1 was indispensable for Snf1 function [10].  
 In mammals, PASKIN-dependent phosphorylation inhibits the activity of glycogen 
synthase (GYS) [11]. PASKIN has also been suggested to be required for glucose-dependent 
transcriptional induction of preproinsulin gene expression, which might be related to 
PASKIN-dependent regulation of the nuclear import of pancreatic duodenal homeobox-1 
(PDX1) transcription factor [12,13]. However, by generating PASKIN-deficient knock-out 
mice, we could not demonstrate any PASKIN-dependent difference in insulin gene expression 
or glucose tolerance [14,15]. Moreover, conflicting data were also reported on the resistance 
of these Paskin knock-out mice towards high fat diet-induced metabolic syndrome [16,17].  
 We previously found that the eukaryotic translational elongation factor (eEF)1A1 is 
phosphorylated by PASKIN, probably leading to increased protein translation [18]. By 
screening for new PASKIN kinase targets, we demonstrate here that another crucial 
translation factor, ribosomal protein S6, can be phosphorylated by PASKIN, suggesting that 
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PASKIN regulates protein translation not only in yeast but also in mammals. Moreover, we 
identified phospholipid ligands binding to PASKIN and studied their effects on PASKIN 
activity. 
 
RESULTS 
 
Identification of novel PASKIN kinase targets 
Two approaches were applied to search for novel mammalian PASKIN targets: yeast two-
hybrid and phosphorylation of peptide arrays. By yeast two-hybrid screening of a HeLa cell-
derived library, we previously identified eEF1A1 as a PASKIN target [18]. In addition to 
novel proteins interacting with PASKIN, we also screened for novel proteins which can be 
phosphorylated by PASKIN. Therefore, a peptide microarray containing 1176 potential 
phosphoacceptor peptides was incubated with recombinant PASKIN and radioactively 
labelled ATP. As shown in Fig. 1A, distinct peptides were strongly phosphorylated by 
PASKIN (see supplemental Table S1 for a list of the 75 most strongly phosphorylated 
peptides). The consensus phosphoacceptor site of the 30 most strongly phosphorylated 
peptides was found to be similar to protein kinase (PK) A and C motifs (Fig. 1B). These data 
are supported by recent findings based on a combinatorial peptide library, demonstrating a 
strong preference for arginine at position -3 [19]. Accordingly, from the 75 strongest hits in 
our screening, 70 hits indeed contain arginine three amino acids before the serine or threonine 
phosphoacceptor site (supplemental table S1). Several proteins were identified more than 
once either because more than one phosphoacceptor site within the same protein could be 
phosphorylated, or because overlapping peptides containing the same phosphoacceptor site 
were present, or because the peptide was derived from the same site but from distinct species. 
Seventeen different pyruvate kinase-derived peptides, for example, were identified by this 
way. One of the proteins listed in Fig. 1B is glycogen synthase which has previously been 
identified by others as a PASKIN kinase target [11]. Thus, glycogen synthase identification 
confirmed the feasibility of our approach and was used as a reference target protein for the 
next experiments.  
 To corroborate PASKIN-dependent phosphorylation of these rather short arrayed 
peptides, 11 of the most strongly phosphorylated candidate PASKIN kinase targets were 
synthesized as 20-mer peptides and used for in vitro phosphorylation by recombinant 
PASKIN (see supplemental Table S2 for sequences and references). As shown in Fig. 1C, 6 
peptides were significantly better phosphorylated by PASKIN than the unrelated control 
peptide and 3 of them showed an even stronger phosphorylation than the known PASKIN 
targets GYS and PDX1, i.e. 40S ribosomal protein S6 (S6), phosphorylase kinase β (PHKB) 
and phosphofructo kinase/fructose bisphosphatase (PFKFB). 
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Fig. 1. Identification of novel PASKIN kinase targets. (A) Recombinant His6-PASKIN purified from SF9 
insect cells was used for in vitro phosphorylation of a microarray of 1176 peptides in the presence of (γ-33P)-ATP. 
The magnified inset shows an example of the results following detection by phosphorimaging. (B) Peptide 
sequences of the 30 most phosphorylated targets and their similarities to PKA and PKC consensus motifs. (C) 
Target validation. Biotinylated peptides of 20 amino acids length were incubated together with recombinant 
PASKIN in the presence of (γ-33P)-ATP, captured with streptavidin sepharose beads and quantified by liquid 
scintillation counting. The sequences were normalised to a GYS-derived peptide, a known target for PASKIN. A 
PDX-1-derived peptide, another known PASKIN target, served as second positive control. Shown are mean values 
+ SD of n = 3 independent experiments. Asterisks indicate statistically significant differences compared to the 
unrelated negative control peptide derived from activating transcription factor ATF-4 (*, p < 0.05; ** p < 0.01; 
paired t-test). The peptides were named as follows: GYS, glycogen synthase; PDX1, pancreatic and duodenal 
homeobox 1; PIAS1, protein inhibitor of activated STAT 1; RAB11BP, RAB11-binding protein; FXN, frataxin; 
HERG, human ether-a-go-go related gene; CREB1, cAMP response element-binding protein; NFATC4; nuclear 
factor of activated T-cells c4; 4E-T, eIF4E-transporter; S6, 40S ribosomal protein S6; PHKB, phosphorylase 
kinase β; PFKFB, 6-phosphofructokinase/fructose-2,6-bisphosphatase. Note that some of the PASKIN target 
sequences as shown in (B) can be found in several distinct proteins, leading to the partially altered designations in 
(C), as outlined in supplemental Table S2. 
 
Ribosomal protein S6 is phosphorylated by PASKIN 
Because others and we previously reported a role for PASKIN in protein translation [8,18], 
the finding that a S6-derived peptide was strongly phosphorylated by PASKIN was further 
investigated. S6 is a target of the mTOR signalling pathway that regulates nutrient-dependent 
protein translation by p70 S6 kinase (p70S6K)-mediated phosphorylation of S6 serine 
residues 235 and 236 [20]. Therefore, recombinant S6 was expressed and purified either as 
wild-type, C-terminally truncated or Ser235/236Ala double-mutant GST fusion protein (Fig. 
2A). As shown in Fig. 2B, PASKIN phosphorylated wild-type but not truncated or serine 
double-mutant S6 in vitro, suggesting that PASKIN also targets S6 at serines 235/236. 
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Fig. 2. Ribosomal protein S6 is phosphorylated by PASKIN. (A) Sequence comparison of the S6 
peptides used in the microarray, 20-mer peptide used for the in vitro reactions, and recombinant GST fusion 
proteins purified from Sf9 insect cells. (B) Phosphorylation reactions in vitro using purified His6-PASKIN and 
recombinant S6 in the presence of (γ-33P)-ATP. Following SDS-PAGE, the phosphorylated proteins were 
visualized by phosphorimaging. Equal input was controlled by immunoblotting against S6 and the GST-tag. (C) 
Immunoblot analysis of the phosphorylation status of p70S6K and S6 in Paskin+/+ and Paskin-/- MEFs. (D) 
Immunoblot analysis of the phosphorylation status of p70S6K and S6 in S6K1-/-/S6K2-/- double knock-out MEFs 
following overexpression of a negative control (EGFP), myc-PASKIN or myc-KIN. Anti-myc and anti-PASKIN 
antibodies were used to confirm PASKIN overexpression. 
 
 To analyse PASKIN-dependent phosphorylation of endogenous S6 in vivo, we used 
MEFs derived from either Paskin+/+ wild-type or Paskin-/- knock-out mice [14]. However, as 
shown in Fig. 2C, no difference in constitutive p70S6K or S6 phosphorylation could be 
detected in these cells. Since basal S6 phosphorylation by p70S6K might overcome subtle 
changes caused by PASKIN, we next used MEFs deficient for both genes encoding mouse 
p70S6K (S6K1-/-/S6K2-/-) [21], and transiently overexpressed full-length PASKIN or an N-
terminally truncated version preserving the kinase domain in these cells. Whereas S6 total 
protein levels remained unchanged, phosphorylated S6 was strongly reduced in S6K1-/-/S6K2-
/- double knock-out MEFs (Fig. 2D). Interestingly, overexpression of myc-tagged PASKIN, or 
its kinase domain alone, led to increased phosphorylation of S6 at serines 235/236 (Fig. 2D). 
In summary, while these data demonstrate that S6 is a new in vitro target, PASKIN can also 
phosphorylate S6 in vivo and might even partially contribute to the residual S6 
phosphorylation observed in p70S6K-deficient cells [22]. However, a more prominent S6 
kinase function in vivo probably awaits the identification of the endogenous stimulus of 
PASKIN catalytic activity. 
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Autophosphorylation of recombinant PASKIN is activated by phospholipids 
A possible mechanism of PASKIN activation in vivo might be the binding of a so far 
unknown ligand like it has been suggested previously [7]. However, no endogenous PASKIN 
ligand is known so far. By comparing the activity of PASKIN with PKCδ we obtained first 
hints for a potential endogenous ligand. We previously reported that both PASKIN and PKCδ 
phosphorylate the eukaryotic translation elongation factor eEF1A1 [18], and both kinases are 
known to autophosphorylate themselves [6,23]. Because PKCδ kinase activity is known to be 
stimulated by diacylglycerol (DAG) and phosphatidylserine (PS) [24], we wondered whether 
other similarities exist between PASKIN and PKCδ. Interestingly, a mixture of PS and DAG 
(used in the form of dioctanoylglycerol, DOG) not only enhanced PKCδ but also PASKIN 
autophosphorylation (Fig. 3A).  
 In order to systematically analyze the lipid activation of PASKIN, all major 
phospholipids were compared for their effects on PASKIN and PKCδ autophosphorylation. 
As shown in Fig. 3B, all tested phospholipids but not DOG alone increased PASKIN 
autophosphorylation. In contrast, PKCδ autophosphorylation was induced by DOG alone, to 
some extent also by PS or PC, but all other phospholipids had only marginal effects on PKCδ. 
As shown before [24], a mixture between DOG and PS was required to maximally induce 
PKCδ activity. However, combining DOG with phospholipids did not further induce PASKIN 
(data not shown).  
 The rather unselective stimulation of PASKIN activity by all tested phospholipids 
suggested that the core phospholipid moiety might confer PASKIN binding. Indeed, as shown 
in Fig. 3C phosphatidic acid alone was sufficient to stimulate PASKIN autophosphorylation. 
The finding that PA but not DOG strongly bound PASKIN suggested that PLD might target 
PASKIN by converting phospholipids into PA. To directly demonstrate this assumption, 96-
well plates were coated with constant amounts (1 µg) of PC. Following treatment with 
phospholipase (PL) D or C, increasing amounts of PASKIN were added and detected by 
ELISA. As shown in Fig. 3D, PASKIN bound with clearly higher affinity to PA than to PC. 
However, lipid binding was restored when PC was treated with PLD (generating PA) but not 
with PLC (generating DAG). 
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Fig. 3. Phospholipid stimulation of PASKIN autophosphorylation. (A) Lipid stimulation of PKCδ and 
PASKIN autophosporylation as assessed by incubating the purified recombinant proteins with DOG/PS mixtures 
and (γ-33P)-ATP. Following SDS-PAGE, the phosphorylated proteins were visualized by phosphorimaging. (B, C) 
Stimulation of PASKIN and PKCδ autophosphorylation by increasing amounts of the indicated phospholipids. 
Following SDS-PAGE, the phosphorylated proteins were visualized (upper panels) and quantified (lower panels) 
by phosphorimaging. The values were normalised to 100 µg/ml PS and 10 µg/ml DOG/100 µg/ml PS mixtures for 
PASKIN and PKCδ, respectively (filled columns). (D) PLD but not PLC converts PC from a low affinity to a high 
affinity PASKIN ligand. 96-well plates were coated with increasing amounts of PC, followed by treatment with 
PLD or PLC as indicated. Binding of 100 ng PASKIN added to each well was detected by ELISA. Shown are 
mean values ± SD of a representative experiment performed in triplicates. 
 
Inositol phosphorylation determines the affinity of phospatidylinositol 
interaction with PASKIN 
The experiments described above suggested that an isolated phosphate group such as in PA is 
necessary for maximal PASKIN-lipid interaction. Because phosphatidylinositols (PtdIns) with 
varying numbers of phosphate groups belong to the most important cellular lipid signalling 
molecules, we next investigated whether the number and location of the phosphate groups on 
the inositol ring affect their interaction with PASKIN. Therefore, dot blots containing mono-, 
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di- and tri-phosphorylated PtdIns were incubated with recombinant PASKIN and 
immunodetected using anti-PASKIN antibodies. Surprisingly, whereas unphosphorylated PI 
showed only relatively low PASKIN binding, this interaction was strongly increased by the 
presence of a single phosphate group in PtdIns(4)P, and reduced again when two or three 
phosphate groups were present in PtdIns(4,5)P2 and PtdIns(3,4,5)P3, respectively (Fig. 4A). 
This finding was corroborated by using dot blots with increasing amounts of all possible 
PtdIns-phosphates: PASKIN dose-dependently bound better PtdIns-monophosphates than 
PtdIns-diphosphates, and non-phosphorylated or tri-phosphorylated PtdIns bound PASKIN 
only weakly (Fig. 4B, left panel). Similar results were obtained with autophosphorylated 
PASKIN (Fig. 4B, right panel), suggesting that PASKIN phosphorylation status does not 
interfere with selective PtdIns-monophosphate binding. 
 To localise the region responsible for PtdIns-monophosphate binding, four different 
fragments of PASKIN as indicated in Fig. 4C (left panel) were expressed and purified as His6-
tagged fusion proteins. However, only the kinase (KIN) domain of PASKIN bound PtdIns-
monophosphates (Fig. 4C, right panel), rather than the previously suggested ligand-binding 
PAS domain (data not shown). We next sought to determine the effects of differently 
phosphorylated PtdIns on PASKIN autophosphorylation. As shown in Fig. 4D, 
autophosphorylation was dose-dependently enhanced by all three PtdIns-monophosphates, 
whereas especially high concentrations of PtdIns(4,5)P2 and PtdIns(3,4,5)P3 even inhibited 
autophosphorylation, establishing a structure-function relationship between kinase domain-
lipid interaction and kinase activity. 
 
PtdIns-monophosphate-dependent regulation of PASKIN target 
phosphorylation 
Because PtdIns-monophosphates stimulated PASKIN autophosphorylation, we wondered 
whether they could also stimulate phosphorylation of the PASKIN targets S6 and eEF1A1. 
Therefore, wild-type and phosphoacceptor site mutant recombinant S6 and eEF1A1 were 
used for PASKIN in vitro phosphorylation reactions in the presence of differently 
phosphorylated PtdIns-phosphates. As shown in Fig. 5, PASKIN auto-phosphorylation was 
again stimulated by all three PtdIns-monophosphates but inhibited by PtdIns(4,5)P2 and 
PtdIns(3,4,5)P3. While the phosphoacceptor site mutant S6 and eEF1A1 GST fusion proteins 
remained unphosphorylated, their wild-tpye counterparts were phosphorylated by PASKIN. 
Unexpectedly, both S6 and eEF1A1 target phosphorylation was inhibited by PtdIns-
phosphates. The more phosphate groups the inositol ring carries, the stronger was PASKIN 
target protein phosphorylation inhibited. However, non-phosphorylated PtdIns did not 
significantly change target phosphorylation efficiency. 
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Fig. 4. Preferential PASKIN binding to, and activation by, phosphatidylinositol monophosphates. 
(A) Recombinant His6-PASKIN protein was allowed to bind to the indicated lipids immobilised on a membrane, 
and subsequently detected using an anti-PASKIN antibody. (B) PASKIN dose-dependently bound preferably 
phospatidylinositol (PtdIns) monophosphates. PASKIN was either detected by immunoblotting (left panel) or by 
phosphorimaging following autophosphorylation in the presence of (γ-33P)-ATP (right panel). (C) Fragments of 
PASKIN were expressed in E. coli and purified as His6-tagged fusion proteins (left panel). Following binding to 
the lipid dot blots and detection using a His-tag antibody, only the kinase (KIN) domain of PASKIN was found to 
interact with PtdIns-monophosphates (right panel). (D) His6-PASKIN autophosphorylation was mainly stimulated 
by the presence of the PtdIns-monophosphates. In vitro phosphorylation reactions in the presence of (γ-33P)-ATP 
and the indicated synthetic diC8 PtdIns (3.16 µM, 10 µM, 31.6 µM and 100 µM) were separated by SDS-PAGE 
and quantified by phosphorimaging. Values were expressed relative to lipid-free control reactions and are 
represented as mean + SD of n = 4 independent experiments (*, p < 0.05; ** p < 0.01; ***, p < 0.001; t-test). 
 
 
DISCUSSION 
 
In this work, we identified various novel potential PASKIN substrates by peptide microarray 
phosphorylation, including glycogen synthase that was known before to be phosphorylated by 
PASKIN [11]. Thus, the repetitive identification of this PASKIN target confirms, at least 
partially, the validity of the peptide array approach. Other peptides derived from proteins 
involved in glycogen metabolism included phosphorylase kinase, inhibitor of protein 
phosphatase 1 and yeast glycogen phosphorylase (supplemental Table S1). The involvement 
of PASKIN in the regulation of glycogen synthesis has previously been demonstrated by 
showing that both mammalian and yeast glycogen synthases as well as yeast UDP-glucose 
pyrophosphorylase are known phosphorylation targets of mammlian PASKIN and yeast 
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PSK1 and PSK2, respectively [8,11]. However, whereas Ser640 was the main PASKIN 
kinase target residue of mammalian glycogen synthase [11], the peptides phosphorylated by 
PASKIN on the microarray contained Ser3 and Ser7 but not Ser640. Of note, a Ser640Ala 
mutation did not completely prevent phosphorylation [11]. Therefore, our data suggest that 
PASKIN might phosphorylate Ser3 and/or Ser7 of glycogen synthase in addition to Ser640. 
 Two peptides phosphorylated by PASKIN were derived from enzymes involved in 
glycolysis: pyruvate kinase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 
(PFKFB1) (supplemental Table S1). Obviously, the coordination of glycolysis, 
gluconeogenesis and glycogen synthesis appears to be physiologically meaningful, and it is 
hence tempting to speculate that PASKIN is involved in the regulation of all of these 
metabolic pathways. However, pyruvate kinase could not be confirmed as a PASKIN target 
using purified full-length pyruvate kinase GST fusion proteins in in vitro assays (data not 
shown). 
 Interestingly, S6 was among the peptides phosphorylated by PASKIN and this 
phosphorylation could be confirmed on the full-length protein level. Together with the 
previously reported eEF1A1 phosphorylation [18], this finding provides additional evidence 
that PASKIN is involved in mammalian protein translation. The most important and best 
characterised S6 kinases are the mTOR dependent p70 S6-kinases that sequentially 
phosphorylate all five phosphorylatable serines of S6, starting with S236 and S235 - the same 
sites as shown herein for PASKIN - followed by S240, S244 and S247 [25]. A second family 
of S6 kinases are p90 ribosomal S6 kinases (RSK) that phosphorylate S6 upon mitogenic 
stimulation at the same sites as PASKIN [22]. Phosphorylation of S6 by p70S6K has long 
been thought to increase protein translation by selectively enhancing the translation of 5'-TOP 
mRNAs, a subset of mRNAs containing an oligopyrimidine tract in their 5'-untranslated 
regions. Of note, the 5'-TOP mRNAs code for ribosomal proteins and translation factors 
including PASKIN targets S6 and eEF1A1 [26]. However, S6 phosphorylation and increased 
5'-TOP mRNA translation might be coincidental rather than causally related [27], and, 
according to a newer hypothesis, might even negatively influence translation if 
phosphorylation of S6 is considered an inhibitory feed-back signal [28]. However, no 
significant difference in global (35S)-Met incorporation could be observed in Paskin-/- MEFs 
(data not shown).  
 Based on the known functions of the PASKIN-related FixL oxygen sensor in bacteria 
and the PASKIN orthologs in yeast, and considering the lack of any obvious phenotype in 
Paskin knock-out mice kept under normal housing conditions, it is tempting to assume that 
PASKIN has a ligand-mediated sensor function that becomes apparent under currently ill 
defined stress situations [17]. However, only artificial but no endogenous PASKIN ligands 
have been reported up to now to bind the PAS domain and lead to the de-repression of the 
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kinase domain dependent autophosphorylation [7]. Here, we identified phospholipids as the 
first biologically relevant PASKIN ligands. Apparently, the presence of a charged phosphate 
moiety is required for stimulation of PASKIN kinase activity, and PLD, but not PLC, can 
convert phospholipids from low into high-affinity PASKIN ligands. However, we currently 
do not know whether PASKIN is a target of intracellular PLD cell signalling. 
 Surprisingly, PtdIns-monophosphates were found to be the best ligands of PASKIN 
with clearly higher affinities than PtdIns-diphosphates or PtdIns-triphosphate. PtdIns binding 
domains have been reported to display either well-defined three dimensional folds [29], or 
rather unstructured regions with basic (for binding of the phosphate groups) and hydrophobic 
residues, like in the non-canonical pleckstrin homology (PH) domain of Tiam1 [30]. We 
identified a lysine rich region, spanning from Lys1019 to Lys1034 of PASKIN, which shares 
characteristic features with non-canonical PH domains, including a double lysine motif 
(Lys1031/1032). However, mutation and deletion analyses of this putative binding region did 
not affect lipid binding by PASKIN (data not shown). Thus, it is difficult to predict the 
PtdIns-monophosphate binding site within the PASKIN kinase domain and further work will 
be necessary to identify the specific residues involved in lipid binding.  
 Whereas PtdIns(4,5)P2 and PtdIns(3,4,5)P3 are involved in signalling processes at the 
plasma membrane, PtdIns-monophosphates are more abundant in intracellular membrane 
structures such as the Golgi apparatus and endosomes [31]. Within these structures, PtdIns-
monophosphates are involved in sorting and signalling, since the concentrations and 
localization of differentially phosphorylated PtdIns can change rapidly [29]. Therefore, it 
might be possible that PtdIns-monophosphates not only regulate PASKIN activity but also its 
subcellular localization. This hypothesis needs further investigations but is dependent on the 
prior identification of the specific environmental conditions that regulate PASKIN function. 
 As could have been expected, we found a direct correlation between ligand affinity and 
PASKIN autophosphorylation efficiency. However, it turned out to be the kinase domain 
rather than the PAS domain which binds the PtdIns-phosphates. This finding might explain 
why the activation of PASKIN-dependent S6 and eEF1A1 target phosphorylation failed to 
comply with our initial expectations: PASKIN autophosphorylation was not directly related to 
target phosphorylation. However, our results are consistent with a recent report demonstrating 
that PASKIN kinase activity is independent of activation loop phosphorylation [19]. Thus, the 
original model of autophosphorylation-dependent kinase activity needs to be revised, and the 
functional meaning of PASKIN autophosphorylation remains to be elucidated. 
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Fig. 5. In vitro target phosphorylation of His6-PASKIN is reduced in presence of 
phosphatidylinositides. Recombinant His6-PASKIN purified from Sf9 insect cells was used to in vitro 
phosphorylate recombinant GST fusion proteins with wild-type S6, with the non-phosphorylatable double mutant 
S235/236A, with eEF1A1, or with its non-phosphorylatable T432A mutant, in the presence of (γ-33P)-ATP and 
PtdIns phosphates (100 µM) as indicated. Following separation by SDS-PAGE, protein phosphorylation was 
viusalized (left panel, representative images) and quantified (right panel) by phosphorimaging. His6-PASKIN 
autophosphorylation without lipid and target (first lane from the left) was used for intra-assay normalisation of the 
values. Columns represent mean values + SD of n = 3 independent experiments (*, p < 0.05; ** p < 0.01; ***, p < 
0.001; t-test). 
 
 In conclusion, our in vitro data suggest similar downstream effector functions of 
mammalian PASKIN as known from yeast: the coordination between energy flux and 
translation. With the identification of endogenous small molecule activators of PASKIN, we 
obtained the first hints on the upstream regulators of PASKIN activity and it will be 
interesting to examine how these regulators affect the downstream processes mediated by 
PASKIN. 
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EXPERIMENTAL PROCEDURES 
 
Plasmids 
All cloning work was carried out using Gateway technology (Invitrogen). The human 
PASKIN cDNA containing plasmids pENTR4-hPASK and pENTR4-hKIN, and plasmids for 
recombinant expression of full length His6-PASKIN, PASKIN truncations and eukaryotic 
elongation factor 1A1 have been published previously [18]. pENTR4-hPASK and pENTR4-
hKIN were recombined into pcDNA3.1/c-myc-DEST [32] using LR recombinase (Invitrogen) 
to generate pcDNA3.1/c-myc-hPASK and pcDNA3.1/c-myc-hKIN for c-myc-tagged 
expression of PASKIN or its kinase domain, respectively, in mammalian cells. Human 
ribosomal protein S6 (IRAUp969B0849D6, Deutsches Ressourcenzentrum für 
Genomforschung) was cloned into pENTR4 using forward and reverse primers 5'-
ttatgtcgacatgaagctgaacat-3' and 5'-tacgtgcggccgcttatttctgactggattcagacttag-3', respectively, or 
5'-tacgtggcggccgcttaaagtctgcgtctcttcgc-3' to introduce a stop codon after residue L234. The 
PCR products were ligated into the SalI and NotI restriction sites. The S6 S235/236A double 
mutant was produced with primers 5'-gcgaagagacgcaggctagccgctctgcgagcttctac-3' and 5'-
gtagaagctcgcagagcggctagcctgcgtctcttcgc-3' by Pfu polymerase-based site-directed 
mutagenesis (Stratagene). For expression as GST-tagged fusion proteins, pENTR4 based 
plasmids with the different S6 constructs were recombined into pDEST15 using LR 
recombinase. 
 
Purification of recombinant proteins 
Recombinant proteins were purified as described in detail previously [18]. Briefly, full-length 
PASKIN was purified from Sf9 cells using the Bac-to-Bac Baculovirus expression system 
(Invitrogen). GST-tagged fusion constructs and His6-tagged PASKIN fragments were 
expressed in arabinose inducible BL21 E. coli. Recombinant proteins were purified by FPLC 
(BioLogic DuoFlow, Biorad) using HiTrap Chelating HP and GSTrap FF columns (GE 
Healthcare), respectively. The kinase activity of purified recombinant PASKIN was verified 
by auto-phosphorylation assays. 
 
Kinase assays 
His6-PASKIN or PKCδ (Invitrogen) were incubated with or without 2 µg recombinant target 
proteins in kinase buffer (25 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM DTT) for 20 
minutes in the presence of 3 µCi (γ-33P)ATP (Hartmann Analytic). Proteins were separated by 
SDS-PAGE and analyzed by phosphorimaging of the dried gels (Molecular Imager FX, Bio-
Rad) using Quantity One software (Bio-Rad). Lipids (Sigma or Fluka) were dissolved in 
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CHCl3, aliquotted in test tubes and the CHCl3 evaporated under a stream of nitrogen. Lipids 
were then resuspended in kinase assay master mixes by thorough vortexing. 
Phosphatidylinositides present in the phosphorylation reactions were obtained from Echelon 
Biosciences as synthetic diC8-lipids and added to the reactions from 1 mM aequous stock 
solutions to the final concentrations indicated. 
 
Peptide microarrays 
Peptide microarrays were phosphorylated with recombinant PASKIN according to the 
manufacturer's instructions (Pepscan). In brief, 50 µl of a solution containing 500 ng 
recombinant PASKIN, 50 mM HEPES pH 7.4, 20 mM MgCl2, 10% glycerol, 300 µCi/ml (γ-
33P)ATP, 0.01% (v/v) Brij-35 and 0.01 mg/ml BSA was added to the glass slide, covered with 
a glass coverslip and incubated at 30°C for 2 hours in a humidified incubator. After 
incubation, the coverslip was removed with 1% Triton X-100 in PBS and the glass slide was 
washed twice with 1% Triton X-100 in 2 M NaCl and twice with water by over-head shaking, 
air-dried and analyzed by phosphorimaging (Bio-Rad). 
 
Phosphorylation of biotinylated peptides 
PASKIN phosphorylation reactions were performed as described above in the presence of N-
terminally biotinylated 20-mer target peptides (JPT peptide technologies) at 200 µM final 
concentration. The reactions were stopped by adding SDS to 0.5% final concentration and 
heating at 95°C for 5 minutes. Streptavidin sepharose beads (25 µl, GE Healthcare) and 500 
µl of 100 mM Tris-HCl pH 8.0 were added and incubated for 30 minutes at 4°C. The beads 
were washed three times with 500 µl of a buffer containing 10 mM Tris-HCl pH 8.0, 1 mM 
EDTA, 400 mM NaCl, 0.1% Nonidet P-40 and once with 500 µl 100 mM Tris pH 8.0. 
Phosphorylation of the beads was quantified by liquid scintillation counting (Tri-Carb 
2900TR, Packard-Perkin Elmer). 
 
Cell culture, transfections and immunoblotting 
Mouse embryonic fibroblast (MEF) cells were generated from Paskin+/+ and Paskin-/- mice 
[14] at embryonic day 14 (E14). S6K1-/-/S6K2-/- double knock-out MEFs were kindly provided 
by G. Thomas and S. C. Kozma (Basel, Switzerland). MEF cells were cultivated in 
Dulbecco’s modified Eagle medium (DMEM, Sigma) supplemented with 10% FCS 
(Invitrogen) up to passage 12, implying that they immortalised spontaneously. MEFs were 
transiently transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's 
protocol. 36 hours post transfection, cells were harvested and whole cell lysates were 
generated by heating the cells in 1% SDS for 5 minutes at 95°C. After SDS-PAGE and 
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immunoblotting, the following primary antibodies were used: human PASKIN (Affinity 
Bioreagents); mouse PASKIN, phospho-S6 (S235/236), S6 kinase and phospho-S6 kinase 
(T389) (Cell Signaling); S6 (Bethyl); β-actin and GST-tag (Sigma); His-tag (Novagen). 
 
Lipid binding assays 
Interactions between PASKIN and lipids were measured by an ELISA-based assay described 
previously [33]. Briefly, 96-well plates (Sarstedt) were coated overnight with phospholipids 
dissolved in methanol, followed by blocking with 3% BSA in PBS for 1 hour. Purified His6-
PASKIN (100 ng) was diluted in kinase buffer and allowed to bind for 1 hour at 30°C. After 
three washing steps (0.3% Tween-20 in PBS), bound PASKIN was detected by anti-PASKIN 
mAb6, followed by secondary goat anti-mouse HRP-conjugated antibodies (Pierce) using the 
3,3',5,5'-tetramethylbenzidine substrate kit (Pierce). The peroxidase reaction was stopped by 
adding H2SO4 (1 M final concentration) and absorbance was determined at 450 nm in a 
microplate reader (Digiscan, Asys Hitech). For phospholipase (PL) experiments, 
phospholipid-coated 96-well plates were treated with 0.2 units PLC or PLD (Sigma), diluted 
in reaction buffer (120 mM CaCl2, 300 mM sodium acetate pH 5.6) for 1 hour at room 
temperature. 
 
Lipid binding arrays 
Membranes spotted with phospholipids were obtained from Echelon Biosciences (P-6002, P-
6100) and used according to the manufacturer's protocol. Generally, 1 µg of protein diluted in 
1% skimmed dry milk in TBS was allowed to bind to spotted phospholipids for 16-20 hours 
at 4°C. Binding was detected using primary antibodies as indicated and HRP-coupled 
secondary antibodies for enhanced chemiluminescence detection (Pierce). 
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Target Protein Gene Symbol Species Swissprot Sequence Length Phosphosite Known kinase Radioactivity
Lamin B receptor LBR chicken P23913 SRSRSRSRS 9 S-80 SRPK1 / LBRK 14628.8
Lamin B receptor LBR chicken SRSRSRSPG 9 S-82 SRPK1 / LBRK 3816.9
Lamin B receptor LBR chicken RRSRSRSRS 9 S-78 SRPK1 / LBRK 2472.0
Peptide derived from cAMP dependent Protein Kinase Inhibitor alpha (14-22aa) PKIA human P61925 GRTGRRNSI 9 S-8 / 14221.6
Phosphorylase b kinase ȕ regulatory chain PHKB human Q93100 RTGRSGSV 8 S-26 (K24G) PKA 10948.7
Phosphorylase b kinase ȕ regulatory chain PHKB human RTKRSGSV 8 S-26 PKA 5074.4
Phosphorylase b kinase beta regulatory chain PHKB rabbit P12798 RSKRSGSV 8 S-26 (T23S) PKA 4953.5
Phosphorylase b kinase beta regulatory chain PHKB rabbit ARTKRSGSV 9 S-26 PKA 3528.0
Phosphorylase b kinase beta regulatory chain PHKB rabbit RTKRSGSV 8 S-26 PKA 2856.0
Phosphorylase b kinase beta regulatory chain PHKB rabbit RAKRSGSV 8 S-26 (T23A) PKA 2058.5
Microtubule-associated protein TAU MAPT human P10636 SRSRTPSLP 9 T-212 GSK3 10459.9
Myelin Basic Protein MBP bovine P02687 GRGLSLSR 8 S-136 / 10191.0
Voltage-dependent L-type calcium channel alpha-1S subunit CACNA1S rabbit P07293 SRRSSLGSL 9 S-1854 PKA 8368.0
Voltage-dependent L-type calcium channel alpha-1S subunit CACNA1S rabbit QRRTSLTGS 9 S-1757 PKA 7337.6
cAMP response element binding protein CREB1 human P16220 REILSRRPS 9 S-129 GSK3 8292.6
Pyruvate kinase isozyme L PKLR bovine / RRASLG 6 S-12 PKA 6524.6
Pyruvate kinase isozyme L PKLR bovine LRRGSLG 7 S-12 (A11G; A14G) PKA 5140.2
Pyruvate kinase isozyme L PKLR bovine LRRASLG 7 S-12 PKA 4409.3
Pyruvate kinase isozyme L PKLR bovine LRRATLG 7 S-12 (S12T) PKA 3538.9
Pyruvate kinase isozyme L PKLR bovine LRRPSLG 7 S-12 (A11P) PKA 2409.1
Pyruvate kinase isozyme L PKLR bovine LRRASLAG 8 S-12 (G14A) PKA 2347.2
Pyruvate kinase isozyme L PKLR bovine LRRASLRG 8 S-12 (G14R) PKA 2205.1
Pyruvate kinase isozymes R/L PKLR rat P12928 RRASS 5 S12/S-43 (V44S) PKA 6374.1
Pyruvate kinase isozymes R/L PKLR rat RRGSV 5 S12/S-43 (A42G)) PKA 5923.5
Pyruvate kinase isozymes R/L PKLR rat RRATVA 6 S12/S-43 (S43T) PKA 5449.2
Pyruvate kinase isozymes R/L PKLR rat RRVSV 5 S12/S-43 (A42V) PKA 5410.7
Pyruvate kinase isozymes R/L PKLR rat RRRRAASVA 9 PKA 5166.8
Pyruvate kinase isozymes R/L PKLR rat RRASL 5 S12/S-43 (V44L) PKA 5082.9
Pyruvate kinase isozymes R/L PKLR rat RRRASVA 7 PKA 4982.9
Pyruvate kinase isozymes R/L PKLR rat RRRRPTPA 8 PKA 4964.1
Pyruvate kinase isozymes R/L PKLR rat RRRRSVA 7 S12/S-43 (L39R; A42R)PKA 4591.3
Pyruvate kinase isozymes R/L PKLR rat RRFSV 5 S12/S-43 (A42F) PKA 3823.5
Pyruvate kinase isozymes R/L PKLR rat RRASI 5 S12/S-43 (V44I) PKA 3464.9
Pyruvate kinase isozymes R/L PKLR rat RRRRASVA 8 S12/S-43 (Y38R; L39R)PKA 2645.2
Pyruvate kinase isozymes R/L PKLR rat RRAASVA 7 S12/S-43 (L39R; R41A)PKA 2341.2
Pyruvate kinase isozymes R/L PKLR rat RRASR 5 S12/S-43 (V44R) PKA 2182.3
Pyruvate kinase isozymes R/L PKLR rat LRRASVA 7 S12/S-43 PKA 2170.1
Pyruvate kinase isozymes R/L PKLR rat RRASVA 6 S12/S-44 PKA 2079.1
Pyruvate kinase isozymes R/L PKLR rat RRPSV 5 S12/S43 (A42P) PKA 2028.6
40S ribosomal protein S6 RPS6 human P62753 RRLSSLRAS 9 S-236 S6K 6258.7
Neutrophil cytosol factor 1 NCF1 human P14598 PPRRSSIRN 9 S-303 / 5853.3
Glial fibrillary acidic protein GFAP bovine Q28115 RRVTSATRR 9 S-8 PKA 5674.0
Glial fibrillary acidic protein GFAP bovine Q28115 ATRRSYVSS 9 S-13 PKA 3168.5
Protamine Z1and Z2 PRM2 tuna P02322 RRSTVA 6 T-21 PKA 5571.2
Protamine Z1 and Z2 PRM2 salmon (clupa) P02336 RRRRSRRAS 9 S-6 PKA and PKC 4681.7
Protamine YI PRM3 salmon (clupa) P02337 RRSSSRPIR 9 S-8 PKA and PKC 4905.9
Heat shock protein 27 HSPB1 human P04792 SRALSRQLS 9 S-78 MAPKAPK2 5046.3
Inhibitor of protein phosphatase 1 PPP1R1A rabbit P01099 RRPTVA 6 T-35 PKA 4772.6
cAMP-dependent protein kinase type II-alpha regulatory subunit PRKAR2A bovine P00515 REARSRAST 9 S-44 GSK3 4407.1
Vitronectin [precursor] VTN human P04004 SRRPSRATW 9 S-397 PKA 4181.5
Keratin, type II cytoskeletal 8 KRT8 human P05787 FSSRSYTSG 9 S-23 / 3799.4
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 PFKFB1 rat P07953 RRRGSSIPQ 9 S-32 PKA 3746.0
Ras-related protein Rab-4A RAB4A human P20338 RQLRSPRRT 9 S-199 p34cdc2 3628.9
ATP citrate synthase ACLY rat P16638 TRAPSRTAS 9 S-450 MFPK 3514.9
Myosin IC heavy chain MYSC macaque P10569 RGRSSVYSA 9 S-311 myosin 3502.2
Hepatocyte growth factor receptor [precursor] MET human P08581 DRLVSARSV 9 S-985 PKC 2892.5
Acetylcholine receptor protein, delta subunit [precursor] ACHD torpedo californica P02718 RRSSSVGYI 9 S-383 PKA 2838.3
glycogen (starch) synthase GYS1 rabbit P13834 PLSRTLSVS 9 S-7 PKC/CAMII 2791.9
Lysozyme C [precursor] LYC chicken P00698 RGYSLG 6 S-42 PKA 2776.0
Interleukin-2 receptor alpha chain [precursor] IL2RA human P01589 RQRKSRRTI 9 S-268 PKC 2594.4
Troponin I, cardiac muscle TNNI3 rabbit P02646 GRALSTRAQ 9 S-72 PhK 2521.8
Troponin I, cardiac muscle TNNI3 rabbit P02646 RRRS 4 S-20 (V17R) PKA 2010.5
Glycogen phosphorylase GPH1 yeast P06738 TRRLTGFLP 9 T-30 / 2475.4
Desmin DES chicken P02542 GSRGSGSSV 9 S-35 PKA 2451.3
Desmin DES chicken P02542 QRVSSYRRT 9 S-12 PKC 2234.4
Ryanodine receptor 2 RYR2 rabbit P30957 TRRISQTSQ 9 S-2809 CaM-II 2394.6
Lamin-A LMNA human P02545 RGRASSHSS 9 S-403 PKC 2303.7
Lamin-A LMNA human P02545 TVTRSYRSV 9 S-625 PKC 2030.6
Inositol 1,4,5-trisphosphate receptor type 1 ITPR1 rat P29994 GRRESLTSF 9 S-1755 PKA 2290.7
Vimentin VIM mouse P20152 STSRSLYSS 9 S-50 PKA 2181.2
Vimentin VIM mouse P20152 SRPSSNRSY 9 S-25 autophosphorylation 2147.0
Lamin-B1 LMNB1 human P20700 RASSSRSVR 9 S-405 PKC 2084.2
Fibrinogen alpha chain [precursor] FGA human P02671 TTRRSASKT 9 S-460 PKA 2036.1
Parathyroid hormone/parathyroid hormone-related peptide receptor [precursor] PTH1R Didelphis marsupialis virginiana P25107 ARSGSSTYS 9 S-485 PKA 2029.3
Protein phosphatase 1 regulatory subunit 3A PPP1R3A rabbit  Q00756 SPQPSRRGS 9 S-44 GSK3 2004.9
Table S1.  Rank order of the 75 most strongly phosphorylated PASKIN kinase targets on the peptide microarray.
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Table S2. Sequences of the eleven biotinylated peptides tested for phosphorylation by 
recombinant PASKIN. Control peptides were derived from glycogen synthase(GYS) and 
pancreatic and duodenal homeobox (PDX)1 which have been reported previously to be 
phosphorylated by PASKIN. The other sequences tested were derived from the peptide 
microarray (underlined) and extended to 20 amino acids as indicated. Because some of the 
short sequences of the peptide microarray form consensus motifs, they can be found in 
multiple proteins. Therefore, some of the designations of the peptide microarray differ from 
the 20-mer biotinylated peptides. Abbreviations: GYS, glycogen synthase; PDX1, pancreatic 
and duodenal homeobox 1; PIAS1, protein inhibitor of activated STAT 1; RAB11BP, Rab11-
binding protein; FXN, frataxin; HERG, human ether-a-go-go related gene; CREB1, cAMP 
response element-binding protein 1; NFATC4, nuclear factor of activated T-cells c4; 4E-T, 
eIF4E-transporter; RPS6, 40S ribosomal protein S6; PHKB, phosphorylase kinase E; PFKFB, 
6-phosphofructokinase/fructose-2,6-bisphosphatase; MAPT, microtubule-associated protein 
tau; CACNA1S, calcium channel, voltage dependent, L type, alpha 1S subunit; PKLR, 
pyruvate kinase, liver and red blood cell; GSK3, glycogen synthase kinase 3; PKA, protein 
kinase A; S6K, p70 S6 kinase; RSK, p90 ribosomal S6 kinase; PKG, protein kinase G. 
References 
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ABSTRACT  
PASKIN is a PAS domain containing AMP-related serine/threonine sensory kinase which is 
ubiquitously expressed at low levels with highest expression in testis. We previously 
generated PASKIN knock-out mice that did not display an apparent phenotype. However, a 
function for PASKIN in the regulation of insulin and glucagon expression and secretion has 
been reported. Glucose stimulated insulin expression in pancreatic β-cells relies on the 
activity of the transcription factor pancreatic and duodenal homeobox protein 1 (PDX-1). It 
has been shown that PASKIN modulates the both expression and activity of PDX-1. In 
yeast, a PASKIN phenotype only appears under high temperature stress conditions with 
galactose as only energy source, where the yeast orthologue Psk phosphorylates target 
proteins involved in energy metabolism and protein translation. One of the targets is yeast 
glycogen synthase, of which also its mammalian orthologue can be phosphorylated by 
PASKIN leading to a breakdown of intracellular glycogen. We speculate that PASKIN might 
sense the concentration of an unknown metabolic ligand and signal as a sensor of 
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 metabolic homeostasis. Herein we show that upon feeding a 45% high fat diet, Paskin-/- 
mice are partially protected from obesity and insulin resistance. However, feeding of a 
60% high fat diet did not increase the phenotype, in the contrary, any differences in body 
weight gain disappeared. Furthermore, we could not find a hypermetabolic phenotype in 
indirect calorimetry and body temperature measurements. We demonstrate that energy 
homeostasis mediated by PASKIN on cellular level is independent of AMPK but might 
involve thyroid hormones which negatively influence PASKIN kinase activity in vitro and 
therefore might be a repressive metabolic ligand of PASKIN. 
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 INTRODUCTION  
PAS (Per-Arnt-Sim) proteins are known from all three kingdoms of life where they represent 
protein sensors involved in the perception of light intensity, oxygen partial pressure, redox 
potentials, voltage and certain ligands (1-2). Mammalian PAS domains can also serve as 
heterodimerisation interfaces of transcription factors involved in xenobiotic response, 
adaptation to hypoxia and circadian rhythm generation (3-6). By database searches using the 
PAS sequence as a bait, we and others identified a mammalian PAS protein termed PASKIN 
(7) or PASK (8). PASKIN contains two PAS domains showing a high sequence similarity to 
the oxygen sensor protein FixL of Rhizobium species, and a serine/threonine kinase domain 
related to the AMP-kinases. According to the current model, the PAS domain of PASKIN 
represses the kinase activity in cis. Upon binding of a ligand to the PAS domain, the kinase 
domain is de-repressed, therefore activated and can autophosphorylate (9). Synthetic ligands 
have been identified that show a structural similarity to dioxin, a molecule known to bind the 
PAS domain of the aryl hydrocarbon receptor (9). However, an endogenous ligand for 
PASKIN activation has not been identified so far.  
To elucidate the function of PASKIN, our lab previously generated PASKIN deficient knock-
out mice (10). We found that PASKIN mRNA expression was remarkably higher in testis 
than in any other tissue (11). Immunohistochemistry showed that PASKIN is upregulated 
during the post-meiotic stages of spermatogenesis and concentrates at the mid-piece of the 
sperm tail (12). Functionally, however, neither male fertility nor sperm production and 
motility was affected in PASKIN knock-out mice (10).  
In yeast, a double knockout of the PASKIN homologs PSK1 and PSK2 displayed decreased 
growth at elevated temperature (39°C) and galactose supply (13). PSK1 and PSK2 
phosphorylate three translation factors (Caf20, Tif11 and Sro9) and two enzymes involved in 
glycogen and trehalose synthesis (Ugp1, Gsy2), thus controlling translation and sugar flux 
(13). It has been shown that mammalian glycogen synthase interacts with the midregion of 
human PASKIN and can be phosphorylated at Ser-640 (14). However, mammalian PASKIN 
has mainly been involved in insulin signaling. In pancreatic β-cells PASKIN mRNA is 
upregulated upon glucose stimulation (15-16). Several findings involve PASKIN in 
upregulation of PDX-1 mRNA (15-16), a major transcription factor of the insulin gene, and it 
has been shown that PASKIN kinase function might phosphorylate PDX-1, leading to 
translocation of the transcription factor into the nucleus (17). However, we have challenged 
the role for PASKIN in glucose stimulated insulin gene expression as in our hands Paskin 
mRNA levels were not increased upon glucose stimulation (11). 
Using our Paskin-/- mouse model it has been found, that male Paskin-/- mice were partially 
protected from high fat diet induced obesity and showed better glucose tolerance (18). This 
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 observation together with increased O2 consumption and CO2 production led to the hypothesis 
that Paskin-/- male mice were hypermetabolic. Futhermore, it has been shown that ATP 
synthesis rate was increased in Paskin-/- soleus muscle and a knockdown of Paskin in L6 
myoblasts resulted in increased glucose and palmitate oxidation (18). It is well acknowledged 
that the main cellular metabolic sensor is represented by AMP activated protein kinase 
(AMPK), a well-conserved serine/threonine kinase (19). AMPK is formed by a catalytic 
subunit (α) and two regulatory subunits (β and γ) and is activated allosterically by an 
increased intracellular AMP/ATP ratio and by phosphorylation of the threonine 172 residue 
located in the activation loop of the α subunit (20). Once activated, AMPK leads to a 
concomitant inhibition of energy-consuming biosynthetic pathways and activation of ATP-
producing catabolic pathways.  
Herein we show that PASKIN is to some extent a direct counterplayer of AMPK signaling 
pathway. By changing the diet to 45% fat by calories, Paskin-/- mice resisted to fat 
accumulation and glucose intolerance. However, elevating the fat content to 60% fat by 
calories did not show any further increase of the phenotype, in the contrary, the phenotypic 
differences were lost. To find potential cellular explanations, we particularly focused on 
AMPK signaling and growth of mouse embryonic fibroblasts and thyroid hormone as 
potential ligand of the PAS domain of PASKIN.  
 
METHODS  
Animals  
Paskin-/- mice (10) were backcrossed into C57BL/6J (The Jackson Laboratory) for 10 
generations. C57BL/6J control animals were raised in the same room under the same 
conditions. Mice were maintained on a normal chow diet or a high fat diet beginning at 12 
weeks of age (Research Diets, D12451 with 45% fat by calories, D12492 with 60% fat by 
calories). In each experiment, age-matched wild type were used as controls for Paskin-/- mice. 
All animal handling followed the guidelines for the use and care of laboratory animals of the 
Bundesamt für Veterinärwesen and was approved by the Kantonales Veterinäramt Zürich (Nr. 
192/2003 and 8/2008).  
 
Immunoblotting  
Total protein extracts of cultured cells were prepared using cell lysis buffer (10 mM Tris-HCl 
pH 8, 1 mM EDTA pH 8, 400 mM NaCl, 0.1% NP-40, protease inhibitor cocktail (Roche)) 
and centrifuged (5 min, 15´000 rpm, 4°C). Proteins from tissues were prepared as described 
previously (21). Concentrations of supernatants were determined according to Bradford (22). 
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 Proteins were seperated by SDS-PAGE and transferred onto nitrocellulose membranes 
(Amersham). The following primary antibodies were used: rabbit monoclonal antibody 
(mAb) anti-AMPKα (Cell signaling) and rabbit mAb anti-phospho-AMPKα (Τ172) (Cell 
signaling), rabbit polyclonal anti-β-actin (Sigma); and secondary polyclonal goat anti-mouse 
or anti-rabbit antibodies coupled to horseradish peroxidase (Pierce) Chemiluminescence 
detection was performed with the Supersignal West Dura kit (Pierce) and recorded with a 
CCD camera (FluorChem8900, AlphaInnotech, Switzerland) or by exposure to X-ray films 
(Fuji).  
 
Motor activity recordings and analysis  
Mice were housed individually in sound-proof and light-tight environment with a light/dark 
cycle of 12 h each in cages equipped with a running wheel or infrared sensors. Wheel 
revolutions were monitored in 1 minute intervals continuously using the Chronobiology Kit 
(Stanford Software Systems) as described previously (23). The experiment was conducted for 
the indicated number of animals at the age of 11-13 weeks for 10 consecutive days. 
 
Glucose / insulin tolerance test 
Animals tested were 9 months of age and were fed a HFD for 6 months. For glucose tolerance 
tests (GTT), the animals were fasted for 16 h before injection of 20% glucose in 0.9% NaCl 
(2 g glucose/kg body weight) i.p. At the indicated times, tail vein blood was sampled for 
electrochemical glucose determination (Accu-Chek Aviva, Roche Diagnostics). For insulin 
tolerance tests (ITT), human recombinant insulin (0.75 U/kg body weight) was injected 
intraperitoneally to fasted (16 h) mice and blood glucose levels were determined at the 
indicated times. 
 
Indirect calorimetry  
At 14 weeks of age, mice were fed a 60% high fat diet. For assessment of body temperature, 
mice were implanted a transmitter (PhysioTel PA-C10, Data Science International, St. Paul, 
MN) into the peritoneal cavity under isoflurane anesthesia at 18 weeks of age. This 
transmitter allowed telemetric assessment of body temperature and physical activity. Body 
temperature and physical activity were simultaneously monitored by the DataScience ART4.0 
telemetry system (DataScience International, St. Paul, MN). Indirect calorimetry 
measurements were performed at 28 weeks of age in an open circuit calorimetry system 
(AccuScan Inc., Columbus, OH). Room air was passed through each cage with a flow rate 
controlled at approximately 2 l/min. Every 2 min, air was sampled during 20 s for each 
individual cage and analyzed for V(O2) and V(CO2) (ml/kg/min). All data were analyzed with 
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 AccuScan Integra ME software. Energy expenditure was calculated according to Weir (24) 
using the following equation: total energy expenditure (kcal/h) = 3.9 × V(O2) ml/h + 1.1 × 
V(CO2) ml/h. The respiratory quotient (RQ) is defined as the quotient between CO2 
production and O2 consumption. 
 
Metabolic blood analysis  
Paskin-/- and Paskin+/+ mice were 11 months old and one group had been fed a 45% HFD for 
the last 8 months. Animals were fasted for 6 hours before anaesthesia (200 mg/kg body 
weight Ketamine, 10 mg/kg body weight Xylazine). Up to 1 ml blood was removed from the 
portal vein into a heparinised syringe with a 25 Gauge needle. After centrifugation (5 min, 
8000 g, 25°C) the plasma was stored at -80°C. Measurements of indicated analytes were 
performed by the institute for clinical chemistry (IKC, USZ Zürich, Switzerland). For the 
measurement of total T3 and total T4 thyroid hormones, mice were anesthesized and blood 
was removed by heart puncture. Plasma was analysed by Unilabs Dr. Weber (St. Gallen, 
Switzerland). 
 
Intracellular ATP measurements and MEF growth analysis 
ATP measurements were performed in 96-well format. 5000 cells were seeded per well and 
grown in Dulbecco’s modified eagles medium with 4.5 g glucose per liter. 16 hours post 
seeding, cells were washed three times with PBS and supplemented with media of different 
glucose concentrations with or without fetal calf serum for 2 hours, as indicated. Thereafter, 
ATP concentration was measured by a luminescence based assay using CellTiter-GloR 
reagent (Promega). Measurements were performed by mixing the cells with 25 µl of DMEM 
without FCS and 25 µl of CellTiter-GloR reagent. After 10 minutes of passive lysis whith 
vertical shaking, luminescence of lysates was measured on a luminometer (Centro LB 960, 
Berthold  Technologies), and quantified versus an ATP standard dilution series ranging from 
1 nM to 10 µM. For normalisation, protein concentration of entire wells was determined by 
BCA assay (Pierce). Growth curves and cell size were analysed using a cell counter (ViCell, 
Beckman Coulter). 
 
Kinase assay 
Recombinant proteins were purified as described previously (12). Briefly, full-length 
PASKIN was expressed in Sf9 cells using the Bac-to-Bac Baculovirus expression system 
(Invitrogen). Recombinant His6-PASKIN was purified by FPLC (BioLogic DuoFlow, Biorad) 
using a HiTrap Chelating HP column (GE Healthcare). The kinase activity of purified 
recombinant PASKIN was verified by auto-phosphorylation assays. His6-PASKIN was 
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 incubated in kinase buffer (25 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1 mM DTT) for 10 
minutes in presence of 3 µCi [γ-33P]-ATP (Hartmann Analytic). The individual reactions 
contained thyroid hormones (Sigma) in a 10-fold serial dilution ranging from 100 µM to 1 
nM (dissolved in 50 mM NaOH added 1:10 to each reaction) including a solvent control. 
Reactions were stopped with 1% SDS, separated by SDS-PAGE and analyzed by 
phosphorimaging of the dried gels (Molecular Imager FX, Bio-Rad) using QuantityOne 
software (Bio-Rad).  
 
Computed tomography 
Mice fed a 60% high fat diet were analysed for body fat content and liver steatosis post 
mortem using a La Theta LCT-100 (Aloka) tomograph as previously described (25). Briefly, 
X-ray source voltage was set to 50 kV with a constant current of 1 mA. Mice were measured 
in a 48 mm holder at 1 mm pitch size in high speed settings. Mice tails were excluded from 
measurements, as they contained negligible amounts of fat. The experiment was performed 
using n=6 Paskin+/+ and Paskin-/- mice, respectively. Using Aloka software, subcutaneous and 
intraabdominal fat were separated by the abdominal wall for estimation. Liver fat content was 
determined from two sequential slices where liver, spleen and adipose tissue were 
simultaneously present. In humans, attenuation of liver is at least 4 Hounsfield units greater 
than for spleen, whereas in individuals with hepatic steatosis, liver attenuation is smaller than 
spleen attenuation (26). Attenuations were determined by averaging the Hounsfield units of 
two adjacent slices and liver/fat and liver/spleen ratios as well as liver-spleen differences were 
calculated. 
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 RESULTS  
Body weight of Paskin-/- and Paskin+/+ mice 
Body weight of Paskin-/- mice was analysed on a daily base from day 6 on and after weaning 
on a weekly base until the age of three months. The graphs in Fig. 1A represent the mean 
weight of the animals at an age of 65 days, when a small but significant elevation of body 
weight could be detected in male but not female Paskin-/- mice. 
 
Fig. 1. Body weight of Paskin+/+ and Paskin-/- mice under chow diet and high fat diet. (A) Paskin+/+ 
and Paskin-/- mice under normal chow diet. The body weight at the age of 65 days is shown for the 
indicated number of animals (mean ± SEM, Student’s t-test, * p<0.05). (B) The left panel shows body 
weight and body weight gain for male mice under chow diet and 45% high fat diet (n=8 mice per 
group, high fat diet started at the age of 14 weeks). The right panel shows female mice, accordingly. 
Despite similar food intake (data not shown), Paskin-/- animals gain less body weight under a 45% high 
fat diet. Data are represented as mean ± SEM. 
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 To challenge metabolic homeostasis, Paskin-/- and Paskin+/+ mice were fed a diet consisting of 
45% fat by calories. At the age of 14 weeks, 16 Paskin-/- mice (8 females and 8 males) were 
fed either a high fat diet (HFD) or normal chow diet (NCD, 11.7% fat by calories). 
Analogously, 16 Paskin+/+ control animals were included. The left panels of Fig. 1B represent 
the body weight and the cumulative body weight gain under NCD for male and female mice, 
respectively, while on the right panels the same evaluation is illustrated under HFD 
conditions. Male Paskin-/- mice showed the expected significant increase in body weight on 
NCD but no difference in cumulative body weight gain. Under HFD, however, Paskin-/- mice 
showed a lower body weight after 8 weeks on HFD compared to the body weight of Paskin+/+ 
mice as a result from decreased body weight gain under HFD. Similarly, female Paskin-/- mice 
were heavier on NCD but gain less body weight under HFD. Thus, the protective effect on 
development of obesity for male Paskin-/- animals on HFD, as published before (18), could be 
reproduced in our hands. In our feeding experiment this result holds true for female Paskin-/- 
mice as well. This encouraged us to investigate the metabolic phenotype in more detail. 
 
Intraperitoneal glucose tolerance tests with HFD fed mice  
Feeding of a HFD induces obesity and is a model the metabolic syndrome (27). The 
maintainance of stable basal blood glucose levels is ensured by the peptide hormones insulin 
and glucagon. Type 2 diabetic patients usually show peripheral insulin resistance as a 
consequence of hyperglycemia. Intraperitoneal glucose tolerance and insulin tolerance tests 
(IPGTT/IPITT) are standard methods to phenotype strains with impaired glucose 
homeostasis. We have previously shown that under NCD the ability of glucose clearance after 
injected glucose is identical between Paskin+/+ and Paskin-/- mice (11). However, it has been 
published that male Paskin-/- mice appeared to be partially protected from insulin resistance 
when fed a HFD (18). As expected, we did not observe any difference in IPGTT for NCD fed 
mice (Fig. 2A, left panel) and only HFD fed male but not female Paskin-/- mice showed a 
partial protection from insulin resistance. Therefore we assume that HFD-feeding causes no 
defect in glucose tolerance in Paskin-/- males. According to published literature, this 
phenotype does not occur in Paskin-/- females on HFD, confirming our results (18).  
Insulin tolerance tests were performed with the same animals one week later. In this 
experiment, especially male animals hardly lowered their blood glucose levels independent of 
their genotype. However, the blood glucose levels of HFD fed Paskin-/- males were generally 
lower for the whole duration of the insulin tolerance test. Female mice showed a drop of 40 
mg/dl, however, the fasted blood glucose levels were already low in NCD animals (80 mg/dl). 
This result is contradictory to published observations on randomly HFD fed animals, where 
increased insulin sensitivity in male Paskin-/- mice was observed (18).  
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Fig. 2. Glucose tolerance test and insulin tolerance test for Paskin+/+ and Paskin-/- mice under chow 
diet and high fat diet. (A) Glucose tolerance test for Paskin+/+ and Paskin-/- mice under normal chow 
diet and high fat diet. Fasted mice were administered 2 g/kg body weight of glucose intraperitoneally. 
Each group consisted of three to four animals at the age of 9 months. Only male mice fed a 45% high 
fat diet display an effect of partial protection of an insulin resistance for the Paskin-/- genotype. (B) 
Intraperitoneal insulin tolerance test of the same animals as in (A). Fasted mice were administered 
0.75 U/kg body weight of human insulin. No difference could be found. Although Paskin-/- male mice 
generally had lower glucose levels than Paskin+/+ males, the animals did not raise their blood glucose 
levels prior to the insulin tolerance test and did not respond to administered insulin. Data are 
represented as mean ± SEM (Student’s t-test, * p<0.05, ** p<0.01). 
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 Indirect calorimetry measurements with Paskin-/- and Paskin+/+ mice  
Since we could confirm that at least male Paskin-/- mice are partially protected from high fat 
diet induced obesity and might be hypermetabolic, a second round of feeding experiments 
was started using a diet consisting of 60% of fat by calories instead of 45%, with the goal of 
increasing potential phenotypic effects on body weight. The body weight of 7 Paskin-/- and 7 
Paskin+/+ male mice on 60% fat HFD was monitored for 16 weeks. Fig. 3A, however, shows 
that instead of increasing the protective effect on obesity (as shown in Fig. 1B), Paskin-/- 
males did not differ from control animals following an increase in dietary fat content from 
45% to 60%. 
 
 
Fig. 3. Feeding of a 60% fat by calories high fat diet and indirect calorimetry for Paskin+/+  and 
Paskin-/- male mice. (A) Growth curve for Paskin+/+ and Paskin-/- male mice under a high fat diet of 
60% of fat by calories. Paskin-/- males were slightly heavier at the age of 14 weeks, when the HFD 
feeding was initiated. The slight difference in body weight gain can be explained by a slightly lower 
food intake for Paskin-/- mice. Instead of increasing the effect seen for a 45% HFD (Fig. 1), the 60% 
HFD did not show any significant difference between Paskin+/+ and Paskin-/- male mice (n=7 mice per 
group). (B) To see a potential difference in energy expenditure, we performed indirect calorimetry 
experiments for male mice fed a 60% HFD including the continuous recording of body temperature by 
a sensor implanted intraperitoneally. While the animals were eating equal amounts of food and 
showed stable body weight, we expected differences in body temperature or energy expenditure. 
Analysis was split into 12 h light and 12 h dark phase but did not show differences in any of the 
parameters measured for an n = 6 animals. Data are represented as mean ± SEM. 
 
Obesity occurs from an imbalance between energy intake (food intake) and energy 
expenditure (basal metabolism and physical activity) (28). Therefore, we were interested, 
whether the hypermetabolic phenotype was manifested in indirect calorimetry hypothesizing 
that despite similar body weight, energy expenditure was impaired. Additionally, we 
intraperitoneally implanted sensors that allowed a continuous measurement of body 
temperature. We conducted this experiment on male Paskin-/- and Paskin+/+ mice on 60% high 
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 fat diet with n=6 animals each group. The mice were adapted to the metabolic cages for 5 
days before measurement. The analysis was split into a 12 hour light phase and a 12 hour dark 
phase. As expected, animals were more active during dark phase showing increased energy 
expenditure, respiratory quotient and body temperature (Fig. 3B). However, we could not 
confirm a Paskin-/- specific hypermetabolic phenotype. During the measurement, both groups 
consumed equal amounts of food and displayed equal body weight gain (data not shown) 
while not differing in any of the calorimetric parameters measured. 
 
Running Wheel performance of Paskin-/- and Paskin+/+ mice  
Another possible parameter that might lead to differences in body weight is locomotor 
activity. The fact that male Paskin-/- mice under NCD are slightly heavier might be caused by 
a lower spontaneous activity. The extent of locomotor activity was assessed with infrared 
sensors as well as by monitoring running wheel activity in a normal 12h dark/12h light cycle. 
For running wheel activity, we included 14 Paskin+/+ and 21 Paskin-/- male mice and for IR-
beam breaks we tested 6 Paskin+/+ and Paskin-/- males, each. The locomotor activity for each 
setup was recorded for 10 subsequent days. As expected, the animals were barely active 
during the light phase, not running more than an average of 101 meters per day and showing 
an IR-beam break activity 10 fold lower than during the dark phase. Therefore the run 
distance in the dark phase is shown. For every animal, the average distance covered in the 
running wheel per 12 hours dark phase was calculated (Fig 4A). However, the average 
running wheel distances do not differ between Paskin+/+ and Paskin-/- mice with 11.6±0.9 and 
11.9±0.5 km per night, respectively. More random and subtle movements in the cages were 
assessed by IR-beam break activity. Fig 4B shows the average number of IR-beam breaks per 
12 h dark phase. Confirming the result from the running wheel, no difference in activity could 
be observed. 
 
Fig. 4. Basal locomotor activity of Paskin+/+ and Paskin-/- male mice. (A) Mice were kept in cages with 
a running wheel option with a LD cycle of 12 h. As the animals were barely active during the light 
phase, dark phase activity is shown as m / 12 h averaged over 10 days of experimentation. No 
difference between Paskin+/+ (n = 14) and Paskin-/- (n = 21) male mice can be observed. (B) For n = 6 
mice per group, locomotor activity was assessed by infrared beam breaks. Dark phase activity is 
displayed similar to panel (A). No difference between Paskin+/+ and Paskin-/- male mice could be 
observed in this experiment. All data are represented as mean ± SEM. 
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Fig. 5. Cellular energy status in Paskin+/+ and Paskin-/- MEFs. (A) The cellular energy status of Paskin+/+ 
and Paskin-/- MEFs was analysed for phosphorylation of AMP kinase in three primary isolates (P) and 
spontaneously immortalised (I) MEFs. Phosphorylation of AMP kinase at T172 activates the enzyme 
when energy status is low. A tendency to stronger phosphorylation of Paskin-/- MEFs can be observed 
and would support a hypermetabolic phenotype. (B) In gastrocnemius muscle extracts from mice fed 
either a HFD or a NCD, no difference in phospho-AMPK between Paskin+/+ and Paskin-/- mice could be 
observed. (C) Intracellular levels of ATP in immortalised MEFs were assessed by a luciferase based 
assay. A total of 6 wells of a 96-well microtiter plate per growth condition were measured for ATP 
content and normalised to total protein. No differences could be observed for any of the conditions 
measured. (D, E) Immortalised MEFs were analysed for their growth behaviour. (D) represents a 
typical growth curve of cells seeded in quadruplicates. (E) depicts the doubling times of three 
independent growth curve experiments. (F) Cell size was analysed after detachment of cells in 
PBS/EDTA visually using ViCell counter. Altogether, immortalised MEFs from Paskin+/+ and Paskin-/- 
embryos show similar growth. 
 
AMPK expression in Paskin-/- and Paskin+/+ mouse embryonic fibroblasts  
As the in vivo experiments showed a metabolic phenotype only for male Paskin-/- mice on 
45% HFD, we were interested whether we could transduce a potential role for Paskin in 
energy homeostasis to a cellular level. Therefore, we isolated mouse embryonic fibroblasts 
(MEFs) from our Paskin-/- and Paskin+/+ mice and examined whether PASKIN might have an 
effect on AMPK, which is the major sensor of the cellular metabolic energy status. We kept 
primary MEFs in culture until cells spontaneously immortalised. Immunoblot analysis of 
primary and immortalised MEFs showed a tendency to lower activity of AMPK in Paskin+/+ 
MEFs, detected with a phospho-T172 AMPK antibody (Fig.5A). Quantitative real time PCR 
showed the presence of AMPK subunit α1 and not subunit α2 in our MEF cells. Furthermore 
we could confirm in both, the spontaneously immortalized and the primary MEF, that AMPK 
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 is not regulated on the transcriptional level through PASKIN (data not shown). Analysing 
protein extracts of gastrocnemius muscle from mice fed either a NCD or a HFD did not 
confirm these findings (Fig. 5B).  
To investigate the energy status of our immortalised MEFs more directly, we determined the 
intracellular ATP concentration on a firefly luciferase based readout. We seeded equal 
amounts of MEFs on a 96-well plate with DMEM and different glucose concentrations as 
indicated in Fig. 5C. Lysates generated from these cells could directly be used for 
determination of cellular ATP, since ATP consumed by firefly luciferase directly correlates 
with light emission (29-30). The levels of ATP were normalised to total protein content. 
Intracellular ATP, however does not differ between Paskin+/+ and Paskin-/- MEFs. 
Furthermore, we performed growth curve experiments (Figs. 5D, 5E) and determined cell size 
(Fig. 5F). From three independent growth curve experiments, no difference in doubling time 
could be observed with average of 19.8 hours for Paskin+/+ MEFs and 18.8 hours for Paskin-/- 
MEFs and similar cell size. Therefore we conclude that AMPK is not regulated by PASKIN 
and the cellular metabolic state does not differ in wildtype versus knock-out MEFs. It is, 
however, questionable whether MEFs are the appropriate model for a cellular metabolic 
phenotype to occur.  
 
Blood plasma analysis of Paskin-/- and Paskin+/+ mice  
Blood from Paskin-/- and Paskin+/+ mice either fed 45% HFD or chow diet was collected, and 
metabolites were analysed. As markers for lipid homeostasis, cholesterol and triglycerides 
were estimated. Total cholesterol blood levels are expected to be elevated under HFD (31). 
This held true for the Paskin+/+ female mice (Fig. 7b). Paskin-/- females, however, had lower 
blood cholesterol which is consistent with the finding, that under 45% high fat diet their body 
weight was not elevated to the same extent as the Paskin+/+ body weight. However, for male 
animals the contrary was found leading to very moderate effects when male and female 
values were taken together (Fig. 7b). High triglyceride blood levels arise as a consequence of 
secondary hyperlipemia and are associated with diabetes mellitus (32). Although not 
significant, triglyceride levels were slightly elevated in HFD fed Paskin+/+ male animals when 
compared to Paskin-/- male mice. The contrary was true for female animals (Fig. 7c). 
Conversely, we detected increased free fatty acid levels in HFD and NCD fed Paskin-/- 
females versus Paskin+/+ females (Fig. 7d). 
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Fig. 6. Blood plasma lipid homeostasis in mice fed a chow diet or high fat diet. Mice were fasted for 
6 hours prior to terminal blood sampling from portal vein. See text for detail. Data represent mean ± 
SEM. 
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 Indicative enzymes for proper liver function are alanine-aminotransferase (ALT), aspartate-
aminotransferase (AST) and alkaline phosphatase (ALP). It has been shown that feeding of a 
high fat diet induces hepatic steatosis and leads to elevated blood levels of ALT, AST and 
ALP (33). For ALP, our data indicate a slight increase for Paskin-/- male mice independent of 
the diet. For AST and ALT, one Paskin+/+ and one Paskin-/- male mouse showed increased 
activity when fed a 45% HFD, potentially indicating diet induced steatosis, however, not 
differing between the two genotypes and the number of animals should be increased for 
valuable results. Creatine kinase (CK) is a marker enzyme for myocardial infarction and can 
be elevated, reflecting muscle activity. As obesity is a risk factor for myocardial infarction, 
this parameter is of interest, even though it has been shown that obesity itself does not alter 
CK activity from patient serum (34). However, no changes in blood CK levels could be 
observed between Paskin+/+ and Paskin-/- male mice (Fig. 6e). 
Conclusively, we could not find significant differences in the blood parameter analysis. 
However,  we observed several trends,  such as slightly decreased triglyceride levels in 
Paskin-/- male animals and elevated levels of free fatty acids in female Paskin-/- mice. This 
might reflect a better breakdown of triglycerides in the adipose tissue of Paskin-/- mice. The 
differences observed in cholesterol levels were contradictory and when both genders were 
analysed together, the levels were similar.  Further experiments with an increased number of 
animals are required to get additional hints of a PASKIN function with respect to lipid 
metabolism. Regarding liver function, however, we did not observe any difference at all 
between the two groups. 
 
Thyroid hormones enhance PASKIN autophosphorylation in vitro 
A model for PASKIN enzyme function proposes auto-inhibition of the kinase function of 
PASKIN in cis by its PAS domain. As a potential sensory domain, a yet unknown small 
organic ligand is suggested to bind the PAS domain thereby inducing changes in 
conformation leading to de-repression of the kinase domain (9). Rutter et al. have screened a 
compound library and found that the strongest ligands binding the PAS domain consisted of 
two aromatic rings (9). Therefore we were interested, whether PASKIN activity monitored by 
autophosphorylation is influenced by the presence of the thyroid hormones thyroxine (T4) or 
triiodothyronine (T3), two hormones resembling the before mentioned synthetic compounds. 
As a control, the biosynthetic precursor amino acid L-tyrosine was used. We could observe a 
concentration dependent response of PASKIN autophosphorylation to both T3 and T4 with 
inhibtion at high concentrations and activation at low concentrations of the hormones (Fig. 
7A). However, the concentrations in the in vitro assay are in the micromolar to nanomolar 
range and do not reflect the low intracellular concentrations that range in low picomolar 
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 concentrations (35). Thyroid hormones are important regulators of cellular metabolic 
processes by increasing basal metabolic rate, increasing both breakdown and synthesis of 
cellular energy storage and protein thereby generating heat (36). We therefore wondered, 
whether we could observe any difference of thyroid hormones in blood plasma of Paskin+/+ 
and Paskin-/- mice. As thyroid hormones circulating in the blood stream are bound to thyroid 
binding globulin (TBG) and thereby inactive, our measurements of total thyroid hormones 
rather reflect the synthesis of thyroid hormones that might largely differ from the amount of 
available and active hormones. As depicted in Fig. 7B, no difference in total thyroid 
hormones T3 and T4 was detected between Paskin+/+ and Paskin-/- plasma. 
 
 
Fig. 7. Inhibition of PASKIN autophosphorylation by Thyroid hormones. (A) Recombinant PASKIN 
protein was allowed to autophosphorylate in vitro in presence of thyroid hormones T4, T3 and L-
tyrosine as a control. Concentrations of thyroid hormones and L-tyrosine ranged from 100 µM to 1 
nM in 10-fold dilutions. Compared to negative solvent controls (-/open bars), PASKIN 
autophosphorylation is inhibited by approximately 50% with a concentration of 100 µM of thyroid 
hormones present in the reaction mixture, with a decrease of inhibition along with decreasing thyroid 
hormone concentrations. (B) Total thyroid hormones T4 and T3 in plasma of male Paskin+/+ and 
Paskin-/- mice fed a 60% HFD. Blood was collected terminally by heart puncture. No difference in total 
thyroid hormones could be observed between Paskin+/+ and Paskin-/- mice.  
 
Determination of body fat distribution and liver fat content in Paskin-/- and 
Paskin+/+ mice by computed tomography 
Of the mice on 60% high fat diet, we determined the body fat mass post mortem by computed 
tomography. By applying this method, we could discriminate subcutaneous from visceral fat 
to see potential differences in fat distribution. As shown in Fig. 8A, the animals had an 
average total fat content of 37% for Paskin-/- and Paskin+/+ male mice, but we could not 
observe any difference between the two groups, neither in total adipose tissue nor in the 
distribution of visceral and subcutaneous fat. This result matched our expectations, since we 
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 could not observe any difference in body weight in the animals tested. Additionally, we 
determined the liver fat content of Paskin-/- and Paskin+/+ mice. As estimates of hepatic 
steatosis, liver/spleen ratio and liver-spleen difference are well recognised (37-38). Regarding 
diagnosis of steatosis, proposed cutoff values for human are CTL/S of 0.8 or CTL-S of -9 with 
lower values indicating hepatic steatosis of 30% or greater (37). Our measurements resulted 
in the observation that all animals developed hepatic steatosis, however, no difference in 
degree could be observed between Paskin-/- and Paskin+/+ mice. 
 
Fig. 8. Estimation of fat distribution and liver steatosis by computed tomography. (A) Mice were fed 
a high fat diet of 60% fat by calories for 16 weeks. Sacrified mice were scanned for analysis of visceral 
fat (purple) and subcutaneous fat (yellow) separated by the abdominal wall (lean mass, blue). No 
difference in total fat nor in fat distribution was detected. (B) Liver fat was estimated by computer 
tomography. Huntingfield units of liver (3) were compared to lean mass (spleen, 1) and visceral fat (2). 
Data plots show advanced steatosis for both Paskin+/+ and Paskin-/- mice, but no significant difference 
in liver fat content was observed. See text for details. 
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 DISCUSSION  
When fed a high-fat diet (HFD), C57BL/6J mice are known to develop obesity and a series of 
symptoms reminiscent of the metabolic syndrome, including insulin resistance (27). A recent 
publication by the group of Jared Rutter suggested that Paskin-/- male mice are partially 
protected from the negative effects of a high fat diet, suggesting a hypermetabolic phenotype 
(39). We observed a similar trend that Paskin-/- mice are partially protected from the 
development of obesity under 45% high fat diet not only for male mice but also for females. 
However, feeding a high fat diet of 60% of fat by calories did not confirm the protective 
effect. As obesity results from the imbalance between energy intake and energy expenditure, 
metabolic cages were used to examine whether Paskin-/- mice were hypermetabolic. Rutter et 
al. found Paskin-/- mice to consume more oxygen, to emit more carbon dioxide and to 
generate more heat (18). We encountered another discrepancy to these findings when we 
applied indirect calorimetry to Paskin+/+ and Paskin-/- mice. This discrepancy might be 
explained by the experimental setup, since the published phenotype was obtained from n=3 
animals with an adaptation time to metabolic cages of 4 hours only (18), whereas our n=6 per 
genotype with 5 days of adaptation did not reveal any difference in indirect calorimetry nor 
body temperature. Interestingly, the stated partial protection from HFD induced obesity is 
combined with better blood glucose clearance for male Paskin-/- mice compared to wildtype 
mice. On one hand, the protection against obesity and the lowered bodyweight might 
consequently lead to better glucose clearance, on the other hand this phenotype is very 
common in a huge number of animal models. Mechanistical insights derived from these 
results could come from the observations by Rutter and colleagues that the ATP production 
rate was higher in Paskin-/- than in Paskin+/+ soleus muscle fibres. However, neither an 
increase in mitochondrial number nor mass was observed that could account for this 
difference (18). A second finding of interest was the observation of increased fatty acid 
oxidation in L6 myoblasts with a PASKIN knockdown (18). Third, they found reduced 
triglyceride levels in the liver of Paskin-/- mice on HFD compared to Paskin+/+ animals along 
with reduced levels of components involved in fatty acid synthesis and homeostasis. Although 
we could not confirm the protection from development of hepatic steatosis, we found 
increased levels of triglycerides in plasma of Paskin+/+ animals but not in Paskin-/- samples. 
On the cellular level, we suspected AMP kinase to be the responsible regulator of energy 
balance, influenced by PASKIN. AMPK can inhibit adipocyte lipolysis and stimulate fatty 
acid oxidation in many tissues, both acutely via phosphorylation of ACC2 (40) and 
chronically by upregulating PGC-1α (and thereby mitochondrial biogenesis) (41-42). These 
effects are protective against the development of insulin resistance and type 2 diabetes and 
could explain the increased levels of ATP in permeabilised soleus muscle, all of which are 
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 published effects observed in Paskin-/- mice (18). On the other hand, hyperlipidemia leads to 
abnormal accumulation of triglycerides and fatty acids in muscle and liver that may disturb 
intracellular signaling pathways, leading to a decrease in insulin-stimulated glucose uptake 
(43). Furthermore, high levels of the saturated fatty acid palmitate affected the integrity of the 
endoplasmic reticulum in vitro, leading to cell death (44). When fatty acid oxidation was 
stimulated by pharmacological AMPK activation, this effect could be reversed. Whereas we 
found a tendency to elevated levels of phosphorylated (activated) AMPK (T172) in our mouse 
embryonic fibroblasts, this could not be confirmed in gastrocnemius extracts of Paskin-/- 
versus Paskin+/+ mice. Also, we did not observe any difference in intracellular ATP levels in 
our wildtype versus knockout mouse embryonic fibroblasts. The fact that Rutter et al. did not 
observe a difference in phospho-AMPK in liver extracts (18) is supported by our 
gastrocnemius data, suggesting that PASKIN acts independently of AMPK. This still leaves 
the open question, how PASKIN could interfere with homeostatic patways. One potential 
explanation could be impaired insulin stimulated glucose uptake in peripheral tissues. The 
major glucose transporter in muscle and adipose tissues is GLUT4, a transporter stored 
intracellularly in vesicles that translocate to the cell membrane upon insulin stimulation. This 
step is considered as rate limiting and is severely disrupted in type 2 diabetes. A mouse model 
with muscle specific disruption of GLUT4 showed insulin resistance (45). On the other hand, 
overexpression of GLUT4 in the diabetic db/db mouse model partially restores the effects of 
the metabolic syndrome (46). Insulin dependent translocation to the outer cell membrane 
involves insulin receptor signaling via PI 3-kinase activating Akt and PKCζ. Self-evidently, 
the vesicular transport and membrane fusion machineries or retrograde vesicular recycling 
machineries are required (47). Several signalling pathways regulate the multiple cellular 
functions required for the functionality of insulin stimulated glucose uptake. How PASKIN 
might be involved in a negative regulatory manner in one or more of these functions that 
result in a potential metabolic phenotype for the Paskin-/- mice, remains to be invesitgated. 
However, two findings may involve PASKIN in different signaling mechanisms. First, a 
knockdown of PASKIN in L6 muscle cells showed increased glucose and palmitate oxidation 
(18). Secondly, Paskin-/- livers show decreased triglyceride accumulation and a moderate 
downregulation for many genes involved in fatty acid uptake and synthesis with strong 
downregulation of fatty acid elongase, CD36 or PPARγ (18). Integrating these results into the 
phenotype of Paskin-/- mice also suggests a variety of potential regulatory functions of 
PASKIN. It is well known that insulin resistane may develop upon hyperlipidemia due to 
accumulation of fatty acid metabolites such as diacylglycerols and ceramides within insulin 
responsive tissues (48-49). Interestingly, for plasma of female Paskin-/- mice we saw 
increased levels of free fatty acids, which could be explained by the downregulation of fatty 
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 acid transporter CD36 in Paskin-/- livers. The decreased uptake of fatty acids together with 
increased fatty acid oxidation in Paskin-/- liver or muscle could therefore protect from insulin 
resistance and hepatic steatosis. Interestingly, these effects are normally regulated by AMPK. 
Activated AMPK leads to decreased lipogenic gene expression and fatty acid synthesis and to 
increased fatty acid oxidation largely due to increased mitochondrial biogenesis (50). For high 
fat diet fed subjects, intracellular lipids increase β-oxidation (49). However, for untrained 
situations the oxidative capacity of muscles is not increased and will lead to a lipid overload 
that accumulates intermediate products derived from β-oxidation (48). Thus, induced 
mitochondrial stress is thought to activate stress kinases leading to insulin resistance apart 
from less ‘active’ mitochondria. As we reported herein, that Paskin-/- and Paskin+/+ mice do 
not differ in volontary exercise using running wheels. It would be interesting to see whether 
Paskin-/- mice fed a high fat diet would show a better performance in forced running on a 
treadmill, both acutely as well as in physical exercise training to substantiate a role for 
PASKIN regulating lipid flux and mitochondrial stress response. Additionnal reasons for such 
experiments are contributed by the finding that PASKIN has also been shown to 
phosphorylate glycogen synthase (14), what could lead to a breakdown of cellular glycogen 
storage and could display a phenotype in muscle and liver. 
The different outcomes of the animal experiments in two different laboratories might point to 
subtle experimental parameters such as diet or housing that might differ. However, since we 
lack mechanistic explanations for a PASKIN function in energy homeostasis on a cellular 
level, it is difficult to track down the origins of the discrepancies. Further experiments on lipid 
metabolism in adipose tissue will certainly  shed light on open questions regarding  the 
Paskin-/- phenotype on  HFD. Finally, the identification of a potential activating (metabolic) 
ligand for PASKIN is long sought-for and would most certainly help to integrate PASKIN 
into the complex system of metabolic homeostasis. 
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ABSTRACT 
 
PASKIN is a PAS domain containing serine/threonine kinase which is ubiquitously 
expressed at low levels throughout the body with particularly high expression in 
testis. The yeast orthologs of PASKIN have been shown to be involved in protein 
translation and glucose homeostasis. Recent findings have confirmed PASKIN as a 
regulatory kinase in mammals. Accordingly, PASKIN has been reported to be 
involved in the regulation of insulin expression in the β-cells of pancreatic islets of 
Langerhans as well as in the secretion of glucagon in α-cells. Furthermore, Paskin-/- 
mice have been shown to be partially protected from obesity and detrimental 
effects of the metabolic syndrome upon feeding a high fat diet. However, the 
pathways conferring these phenotypes remain unclear. A current model for 
PASKIN activation speculates about a small endogenous ligand binding to the PAS 
domain and de-repressing the kinase domain. Recently, we identified 
monophosphorylated phosphatidylinositides as potential ligands of PASKIN. This 
encouraged us to investigate PASKIN expression in different cell lines and to 
determine its subcellular localisation. 
9   Manuscript V (unpublished)
-  119  -
 INTRODUCTION 
 
Per-ARNT-Sim (PAS) domains are widespread in sensory proteins of bacteria and archaea 
(1). In nitrogen fixating bacteria of Rhizobium and Bradyrhizobium species the oxygen 
sensing protein FixL contains a heme moiety bound to the PAS domain where oxygen binds 
to ferrous iron, induces conformational changes and inhibits the histidine kinase domain (2). 
In contrast, under oxygen-free conditions, the kinase is de-repressed and induces transcription 
of genes involved in nitrogen fixation. We and others identified a mammalian PAS protein 
with a highly similar PAS domain to FixL (3-4). The two N-terminal PAS domains of this 
protein were linked to a serine/threonine kinase domain, and therefore this protein was named 
PASKIN or PAS kinase. Similar to FixL, a current model for PASKIN function suggests, that 
the PAS domain of PASKIN requires binding of a small endogenous ligand to activate the 
kinase by de-repression (5). Functionally the yeast orthologs Psk1 and Psk2 have been shown 
to regulate glycogen and trehalose synthesis and phosphorylate three translation factors, 
implicating a role for Psk proteins in linking protein translation and energy homeostasis (6).  
Using a human tissue array, we found that PASKIN mRNA was ubiquitously expressed with 
particulary high levels in testis and brain (3). These results were confirmed by quantitative 
PCR of mouse tissue samples, where the expression levels in testis were 100-fold higher than 
in any other tissue, but showed moderately high expression in brain, bone marrow and 
thymus, as well (7). Functionally, most findings were derived from pancreatic α- and β-cells, 
where PASKIN has been reported to be involved in the upregulation of insulin (8-9)  and 
inhibited secretion of glucagon (10). Furthermore, we previously generated Paskin-/- mice by 
replacing the kinase domain of PASKIN with a lacZ-neo fusion construct, resulting in a 
mouse model with no apparent phenotype under standard conditions (11). However, when fed 
a high fat diet, these mice were reported to be partially protected from obesity and detrimental 
effects of the metabolic syndrome, including insulin resistance (12). Yet, we could only 
confirm some of the results of the knock-out animals (13). However, all results involving 
PASKIN in metabolism still lack mechanistical explanations and no activating small 
molecular weight ligand has been identified. Because we found that PASKIN binds to 
monophosphorylated phosphatidylinositides (submitted), we were interested, in what cell 
types and cell culture models PASKIN is expressed. Phosphatidylinositides are mainly 
regulated by lipid kinases and phosphatases and provide hallmarks for intracellular 
compartments (14). Whereas PtdIns(4)P is predominantly localised at the Golgi apparatus, 
PtdIns(3)P is enriched in vesicles of the endosomal compartment. We were therefore 
interested in the subcellular localisation of PASKIN in different cell models to find links to 
phosphatidylinositide binding. This might improve our understanding of potential functions of 
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 PASKIN and reveal further information about the potential mechanistics in metabolic 
homeostasis. 
 
MATERIALS AND METHODS 
 
Cell culture 
HeLa, Hek293, HepG2, MEFs and C2C12 myoblasts were cultured in Dulbecco’s modified 
Eagle’s media (Sigma, D6429) containing 10% FCS; 33.1.1, K-46 and HL-60 were cultured 
in Iscove’s modified Dulbecco’s media (Sigma, I3390) with 10% FCS; Jurkat, THP-1 and 
RAW264.7 were cultured in RPMI 1640 (Sigma, R8758) with 10% FCS. C2C12 myoblasts 
were differentiated to myotubes at approximately 80% confluency by changing media to 
DMEM supplied with 2% horse serum for 4 days, changing the media every 24 hours. AB81 
cells were grown as described elsewhere (15) in RPMI 1640 (Gibco, 52400) containing 10% 
FCS and insulin-transferrin-selenite supplement (Roche Applied Sciences) at 33°C and 
differentiated at 80% confluency by changing incubation temperature to 37°C for 60 hours. 
 
Immunoblotting 
Cells were harvested and whole cell lysates were generated by heating the cells in PBS/1% 
SDS/50 mM β-mercaptoethanol for 5 minutes at 95°C as described previously (16). 
Concentrations of supernatants were determined by Bradford assay (17). Proteins were 
separated by SDS-PAGE and transferred onto nitrocellulose membranes (Amersham 
Biosciences). For immunoblot analysis, anti-mPASK (Cell signaling) and anti-β-actin 
(Sigma) were used. As secondary antibodies, polyclonal goat anti-mouse or anti-rabbit 
antibodies coupled to horseradish peroxidase (Pierce) were used and chemiluminescence was 
recorded with a CCD camera (LAS-4000, Fujifilm).  
 
mRNA quantification 
Total RNA from cultured cells was isolated as described previously (18). Human PASKIN, 
human L28, mouse PASKIN and mouse S12 mRNA were determined by RT-qPCR. RNA 
was reverse transcribed with StrataScript III (Stratagene) and qPCR was performed using a 
SYBRGreen qPCR reagent kit (Sigma) on a MX3000P PCR light cycler (Stratagene) 
according to the manufacturer's instructions. Primers (Microsynth, Switzerland) used were: 
hPASKINfwd 5'-ggaactgctccagtttcctg-3' and hPASKINrev 5'-ggatctccgcttaatgacca-3'; 
mPASKINfwd 5'-agggtccaagaattgacgtg-3' and mPASKINrev 5'-tgactgctcaccatcctctg-3'; 
ribosomal protein L28, hL28fwd 5'-ggaactgctccagtttcctg-3' and hL28rev 5'-
ggatctccgcttaatgacca-3'; mouse ribosomal protein S12, mS12fwd 5’-gaagctgccaaagccttaga-3’; 
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 mS12rev 5’aactgcaaccaaccaccttc-3’ Dilution series of the corresponding gel-isolated PCR 
products were used to obtain standard curves.  
 
Skeletal muscle biopsies 
Informed written consent was obtained from donors. The experimental protocol was approved 
by the ethics committee of the canton of Zurich in accordance with the ethical standards laid 
down in the Declaration of Helsinki for human experimentation. Percutaneous biopsies from 
the middle region of the nondominant vastus lateralis muscle were obtained using a 6-mm 
Bergström needle (Dixons Surgical Instruments, Essex, UK) with suction applied and 
immediately mounted in embedding medium (Tissue-Tek, Sakura) and snap frozen in 
isopentane cooled with liquid nitrogen for subsequent cryosectionning at 12 µm and 
immunofluorescence analysis. 
 
Laser scanning fluorescence microscopy 
Immunofluorescence stainings of cells were performed as described previously (19). Cells 
were cultivated on microscope coverslips, washed twice with ice-cold PBS, fixed on ice for 
30 min with 4% paraformaldehyde, and permeabilized with 0.1% saponin (Merck) in PBS. 
PASKIN was detected using anti-PASKIN antibody (ABR) and visualized with goat anti-
mouse AlexaFluor-488 (Molecular Probes, Invitrogen). F-actin was stained using AlexaFluor-
635 phalloidin (Molecular Probes, Invitrogen) and 4′,6-diamidino-2-phenylindole (Sigma) 
was used to stain nulei. The slides were embedded in Mowiol (Calbiochem) and analyzed by 
confocal laser scanning microscopy (SP2, Leica Microsystems).  In silico analysis of 
colocalisation was performed using Imaris 7.0 software (Bitplane).  
 
RESULTS 
 
Basal expression levels of PASKIN are elevated in lymphocytes 
A high expression of PASKIN in testis and brain has been repeatedly reported (3,7,11). 
However, previously reported functions for PASKIN in metabolism have been derived from 
observations in cell culture models from pancreatic cells, i.e. the mouse β-cell line Min6 (8-9) 
and the human α-cell line alpha-TC1-9 (20) as well as L6 rat skeletal muscle cells (12). To 
find other potential cell culture models, we performed a database search using Gene Atlas 
(http://biogps.gnf.org). In the probe set of a human Affymetrix U133 array that includes 
39.000 hybridisation probes, PASKIN expression in different organs is shown (Fig. 1). 
Interestingly, the highest expression of PASKIN was not observed in testis, even though it 
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 was among the strongest expressing (3 times over median), but in lymphatic cells, especially 
CD8+ cytotoxic T-cells and CD4+ T-helper cells laying >40 times over the median. 
 
Fig. 1. PASKIN expression in different human tissues. The database entry for the oligo 213534_s_at 
from the human affymetrix chip U133A for PASKIN for different organ samples shows increased 
expression in lymphatic cells and organs, whereas the previously reported primary site of PASKIN 
expression, the testis, only appear 3-fold over median. 
 
Intrigued by this finding, we were interested to test various established human and mouse cell 
lines for PASKIN mRNA and protein expression, focusing on lymphoid and myeloid cell 
types. For this purpose, we chose six human cell lines (Fig. 2A/B) and seven mouse cell lines 
(Fig. 2C/D). 
 
Fig. 2. PASKIN mRNA and protein levels in various cell lines. Cell lines tested were analysed by 
quantitative real time PCR (A, B) or Western blot using an antibody directed against mouse Paskin 
with crossreactivity to human PASKIN (C). Shown are mean&SD of n=3 independent experiments for 
mRNA levels and a representative Western blot. 
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 Expression of PASKIN mRNA in human cell lines indeed revealed strongest expression in 
HL-60, a neutrophilic promyelocyte cell line and more than two fold higher expression for the 
T-cell leukemic Jurkat cells and THP-1 monocytes than for HeLa and Hek293. Confirming 
this result, we observed the highest expression of PASKIN in mouse cell lines for the 33.1.1 
pre-B cell line, K-46 B-cells and RAW264.7 macrophages. Regarding protein expression 
levels, the differences in mRNA levels appeared to be blunted but keeping elevated PASKIN 
levels in THP-1 monocytes, 33.1.1 pre-B cells and surprisingly for differentiated C2C12 
myofibers. We tested whether PASKIN mRNA levels were affected when the lymphoid and 
myeloid cell lines were treated with lipopolysaccharides (LPS) as proinflammatory stimulus. 
However, mRNA levels appeared not to be induced (data not shown). 
 
PASKIN is localised along the F-actin cytoskeleton 
As we found that PASKIN binds to monophosphorylated phosphatidylinositides (manuscript 
in preparation), we were interested in the subcellular localisation of PASKIN. For this 
purpose, we performed immunofluorescence experiments in HeLa cells, a cell line showing 
moderate PASKIN expression with the advantage of being adherent cells with a defined 
cellular structure compared to suspension cell lines. 
 
Fig. 3. PASKIN co-localises with filamentous actin at the edges of HeLa cells. PASKIN subcellular 
localisation was determined by confocal laser scanning microscopy on HeLa cells co-stained with 
phalloidin (stain for filamentous actin) (A). A strong signal for PASKIN and co-localisation occurred 
mainly at the edges of the cells, potentially representing focal adhesion sites. (B) The scatter plot 
shows the intensity distribution for the PASKIN (green) and the phalloidin (red) channel. From this 
plot, the region with the strongest intensities in both channels was selected (shaded square) to 
generate the artificial co-localisation image confirming a strong staining at the edges of the cells. 
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 Interstingly, when applying confocal microscopy focusing to the lowest layers of the cell, we 
observed a strong staining for focal adhesion sites and filopodial structures at the edges of the 
cells correlating with the signal for the phalloidin staining for filamentous actin (Fig.3). 
However, as expected for a kinase and published previously, PASKIN could also be detected 
in the cytoplasm (21). To confirm the signal in filopodial structures we aimed for staining of 
another cell line, namely the AB-81 podocyte cell line that proliferates at 33°C growth 
temperature and differentiates to podocytes at 37°C forming cytoplasmic extensions of 
lamellipodial character (15). However, whereas PASKIN was not explicitly expressed at cell 
edges, we observed PASKIN accumulation along the F-actin cytoskeleton in this cell line 
(Fig.4). 
 
Fig. 4. PASKIN localises along the actin cytoskeleton in differentiated AB-81 podocyte cells. PASKIN 
subcellular localisation was determined by confocal microscopy on differentiated AB-81 cells, 
immuno-stained for PASKIN and phalloidin (A). Colocalisation occurred along the filamentous actin 
cytoskeleton. Similar to Fig. 3, a co-localisation channel was generated (B). 
 
To find a physiological link between F-actin co-localisation with PASKIN and a potential 
metabolic function, we stained human vastus lateralis skeletal muscle cross-sections. 
Interestingly, PASKIN seems to be highly expressed in skeletal muscle fibres compared to the 
surrounding connective tissue (Fig. 5), supporting the elevated expression in C2C12 
myotubes (Fig. 2). The distribution of PASKIN within the vastus lateralis fibres resembles 
the distribution of myosin heavy chain that is used to determine the fiber types (22). 
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Fig. 5. PASKIN expression in human skeletal muscle cross-sections. Cross-sections from human 
vastus lateralis muscle were stained for PASKIN and phalloidin. The staining resembles published 
against myosin heavy chain isoform staining which are used to determine the fibre type of skeletal 
muscles (22).  
 
DISCUSSION 
 
We herein aimed to answer two major questions. First, we were interested in identifying cell 
lines of human origin that show elevated basal levels of PASKIN expression, as previously 
published findings are all based on either mouse or rat cell lines or primary human material. 
Secondly, we aimed to investigate the subcellular localisation of PASKIN, since we recently 
discovered that PASKIN binds to phosphatidylinositol monophosphates (submitted). 
Using the Gene Atlas, we were surprised to find high PASKIN expression in lymphatic cells, 
as PASKIN has not been involved into processes of the immune response before. Indeed, 
testing immune cell lines for mRNA and protein expression confirmed this finding. As we yet 
lack information, how PASKIN expression is regulated, activated and what might be the 
potential intracellular ligand for the PAS domain, it was intriguing to test how PASKIN 
expression levels were altered when lymphatic cells were stimulated. Therefore we used 
classical Toll like receptor 4 activating lipopolysaccharides (LPS). However, we did not find 
any differences in PASKIN expression levels after treatment (data not shown). 
To address the question of subcellular localisation, we switched the model from immune cells 
to HeLa. Interestingly, we found PASKIN to be localised at the edges of the cell in structures 
resembling to focal adhesion sites. The co-staining with phalloidin revealed that PASKIN co-
localises with filamentous actin at the lower layers scanned, and was also slightly enriched in 
filopodial structures. To confirm this finding, we were interested in the expression levels of 
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 PASKIN in AB-81, a podocyte cell line of human origin that proliferates at 33°C and 
differentiates at 37°C forming lammellipodia-like structures. Interestingly, we found PASKIN 
localisation in differentiated (and also undifferentiated cells, data not shown) AB-81 cells 
along the filamentous actin cytoskeleton rather than at the cell periphery. Podocytes are 
known for strongly remodelling thecytoskeleton which defines their cell shape, mediates cell-
cell contacts in the glomeruli and might even contract upon shear stress induced by hydraulic 
pressure. This enables podocytes to control the rate of filtration within glomeruli (23). Further 
experiments might disclose the involvement of PASKIN in F-actin reorganisation or vesicular 
trafficking along the filaments. 
Another potential function would explain our recent finding that PASKIN binds to 
PtdIns(3)P, PtdIns(4)P and PtdIns(5)P. As especially PtdIns(4)P is formed in the Golgi 
apparatus and PtdIns(3)P is enriched on vesicular and endosomal structures of cells (14), the 
association of PASKIN to the cytoskeleton might represent the in vivo situation of 
phosphatidylinositide binding.  
F-actin cytoskeleton association or processes involving membrane dynamics and sorting may 
also help to explain several metabolic functions of PASKIN. We previously reported that the 
elongation factor eEF1A1 is a target of PASKIN (21), and it is interesting to note that 
eEF1A1 was shown to bind filamentous actin directly and colocalises with phalloidin staining 
at the cellular membrane (24). Therefore, it is hypothesized that eEF1A1 and other actin-
binding components of the translational machinery might concentrate along the cytoskeleton 
to optimise translation in a spatially restricted manner (25). Other reports on PASKIN 
function in higher organisms speculate about an inhibitory role for PASKIN in glucagon 
secretion in pancreatic α-cells (10), or an activating role in insulin secretion in β-cells (8), 
even though we published conflicting results (7). As secretion of insulin and glucagon 
granules require an intact pool of PtdIns(4,5)P2 (26-28), it is tempting to speculate that 
PASKIN might influence the precursors PtdIns, PtdIns(4)P or PtdIns(5)P, and that this could 
explain the moderate effects that might lead to conflicting results between our lab and the 
results published by da Silva Xavier et al. (8). 
Using our Paskin-/- mouse model, peripheral effects of glucose homeostasis have been 
reported as well. When fed a high fat diet, Paskin-/- mice seem to be protected from 
detrimental effects of the metabolic syndrome with less glucose intolerance (12). As we 
herein present a robust expression of PASKIN in vastus lateralis skeletal muscle cross-
sections, a potential regulatory function in glucose uptake might originate from the secretion 
of GLUT4 containing vesicles. Indeed, GLUT4 translocation not only relies on the formation 
of PtdIns(3,4,5)P3 by PI 3-kinase but also involves other phosphatidylinositides such as the 
PASKIN binding PtdIns(3)P, PtdIns(4)P and PtdIns(5)P that seem to be important for vesicle 
formation and vesicular transport (29). As Paskin-/- mice showed improved blood glucose 
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 uptake in both glucose and insulin tolerance tests, PASKIN might play an inhibitory role for 
GLUT4 containing vesicle exocytosis by modulating processes of vesicle formation, transport 
or fusion via phosphatidylinositide signalling. Most interestingly, PASKIN staining of the 
vastus lateralis skeletal muscle revealed a picture resembling to myosin staining (22). Myo1C 
can be phosphorylated by CaMKII upon insulin stimulation and has been reported to enhance 
GLUT4 translocation (30-31), and therefore, it might be interesting to investigate, whether 
PASKIN, itself a member of the CaM kinase superfamily, might influence GLUT4 
translocation as well. Staining of GLUT4 in insulin stimulated myocytes of Paskin-/- and 
Paskin+/+ mice should clarify such a role for PASKIN in glucose uptake. 
Conclusively, the results herein might present a link between phosphatidylinositide signalling 
and subcellular localisation. The association of PASKIN to the F-actin cytoskeleton provides 
new insight in potential cellular mechanistics that to date are unknown for PASKIN. Future 
research should also clarify, whether metabolic phenotypes for Paskin-/- mice might derive 
from phosphatidylinositide-signalling dependent effects. 
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 10 CONCLUSIONS 
 
PASKIN is a PAS domain containing serine/threonine kinase. Many bacterial and archaeal 
PAS domains are known to bind a ligand that induces conformational changes in the sensory 
PAS fold acting on effector domains that transduce the signal. For PASKIN, a model was 
proposed, where the PAS domain represses the kinase domain which in turn is de-repressed 
upon binding of a putative  and yet unidentified ligand (1). Very little is known about 
potential phosphorylation targets of PASKIN. First hints were derived from the yeast 
orthologue Psk1 that regulates glycogen storage and cell wall glucan synthesis by 
phosphorylating glycogen synthase and UDP-glucose pyrophosphorylase as well as targets 
involved in protein translation (2). Analogously, mammalian glycogen synthase has been 
identified as a target of PASKIN (3). Another target found was pancreatic and duodenal 
homeobox protein 1 (PDX-1) (4) an important transcription factor for the expression of 
insulin in pancreatic β-cells. Accordingly, it has been proposed that PASKIN is involved in 
transcriptional regulation and secretion of insulin in pancreatic β-cells (5-6) as well as 
secretion of glucagon in α-cells (7). Further metabolic roles have been suggested due to the 
fact that Paskin-/- mice could be partially protected from high fat diet induced obesity and 
insulin resistance (8,4). 
Based on all these findings, we were interested in addressing several questions to elucidating 
PASKIN function: 
- What is the substrate specificity of PASKIN and what are potential targets that may 
play a role in metabolism or protein translation? 
- What could be a potential ligand for the PAS domain of PASKIN and how would 
such a ligand influence kinase activity? 
- What could be the mechanisms leading to a metabolic phenotype in Paskin-/- 
knockout mice? 
 
PASKIN substrate specificity and novel kinase targets 
Very recently, the structure of the kinase domain of PASKIN has been resolved and 
experiments regarding substrate specificity have been performed (9). In this report, a peptide 
screening revealed preference for basic residues at positions -5 and -2 and very strong 
preference for an arginine at position -3 relative to a serine or threonine residue. We herein 
present results of a microarray screening where target peptides of various kinases were 
spotted on a slide and were phosphorylated by recombinant PASKIN in vitro. Sorting of the 
phosphorylated hits confirmed that PASKIN kinase target peptides displayed  an arginine at 
position -3 and that they seemed to have a similar consensus target sequence to protein kinase 
A and protein kinase C, themselves sharing arginines at position -3. In refining our screening 
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 to confirm the findings from the short peptides of the microarray, we used longer peptides 
with a biotin tag and phosphorylated them in vitro by PASKIN. In this screening, we 
identified and validated targets of interest: the metabolic targets 6-
phosphofructokinase/fructose-2,6-bisphosphatase and phosphorylase kinase β, the 
mitochondrial iron transport protein frataxin, the T-cell transcription factor nuclear factor of 
activated T-cells c4, the PAS domain containing voltage gated potassium channel hERG and 
ribosomal protein S6. Since it was known from yeast, that PASKIN might be involved in the 
regulation of protein translation (2), we were particularly interested in the latter. The classical 
view of S6 function involved its phosphorylation in upregulating translation of a specific 
subset of mRNAs that display a 5’-terminal oligopyrimidine tract and therefore are called 5’-
TOP mRNAs (10). Many 5’-TOP genes are coding for components of the translational 
machinery itself, such as initiation factors, elongation factors and ribosomal proteins (10-11). 
Therefore, it was thought that phospho-S6 could upregulate total protein translation. 
Nowadays, however, it is rather thought that S6 phosphorylation might just coincide with the 
activation of the mTOR pathway in response to growth stimuli rather than cause increased 
translation (12), and it has even been suggested that phosphorylated S6 might be a negative 
feedback and therefore inhibitory to translation (13). As we were able to show that S6 is a 
target for PASKIN in vitro, we wondered whether we could detect differences of 
phospohrylation of S6 in Paskin-/- versus Paskin+/+ MEFs. Not unexpectedly, S6 was highly 
phosphorylated in Paskin-/- MEFs most likely by p70S6 kinases. Therefore we decided to 
make use of S6K1/S6K2 null MEFs (14) and look for differences in S6 phosphorylation upon 
overexpression of PASKIN. Indeed, with this approach we could confirm increased 
phosphorylation of S6 at S235/236. However, phosphorylation of S6 did not reach the levels 
of wild type MEFs and we therefore assume that upon stimulation of PASKIN by an 
endogenous ligand, this effect could be strengthened. 
We herein also present data that the eukaryotic elongation factor 1A1 is an interaction partner 
of PASKIN. Furthermore we could demonstrate PASKIN-mediated phosphorylation of 
eEF1A1 at T432 in vitro and functionally confirmed that PASKIN leads to increased total 
translation in a cell free system (15). Besides a role of eEF1A1 in translation, several 
additional functions of this protein have been suggested (see Introduction). As we herein 
present immunofluorescence data showing PASKIN co-localisation with the actin 
cytoskeleton, observations involving eEF1A1 in the context of actin bundling and 
remodelling are of particular interest. Indeed, eEF1A can interact directly with filamentous 
actin and colocalises with a phalloidin-staining at the edges of the cell (16). It is hypothesized 
that such effects may spatially restrict the translation of mRNAs and enrich also other 
cytoskeleton associated components of the translational machinery (17). Accordingly, we 
could show a colocalisation of PASKIN with eEF1A in the midpiece of the sperm tail, where 
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 cytoskeletal structures are highly abundant (15). Most interestingly, it has been shown that 
eEF1A and ribosomal protein S6 both colocalise with glycine receptors in neurons (18). 
Along with colocalisation, phosphorylation of S6 could be detected upon glycine receptor 
activation, mediated by a yet unidentified kinase as well as cytoskeleton associated 
localisation of both eEF1A1 and S6 upon synaptic activity or in aging neurons. Hence, it is 
tempting to speculate that PASKIN might be involved in the phosphorylation of S6 in 
neurons and further experiments are needed to identify a function for PASKIN in actin 
bundling, cytoskeletal dynamics and/or vesicular transport.   
 
PASKIN binds to phospholipids 
Since PASKIN shows similarities to PKCδ in substrate specificity and both enzymes are able 
to phosphorylate eEF1A1 at T431 (19), we were wondering whether PASKIN would require 
the same classical phospholipid co-activators as PKCδ. Indeed, we could show that a number 
of phospholipids were activating PASKIN kinase activity. Protein lipid overlay assays, 
however, did not confirm strong binding by most of these phospholipids, but surprisingly we 
identified PtdIns(3)P, PtdIns(4)P and PtdIns(5)P as strong binding partners of PASKIN. We 
hoped that we might have discovered the long sought-after activating ligand for the PAS 
domain of PASKIN, however, we found that PASKIN bound to the phosphatidylinositides 
through the kinase domain and not through the PAS domain. Furthermore, we tested the 
effect of phosphatidylinositides on PASKIN autophosphorylation and target phosphorylation 
in vitro. PtdIns(3)P, PtdIns(4)P and PtdIns(5)P increased autophosphorlylation in 
concentration dependent manner, whereas target phosphorylation was inhibited by all 
phospholipids. This suggests a multiple regulation of PASKIN activity that would not only 
involve PAS domain binding of an activating ligand but eventually repression of kinase 
activity by phospholipids. 
Phosphatidylinositides usually diverge in their occurrence in different membrane structures. 
Whereas PtdIns(4)P is very abundant in the endoplasmic reticulum and PtdIns(3)P in the 
endosomal compartment, the abundance of PtdIns(5)P is very low, and little is known about 
actual binding domains and particular functions of this phospholipid (20). As we also 
investigated subcellular localisation of PASKIN and found localisation of PASKIN at cellular 
edges in HeLa cells as well as along the actin cytoskeleton in the AB-81 podocyte cell line, 
we speculate about a role of PASKIN in vesicular trafficking and potentially in actin 
cytoskeleton dynamics. To fortify these findings, cellular experiments overexpressing 
phospholipid binding domains could eventually displace PASKIN from its subcellular 
localisation and provide functional links. Potential physiologically relevant functions 
integrating metabolism and phospholipid binding will be discussed later in this text. 
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PASKIN in metabolic homeostasis 
Besides functions in pancreatic α and β-cells (see Introduction), PASKIN also regulates 
glycogen storage (3). Therefore, we expected a potential metabolic phenotype in muscle or 
liver, the main glycogen sythesizing organs. Feeding of a high fat diet (HFD) to induce the 
metabolic syndrome and disregulate insulin signaling is a standard method. Observing growth 
upon feeding a HFD of 45% fat by calories, we herein present results that Paskin-/- mice were 
partially protected from HFD induced obesity, and were partially protected from development 
of glucose intolerance, results reported also by the group of Jared Rutter (8). Rutter et al. 
could also show a better glucose clearance for high fat diet fed Paskin-/- mice and better 
palmitate and glucose oxidation in permeabilised Paskin-/- soleus muscle. Therefore, for 
Paskin-/- mice, a hypermetabolic phenotype was suggested. We assumed that such a 
phenotype could be increased when feeding a high fat diet of 60% fat by calories. However, 
as presented in this thesis, we failed in conforming this finding, as the animals showed similar 
body weight gain. A possible explanation might be that body temperature or energy 
expenditure could be higher in Paskin-/- mice. Therefore we decided to perform indirect 
calorimetry experiments and implanted sensors for continuous measurement of body 
temperature into 60% high fat diet fed male mice. However, not only body weight but also 
body temperature and the calorimetric parameters did not differ between Paskin-/- and 
Paskin+/+ mice and we did not observe any differences in body fat distrubution, neither. 
Cellular energy homeostasis is mainly regulated by AMPK, a kinase sensing the ATP/AMP 
ratio. To deduce a role of PASKIN as a potential counterplayer of AMPK we analysed MEFs 
derived from Paskin-/- and Paskin+/+ embryos. Making use of a phospho-AMPK (T172) 
antibody, we found, that Paskin-/- MEFs displayed higher levels of activated AMPK, 
however, intracellular ATP concentrations remained similar. As MEFs might not represent an 
appropriate model for cellular energy homeostasis, we tried to confirm this finding in 
gastrocnemius extracts of Paskin+/+ and Paskin-/- mice, however, we did not observe any 
differences, neither. Rutter et al. confirmed our results in soleus muscle extracts, suggesting 
that differences might be independent from AMPK (8). As they showed increased glucose 
oxidation in permeabilised soleus muscle, it was suggested that PASKIN regulates cellular 
energy homeostasis independent from AMPK. Overall, the differences reported in energy 
homeostasis, glucose and palmitate oxidation and eventually differing ATP levels would 
suggest experiments with forced running on a treadmill eventually including physical training 
of the mice potentially showing better exercise performance for the Paskin-/- genotype. 
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 Metabolism and phospholipids, it’s all about secretion... 
In β-cells it has been repeatidly shown that PASKIN induces insulin expression and 
consequently also secretion (5-6), whereas recent findings propagate that in α-cells PASKIN 
inhibits secretion of glucagon directly without altering glucagon peptide levels (7). Insulin in 
β-cells and glucagon in α-cells are stored in granules for immediate release upon generation 
of action potentials by Na+ or Ca2+ (21-22). However, besides a depolarisation-dependent 
trigger, a machinery for membrane docking and fusion are required to release the peptide 
hormones. Much more is known about the secretion of insulin granules than about glucagon 
secretion. Insulin secretion requires an intact pool of PtdIns(4,5)P2. This has been 
demonstrated by the overexpression of pleckstrin homology domains reducing the availability 
of PtdIns(4,5)P2 and by knock-downs of PtdIns(4,5)P2 generating type II PI4-kinase β (23), 
type I PIP5-kinases α (24) and γ (25) that all reduced glucose stimulated insulin secretion. For 
a PIP5-kinase Iα knock-down it has been demonstrated that the F-actin cytoskeletal structure 
was disrupted, which was accounted for the inhibition of exocytosis. Accordingly, a protein 
called exophilin4 has been involved in targeting glucagon granules to the plasma membrane 
through its C2A domains that bind phosphatidylserine and PtdIns(4,5)P2 (26). As obviously 
the generation of a PtdIns(4,5)P2 pool relies on the availability of its precursors PtdIns, 
PtdIns(4)P and PtdIns(5)P, PASKIN might directly inhibit hormone secretion at the level of 
granule formation, transport or fusion. To connect granule secretion with PASKIN 
phospholipid binding, it would be interesting to modulate phospholipid pools by 
overexpression of pleckstrin homology domains and knockdowns of lipid kinases in Paskin+/+ 
and Paskin-/- islets and microscopically follow an eventual relocalisation of PASKIN. 
Given the fact that Paskin-/- mice are partially protected from high fat diet induced obesity 
under certain laboratory conditions but not under others, might reflect a very subtle role for 
PASKIN that depends on minor differences in age, diet or housing. The observation that 
Paskin-/- mice showed better glucose clearance than Paskin+/+ animals might arise from 
differences in insulin stimulated glucose uptake in peripheral tissues. In skeletal muscle and 
adipose tissue, GLUT4 is the major glucose transporter and is stored in vesicular structures 
that translocate to the cell surface upon insulin stimulation (27). This translocation seems to 
depend on insulin concentration and is opposed by re-integration into sorting endosomes. It is 
therefore tempting to speculate that Paskin-/- mice have an improved blood glucose uptake 
due to either an inhibitory function of PASKIN in GLUT4 exocytosis or an active role for 
PASKIN in GLUT4 recycling.  It is well acknowledged that upon stimulation of the insulin 
receptor, both PI3-kinase dependent (via PtdIns(3,4,5)P3 generation and activation of Akt) and 
independent processes are required for the release of GLUT4 storage vesicles to the cell 
membrane. Besides the importance of PtdIns(3,4,5)P3, however, information accumulates that 
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 GLUT4 vesicle translocation involves also the PASKIN binding PtdIns(3)P, PtdIns(4)P and 
PtdIns(5)P. PtdIns(3)P and PtdIns(5)P levels are transiently increased in response to acute 
insulin and both phospholipids can increase GLUT4 translocation to the outer membrane (28-
30). Interestingly, PtdIns(5)P induces a breakdown of actin stress fibers and leads to F-actin 
reorganisation that is thought to accelerate translocation of GLUT4 (30). The role of 
PtdIns(4)P in GLUT4 translocation is less clear. GLUT4 containing vesicles that display a PI 
4-kinase activity are not reactive to insulin (31). However, it was shown that overexpression 
of PI 4-kinase IIIβ negatively affects GLUT4 translocation, supporting a role of PtdIns(4)P in 
early steps of vesicle formation rather than in later steps of insulin responsive secretion of 
vesicles (32). Interestingly, we observed a robust expression of PASKIN in human skeletal 
muscle cross sections resembling to myosin stainings, and further experiments could clarify 
whether cells overexpressing PASKIN might inhibit insulin stimulated GLUT4 translocation. 
Conversely, we found a trend towards elevated levels of free fatty acids in the plasma of HFD 
fed Paskin-/- mice. As a similar mode of translocation as for GLUT4 occurs for the fatty acid 
transporter CD36 and FATPs (Fatty Acid Transport Proteins) (33), our observation might 
reflect a reduced uptake of fatty acids to peripheral organs, suggesting the possibility of an 
opposite, activating role for PASKIN in fatty acid uptake. However, it has also been shown 
that Paskin-/- livers have reduced CD36 mRNA levels (8), and since adipose tissue has not 
been investigated in the Paskin-/- mouse model yet, it remains a completely open question, 
what role PASKIN plays in whole body lipid homeostasis. 
 
In conclusion we found that the consensus sequence for PASKIN resembles the ones from 
PKA and PKC, requiring an arginine residue at position -3 relative to a serine or threonine 
residue. In accordance with findings from yeast, we could identify novel mammalian targets 
of PASKIN involved in metabolism and translation and characterised the phosphorylation of 
eEF1A1 and S6. Furthermore, we found that PASKIN was able to bind to 
monophosphorylated phosphatidylinositides which inhibit target phosphorylation and might 
represent another layer of PASKIN regulation. Subcellularly, we found increased PASKIN 
localisation at the edges of HeLa cells, probably focal adhesion points, and along the actin 
cytoskeleton in differentiated podocytes, suggesting that PASKIN might be involved in 
dynamic processes of membranes such as vesicular trafficking. As we found metabolic kinase 
targets of PASKIN in vitro, we made use of Paskin-/- mice fed high fat diets. When fed a diet 
of 45% fat by calories, we observed a slight partial protection of Paskin-/- mice from 
detrimental effects of the metabolic syndrome, however, feeding a diet of 60% fat by calories 
did not increase but rather cleared away the differences between Paskin-/- and control animals. 
The cellular mechanistics underlying the PASKIN function as a metabolic sensor remain to be 
elucidated and regulation by phospholipids opens a novel perspective for future research. 
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